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Abstract 
Detection and control of T. brucei s.l. in the historic sleeping sickness foci of NW Uganda 
Lucas J. Cunningham 
Gambian human African trypanosomiasis (gHAT) is a deadly disease caused by Trypanosoma 
brucei gambiense transmitted by tsetse flies (Glossina) and is found only in West and 
Central Africa. The NW of Uganda has been known as a focus of gHAT since the early 20th 
Century but the number of new cases has reduced from 948 in 2000 to 4 in 2015. NW 
Uganda is therefore a good testing ground for alternative control and surveillance strategies 
that could be employed at other foci in the drive towards elimination. 
 
Focussing on the Koboko foci of gHAT in NW Uganda, this study aimed to: (i) assess the 
prevalence of T. b. gambiense in the vector and potential reservoir host animals (cattle and 
pigs), (ii) develop a system for xenomonitoring gHAT and (iii) assess the impact of Tiny-
Targets, a novel vector control technology, on the transmission of salivarian trypanosomes 
amongst local cattle. 
The tsetse population was sampled continuously from April 2013-July 2014 using pyramidal 
traps (four traps operated on average 18 days/month).  A total number of 12,532 G. f. 
fuscipes were captured. A subset of these tsetse (6,664) were analysed for the presence of 
trypanosomes using either microscopy and/or molecular methods. No tsetse tested were 
found to be positive for T. b. gambiense but T. brucei s.l. (2%), T. vivax (3%) and T. 
congolense (4%) were detected.  PCR-based analyses of bloodfed tsetse (131) showed that 
the predominant hosts were humans (37%), cattle (39%) and Monitor lizards (15%).  A 
xenomonitoring system based on commercially available loop-mediated isothermal 
amplification (LAMP) kits were tested for their suitability to detect T. brucei s.l. DNA in 
tsetse. The study demonstrated that the LAMP kits were highly sensitive, being able to 
detect the equivalent of 0.1 trypanosome/mL. They could also detect T. brucei s.l. DNA in 
tsetse midguts six days-post ingestion.  Analyses of 2,877 cattle from areas where Tiny 
Targets were present or absent using microscopy and PCR-based methods found that the 
targets had no significant impact on trypanosome prevalence; prevalence of Trypanosoma 
spp in cattle from areas with or without targets was 10% for both sites.  T. b. gambiense was 
not detected unequivocally in cattle or pigs. 
This study showed that in a setting where gHAT is close to elimination it is extremely 
difficuIt to detect the parasite in the vector population. It also indicates that local cattle and 
pigs are not likely to be playing a role as reservoir hosts. The commercially available LAMP 
kits offer the basis of a novel and more cost-effective system for monitoring T. brucei 
parasites in low-prevalence settings. 
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 : Introduction 
 
1.1 History of sleeping sickness 
1.1.3 Natural history of human African trypanosomiasis  
Human African trypanosomiasis (HAT), commonly known as sleeping sickness, is a disease 
caused by species of Trypanosoma, single celled flagellated parasites from the order 
Trypanosomatidae. Within this family are other species of parasite that cause several 
important veterinary and medical diseases including animal African trypanosomisis (AAT), 
Chagas disease, also known as South American trypanosomiasis, and Leishmaniasis caused 
by the Leishmania parasite. Trypanosomes parasitize a wide range of hosts from plants (1), 
insects (2), fish (3), amphibians, reptiles (4), birds (5) and mammals (6). The life cycle of 
these parasites can either involve one host, a monogenetic life cycle, or two hosts, a 
digenetic life cycle (7). Earlier efforts to infer the evolutionary history of these parasites was 
limited to comparisons of life history and morphology (8).  However, with the development 
of molecular biology it has been possible to study the phylogenetic relationships between 
the Trypanosomatidae (9). These studies have shown that the trypanosomes cluster into 
three separate clades: an African clade which includes the modern African trypanosomes; a 
second clade that incorporates extant South American and Australian trypanosomes and 
finally a third, aquatic clade. This suggests that the African trypanosomes evolved 
independently in Africa while the other trypanosomes evolved in an ancient Southern 
supercontinent (10).  
 
During the course of the trypanosomes evolution two important events occurred one was 
the development of antigenic variation and the other was the parasitism of insects, which 
ultimately led to the close relationship between the salivarian trypanosomes and their 
insect vectors. Antigenic variation is a mechanism used by trypanosomes to evade the hosts 
immune system (11) by constantly changing the variant surface glycoproteins (VSGs) 
surrounding the trypanosomes when it is in the mammalian blood stream. This is essential 
as African trypanosomes live extracellularly and are therefore constantly exposed to the 
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host’s immune system. In African trypanosomes, there are up to 2000 genes dedicated to 
VSG production, making up to 30% of the total genome. The combination of these genes 
allows for a near infinite number of new VSGs to be produced, meaning the trypanosome 
will always be able to present a new surface coat to the immune system (12). This 
constantly changing appearance of the parasite also means that, to date, no vaccines are 
available to protect individuals from this disease.  
 
The second important evolutionary change was the ability to infect insects, which occurs in 
both monogenetic and digenetic trypanosome life cycles. It was suggested that as the 
monogenetic life cycle is simpler, involving one host and the digenetic life cycle more 
complex, involving two hosts, that it would follow the monogenetic life cycle was older. 
Trypanosomes with monogenetic life cycles have been described in insects, ticks and ciliates 
(7) and it was theorised that the African trypanosomes of humans and other mammals 
originated from parasites that had co-evolved with their invertebrate hosts (13, 14). The 
competing theory to this was that the ancestor of the trypanosomes originally colonised the 
gut of early aquatic vertebrates and evolved along with the vertebrate lineage, it later 
colonised the blood and from here was introduced to hematophagous insects, leading to 
the digenetic lifestyle of the modern vector transmitted trypanosomes (15-17). This 
uncertainty as to the origins of digenetic life cycle of trypanosomes was only resolved with 
advent of molecular phylogeny, which found that the earliest lineages to diverge were not 
the monogenetic trypanosomes but rather the digenetic parasites of mammals (18-21).  
 
The importance of the digenetic lifecycle of the trypanosome parasites is that it has resulted 
in insect vectors which are capable of transmitting the disease which increases the basic 
reproduction number, R0, of the parasite (22). There are trypanosomes that are transmitted 
mechanically by vectors (e.g., T. evansi transmitted mechanically by horseflies) but in their 
case they cannot be counted as having a two host life cycle as there is no development 
within the vector. The major vector borne trypanosome diseases can be classified by the 
means of inoculation into the mammalian host. The salivarian group enter the host via 
mouthparts of the vector and are termed salivarian trypanosomes, while those parasites 
transmitted through defecation onto the host are classified as stercoraria (23). The 
veterinary and medically important salivarian African trypanosomes are transmitted by 
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members of the Dipteran order from the genus Glossina. The evolutionary history described 
above is reflected in the modern trypanosome diseases of humans and their domestic 
mammals.  
 
1.1.2 Human origins and trypanosomiasis 
The origins of the human species, Homo sapiens, some 200,000 years ago in Africa (24, 25) 
has resulted in the evolution of the APOL1 gene which codes for the apolipoproteinL1 
(APOL1) in humans and four other primates (26). The primate species that are known to 
possess trypano-lytic factors (TLF) are West African Guinea baboons (Papio papio) (27), 
mandrills (Mandrillus sphinx), gorillas (Gorilla gorilla) and the sooty mangabey (Cercocebus 
torquatus) . The four non-human primates with effective TLF are all considered terrestrial. 
This strongly implies that the more terrestrial an animal is the greater the selection pressure 
trypanosomiasis will play due to the increase in encounters with tsetse. The baboons show 
the greatest level of resistance of all the primate species being resistant to T. brucei s.l. 
(including the human pathogenic species), T. congolense s.l. and T. vivax that commonly 
infect the local wild and domestic fauna (28).  
 
1.1.3 Human trypanosome resistance 
APOL1 is found in human serum and is associated with two different trypano-lytic factor 
complexes TLF-1 and TLF2 (29-31). These protect Homo sapiens from all forms of African 
trypanosomes except for two sub-species of Trypanosoma brucei that have evolved 
resistance to this innate immune response. Conversely the major domesticated mammals 
used in agriculture, cows, pigs, sheep, goats and horses originated from breeding stocks that 
evolved outside of Africa (32-36), this makes them susceptible to the trypanosomes of the 
local African ungulates, suids and bovids. This complex history of evolution and migration of 
people and animals in and out of Africa alongside the co-evolution between Trypanosoma 
and Glossina has resulted in the diseases of sleeping sickness and animal African 
trypanosomiasis (AAT), often referred to as nagana. 
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1.1.3 The study of African trypanosomes 
Trypanosomes were first discovered in 1841 by Professor G. Valentin in the blood of a trout 
and later in that of frogs. Following this, other scientists made similar discoveries from 
descriptions in frogs and these works were published in 1842 and 1843 and it was within 
these early manuscripts that the name Trypanosoma first appeared. The naming of the 
parasite has been attributed to David Gruby and originates from the Greek ‘trypano’ 
meaning auger and ‘soma’ meaning body due to the undulating movement and sinusoidal 
appearance of the parasite. In subsequent years, trypanosomes were identified in a range of 
animals including the first mammals but it was not until 1880 that the link between disease 
and trypanosomes was made. This occurred in India when Griffith Evans was able to prove 
that trypanosomes were responsible for the disease surra in the local horse and camel 
populations. He did this by inoculating healthy animals with the blood of infected animals, 
these inoculated healthy animals then went on to develop surra, with observable 
trypanosomes in their blood (37). 
 
Soon after this, in the early 1890s, British colonial farmers in South Africa were losing their 
herds of European cattle to a local veterinary disease named nagana, named after the Zulu 
word for low in spirit. To uncover the cause of this disease Surgeon-Captain and 
bacteriologist, David Bruce was dispatched to South Africa. By 1895 Bruce had described the 
trypanosomes from cattle suffering from nagana for the first time (38) and in 1903 
identified the tsetse as the vector of the disease (39). In 1899 the parasite described by 
Bruce was named Trypanosoma brucei by Bradford and Plimmer after its discoverer. The 
first description of trypanosomes from a human patient in Africa occurred in 1901 when 
Michael Forde observed them in the blood of a boat captain operating in The Gambia, 
although they were only identified as trypanosomes by Joseph Dutton in 1902 (40). It was 
Dutton that proposed they name the human trypanosome Trypanosoma gambiense (41), 
this name has since been changed to T. brucei gambiense and is one of the two human 
forms of African trypanosomiasis. The second parasite responsible for HAT was discovered 
by Harold Fantham and John Stephens in 1910 when investigating the case of a 26 year old 
man from Northumberland who had contracted the disease in North-East Rhodesia (42). 
This second species of human trypanosome was originally named T. rhodesiense and this 
was later changed to T. brucei rhodesiense.   
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Between the discoveries of the two human forms of African trypanosomiasis other 
important discoveries had been made in relation to the vector and the implication of more 
than one species of animal trypanosome responsible for Nagana.  Bruce had originally 
suggested that the transmission of trypanosomes between mammalian hosts by tsetse was 
a mechanical route (39) however Friedrich Kleine was able to demonstrate cyclic 
transmission of trypanosomes in Glossina (43). In light of Kleine’s research Bruce would 
revisit his work and he was able to publish the complete life cycle within the vector (39). 
From 1904 to 1905 two new species of trypanosome were described by Alphonse Broden 
and Hans Ziemann. The first of these to be described was T. congolense (44) of which there 
are currently three recognised strains identified T. congolense Forest, T. congolense Savanna 
and T. congolense Kilifi (45-49). Ziemann identified T. vivax which is a genetically diverse 
species to the extent that it could be argued it is not a single species but rather these 
distinct genotypes are species in their own right (50-52). The combination of the two human 
species, T. b. gambiense and T. b. rhodesiense plus the three trypanosome species 
responsible for nagana, T. b. brucei, T. congolense and T. vivax make up the five major 
trypanosome species of veterinary and medical importance. 
 
1.2 African trypanosomiasis 
1.2.1 HAT 
Human African Trypanosomiasis (HAT), often called sleeping sickness, is in fact two diseases 
caused by distinct sub-species of trypanosome , T. b. gambiense, which is responsible for 
98% of all HAT cases in the last decade (53), and T. b. rhodesiense. These two parasite 
species have separately evolved a means to survive in the human blood stream, despite the 
presence of trypanosome lytic factors in human sera. Both forms of HAT are considered 
fatal if left untreated and have resulted in hundreds of thousands of deaths (54) although 
there is some evidence to indicate that HAT may not be 100% fatal (55). The two forms of 
HAT are clinically and geographically distinct with Gambian sleeping sickness being a chronic 
disease occurring in West and Central Africa and Rhodesian sleeping sickness, which is an 
acute disease, found in East Africa (Fig1.1). In both diseases there are two phases, an early 
haemolymphatic stage which is then followed by a second, neurological phase caused when 
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trypanosomes cross the blood-brain barrier and invade the central nervous system (CNS). It 
is this secondary phase that the name sleeping sickness derives from as the subsequent 
neurological damage caused by the parasites in the CNS affects the sleep-wake cycle of the 
human host. 
 
 
 
 
Figure 1.1 The distribution of T. b. gambiense and T. b. rhodesiense: 
Image taken from The Atlas of human African trypanosomiasis: a contribution to global mapping of 
neglected tropical diseases (56) covering the preriod from 2000-2009. 
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1.2.1.1 Trypanosoma brucei gambiense 
It has long been recognised that it is many months – and sometimes years -  before some 
people infected with T. b. gambiense starts showing clinical symptoms of disease (57, 58). 
This asymptomatic period of Gambian HAT varies, typically it lasts 18 months  but the (54) 
longest recorded period between infection and the presentation of clinical symptoms was 
29 years (59). Reports of long periods of asymptomatic cases of Gambiense sleeping 
sickness suggests the possibility that humans may be playing a role as reservoirs of disease 
in local sleeping sickness foci (60-62). However, the significance of these individuals in the 
transmission of Gambian sleeping sickness is not known. The role of animal reservoir hosts 
is also poorly understood (60, 63-65), although the general consensus is that Gambiense 
sleeping sickness is an anthroponotic disease which circulates amongst the human 
population via the tsetse fly (66). T. b. gambiense is described as having two genetically and 
phenotypically different groups within the one sub-species, group 1 is the most widespread 
and is always resistant to human sera, however group 2 has a variable resistance to human 
TLF (67, 68). Only in T. b. gambiense group 1 is the TLF resistance mechanism linked with the 
T. gambiense-specific glycoprotein (TgsGP) gene (69). This is a single copy gene that is 
unique to T. b. gambiense group 1, although TgsGP-like gene have been found in T.b. brucei, 
T. b. rhodesiense and T. b. gambiense group 2.(70). The mechanism behind this resistance is 
not fully understood but it is known that the TgsGP gene itself is essential in conferring 
resistance as reintroducing the gene into knockout lines of parasites restored resistance to  
human TLF (71). 
 
1.2.1.2 Trypanosoma brucei rhodesiense 
The clinical symptoms for T. b. rhodesiense manifest themselves a lot sooner than those of 
T. b. gambiense and death can occur within three months. Although it is classified as one of 
the two HAT species it is essentially a parasite of animals. It enters the human population 
when a person is inoculated by an infected tsetse. Once in the human population it can then 
spread between individuals, although this is rare outside of an epidemic. Therefore, unlike 
the Gambiense sleeping sickness the importance of domestic and wild animals in control 
efforts are given a high priority. There is also little evidence to suggest asymptomatic 
carriers of the disease in the human population. 
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1.2.1.3 Trypanosome lytic factor (TLF) resistance 
Another difference between the two trypanosomes responsible for HAT is the mechanism 
each has for overcoming the TLF in human serum. Early studies had shown that the serum 
resistant phenotype would vary in T. b. rhodesiense when it is passaged through different 
host animals (72, 73). The changes in human serum resistance were due to changes in the 
selection pressure from the different host animals and resulted in a change in the VSGs 
expressed on the parasites surface (74). Analysis of the messenger RNA from both TLF-
susceptible and TLF-resistant strains of T. b. rhodesiense allowed for the transcript 
responsible for the resistant phenotype to be identified (75-77). The transcript was coded 
from a VSG-like gene which has been named the serum resistance gene (SRA). Unlike the 
TgsGP gene in T. b. gambiense the SRA gene when inserted into T. b. brucei transferred 
complete TLF resistance (78). This was confirmed in vivo by the accidental self-inoculation 
by a researcher with the transgenic T. b. brucei-SRA strain (79). The TgsGP and SRA genes 
are considered unique for T. b. gambiense and T. b rhodesiense respectively and are used to 
distinguish the parasites responsible for HAT and differentiate them from each other and 
the animal trypanosome, T. b. brucei. 
 
1.2.2 Treatment 
1.2.2.1 Melarsoprol 
Prior to the discovery of the transmission cycle of tsetse by Bruce, the tsetse fly had been 
suspected of causing disease in cattle but not in people, thus in parts of Africa local people 
would avoid taking their cattle to tsetse infested areas, or if they had to cross them they 
would do so at night (39). Once the discovery had been made that trypanosomes caused 
sleeping sickness and nagana, scientists worked to develop drugs that could treat the 
disease. One of the earliest drugs used to target trypanosomes was a preparation of arsenic 
called Atoxyl which had been synthesised by Pierre Bechamps in 1859 and was being used 
to treat sleeping sickness by 1905 (80). The Liverpool School of Tropical Medicine sent 2,800 
grams of Atoxyl to Africa to be used in the treatment of individuals suffering from sleeping 
sickness in the early 20th century (81, 82). Despite being 40 to 50 times less toxic than 
arsenic a review of the drug by Robert Koch found that 2% of patients treated with Atoxyl 
were blinded by the drug due to atrophy of the optic nerve (83). Atoxyl was used to treat 
the haemolymphatic stages of sleeping sickness and in 1919 a derivative of Atoxyl that was 
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capable of crossing the blood brain barrier was developed (84). This new drug, 
tryparsamide, was used for treatment of the neurological phase of sleeping sickness, 
although it too was highly toxic and resulted in cases of blindness (83, 84). Another 
derivative of Atoxyl was developed by Ernst Friedheim, which was also highly toxic, but 
Friedheim combined this new drug, melarsen oxide, with the arsenic antidote, dimercaprol 
(85) to make melarsoprol.  
Melarsoprol was introduced in 1949 for the treatment of second stage T. b. rhodesiense 
sleeping sickness. Although it showed no sign of toxicity toward the optic nerve (86) it can 
induce encephalopathy in 2-10% of patients of which 50-75% die due to this adverse side 
effect (87).  Melarsoprol is still currently in use despite its toxicity. 
 
1.2.2.2 Suramin 
At the time Atoxyl was being assessed as a suitable candidate for the treatment of 
trypanosomiasis, the scientist Paul Ehrlich was assessing the chemotherapeutic potential of 
the compounds developed by the new synthetic dye industry in Germany. Ehrlich screened 
over 100 new synthetic dyes against mice infected with T. b. brucei and identified a 
compound called Nagana Red as having limited trypanocidal properties. It was thought that 
the limited effects of Nagana Red were due to its poor solubility in water and subsequent 
absorption into the bloodstream (83). To increase the effectiveness of the compound a 
version with improved solubility in water was developed called Trypan Red (80). Despite 
these improvements the new Trypan Red drug was only effective against T. equinum. In 
France a second dye Trypan Blue was later discovered to be very effective against 
trypanosomes by scientists Maurice Nicolle and Felix Mesnil (88, 89). The drawback of 
Trypan Blue was that it stained the patient so a colourless derivative of the compound was 
desired. Eventually the chemical Bayer 205, renamed Germanin, was discovered and was 
successful in clearing trypanosome infection in both animals and humans. Due to political 
complications the formula for the drug was withheld by the German company Bayer (90). 
Fortunately, a French pharmacist published the formula for Germanin and the drug was 
renamed Suramin and is still being used to treat the haemolymphatic stage of T. b. 
rhodesiense sleeping sickness. 
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1.2.2.3 Pentamidine 
In developing a protocol for in vitro culturing of trypanosomes it was discovered that they 
require a large amount of sugar in their metabolism, consuming twice their mass in sugar 
every 24 hours (91). Following on from this discovery, investigations altering the blood 
glucose levels of infected animals were carried out (92) resulting in the identification of the 
oral anti-diabetic drug, synthalin, as a trypanocidal drug (93). Modifications of synthal by 
Arthur James resulted in two compounds with trypanocidal activities, stilbamidine and 
pentamidine (94). Currently only pentamidine is still in use for the treatment of the 
haemolymphatic stage T. b. gambiense sleeping sickness. Stilbamidine was dropped as a 
treatment and is no longer in use due to serious side effects (95, 96). 
 
1.2.2.4 Eflornithine 
The last drug to have been approved for treatment of HAT was the anti-cancer candidate 
drug eflornithine (97-99) which was first developed in the early 1970s (99). Almost a decade 
after its discovery, eflornithine was tested against trypanosomes in a mouse model resulting 
in complete cure of the mice from T. b. brucei (100, 101). Following on from the success of 
the use of eflornithine in the mouse models a number of trials treating human cases of T. b. 
gambiense were carried out (102, 103). These trial confirmed that eflornithine was an 
effective form of treatment for the neurological phase of T. b. gambiense, it was also 
effective against strains of T. b. gambiense that were showing resistance to suramin (104). 
Eflornithine has not proven an effective treatment against East African sleeping sickness due 
to T. b. rhodesiense having a higher turnover rate of the enzyme than the drug targets (105). 
 
1.2.2.5 Current strategy and new developments 
Since the approval of eflornithine for use as treatment for West African sleeping sickness, in 
1990, no new drugs have been approved. A combination treatment of eflornithine and 
nifurtimox (a treatment for South American trypanosomiasis) was found to be as effective 
as treatment with elfornithine on its own (106). One of the most recent advances in the 
pursuit of a new treatment for sleeping sickness resulted in the identification of compound, 
GNF6702, which has cleared mice infected with T. b. brucei. This compound was also able to 
clear mice infected with other parasites related to the African trypanosomes, namely T. 
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cruzi and Leishmania donovani (107). Currently the screening and treatment of the human 
population is the main method of controlling West African sleeping sickness. 
 
1.2.3 AAT 
Animal African trypanosomiasis, or nagana, is the animal equivalent of HAT and is 
responsible for disease in many species of domestic animals It has been estimated to cost 
the economy of sub-Sahara an estimated $5 billion dollars per year, due to loss of animals 
and lower meat and milk yields in infected animals (108-110). The presence of the disease 
has also prevented the use of draft animals in agriculture and made large areas of Africa 
unsuitable for raising livestock and productive farming. 
 
Like HAT, AAT is limited by the range of the vector and is confined to sub-Saharan Africa 
with the exception of T. vivax which has spread to South America (111) and is being 
transmitted by local tabanids (112). However, unlike HAT the trypanosome species 
responsible for AAT are found in both East and West Africa and are not as geographically 
discrete as T. b. gambiense or T. b. rhodesiense. There are three major species of 
trypanosomes that cause AAT, these are T. brucei s.l., T. congolense and T. vivax, (23) these 
parasites are able to infect most domestic animals (113). There are other species of 
trypanosome transmitted by tsetse that are of lesser or no veterinary importance, they are 
T. simiae, T. grayi, T. godfreyi and T. suis/T. msubugwe. 
 
1.2.3.1 Trypanosoma brucei brucei 
This parasite is the third member of the T. brucei group, the other two being the species 
responsible for HAT. T. b. brucei is found throughout the sub-Saharan region of Africa and is 
generally the least common out of the three main tsetse transmitted animal trypanosomes. 
There is no morphological difference between the three sub-species of T. brucei s.l. and the 
only way to distinguish the animal from the human species is to use molecular techniques to 
try and identify either the TgsGP gene or the SRA gene. However as these are single copy 
genes it is often not possible to identify the exact species of T. brucei s.l.. In the past 
inoculation of a parasite into a human volunteer was used to distinguish between the 
animal and human diseases (114). Closely related to T. brucei s.l. are two non-salivarian 
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trypanosomes, T. evansi and T. equiperdum (23). As neither of these trypanosomes are 
reliant on Glossina as an obligate vector they can be found across the globe and cause 
significant disease in mammalian livestock , although T. equiperdum is strictly a disease of 
equines. T. evansi is spread via mechanical transmission (115-117) causing the disease surra 
and T. equiperdum is a sexually transmited disease amongst equines and causes the disease 
dourine (23). The two trypanosomes responsible for T. b. gambiense, T. b. rhodesiense 
alongside the following animal trypanosomes T. b. brucei, T. evansi and T. equiperdum make 
up the five species that belong to the sub-genus Trypanozoon. 
 
1.2.3.2 Trypanosoma congolense 
T. congolense is one of the three most important trypanosomes responsible for AAT and is 
comprised of three different strains (23), T. congolense Savanna, T. congolense Forest and T. 
congolense Kilifi (118, 119). Of these three strains the most common are T. congolense 
Forest and T. congolense Savanna, with the latter being the most widespread across sub-
Saharan Africa. The distribution of the different strains is dependent on the environment 
and the local vectors with the Savanna strain found in a wider range of Glossina species 
compared to the Forest strain which is restricted to Glossina species associated with riverine 
habitats (120, 121). All three strains of T. congolense belong to the subgenus Nannomonas 
to which there are three further species of trypanosomes: T. godfreyi, T. simiae and T. 
simiae Tsavo. These last three trypanosome species do cause nagana however they are not 
as prevalent as the T. congolense strains (118, 122). 
 
1.2.3.3 Trypanosoma vivax 
T. vivax are a genetically diverse group of trypanosomes (123-126) that are one of the major 
causes of nagana, especially in ruminants (23). It is also the only member of the medically or 
veterinary important species of salivarian African trypanosomes to have spread beyond 
Africa, despite the lack of any biological vector outside of Africa (111). The pathogenicity of 
T. vivax is dependent on the strain of parasite and on the vertebrate host (23). T. vivax has 
been assigned the subgenus Dutonella.  
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1.2.3.4 Trypanosoma theileri 
As well as trypanosomes of veterinary and medical importance there are also many 
trypanosome species that appear to cause little or no pathology in the infected vertebrate 
hosts. One of the most common non-pathogenic trypanosomes is T. theileri, a trypanosome 
of cattle that is found on every continent except Antarctica (23, 127-132). Trypanosomes 
are classified as T. theileri based on morphological criteria including their large size (24µm-
61µm) (133) and a small kinetoplast located near the nucleus. Another unique feature of T. 
theileri is its host specificity as it has been shown to be unable to infect non-cattle species of 
mammals (23, 134). Trypanosomes that are morphologically similar to T. theileri that are 
found in other mammal species are classified as T. theileri-like. 
 
1.3 Identification of trypanosomes 
1.3.1 Microscopy 
Microscopy is the original method used by Bruce for the identification of African 
trypanosomes (38) and is still used to screen humans, animals and tsetse for the presence of 
a trypanosome infection. The identification of trypanosome species is complicated by the 
close morphological similarity between the different salivarian species, Fig.1.2, coupled with 
the fact that within a single species there can be a range of morphologies present in a single 
sample depending on the life cycle stage (135).  
 
Figure 1.2 Images of three giemsa-stained trypanosome species: 
(A)T. b. brucei, (C)T. congolense and (C)T. vivax. Image taken from (136) 
 
Diagnosis in humans is simplified by the fact that only two species of African trypanosome 
commonly infect humans and both these species are separated geographically. Therefore, 
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any presentation of trypanosomes in human blood in West and Central Africa would be 
designated as T. b. gambiense and likewise trypanosomes positive individuals in East Africa 
would be diagnosed with T. b. rhodesiense. The issue with this approach is that it relies on 
the current, discrete, geographical separation of the two HAT diseases, complications will 
arise if the two diseases ever overlap as the course of disease and treatment is different. 
 
The identification of trypanosomes in the tsetse fly relies on the location within the vector 
for the three groups of salivarian trypanosomes, Trypanozoon, Dutonella and Nanomonas, 
as well as morphology. However not all species are morphologically distinguishable such as 
T. b. brucei, T. b. gambiense and T. b. rhodesiense and unlike in the HAT parasites there are 
areas where these different species overlap. Similarly, trypanosomes that share the same 
developmental pathway are also hard to distinguish, such as T. congolense and T. simiae. 
 
In other vertebrate hosts the same weaknesses associated with the identification in the 
vector and human hosts are also true, and with non-human vertebrate hosts there is also a 
greater range of species that can establish an infection. Therefore, the microscopy method 
is susceptible to lack of specificity. It also depends on the skill and training of the technician 
that is operating the microscope. A study checking the quality of microscopy diagnostics in 
the Democratic Republic of Congo (DRC) found that less than half of the diagnostic 
laboratories routinely screening for HAT were able to identify trypanosomes reliably in 
positive thin blood films (137). 
 
1.3.2 Serology 
Typically, serology relies on the identification of specific antibodies that have been 
generated in response to particular pathogen or foreign proteins (antigens). In 1978 a new 
diagnostic assay for T. b. gambiense sleeping sickness was developed called the card 
agglutination test for trypanosomiasis (CATT) (138). This method uses a suspension of latex 
beads that are covered in one of the predominant VSG proteins expressed by T. b. 
gambiense to act as an antigen to screen for the presence of specific anti-bodies in the 
patients serum.. When either the serum or blood of an infected individual is added to the 
latex bead suspension the beads and antibodies adhere to each other via the antigen on the 
beads surface, causing a clumping together of the two. This is visible to the technician 
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performing the assay and is the indication of a positive result. A negative serum or blood 
sample would not produce this clumping effect and the test remains even in appearance. 
The CATT test is specific, it does not require a high degree of technician training and it is 
cheap and quick to carry out making it useful for large scale screening of the human 
population. The negative aspects of this diagnostic method is that despite its good 
specificity it has a poor positive predictive value, requiring those that have tested positive 
with the CATT test to undergo further parasitological examination (139). Apart from the 
CATT test there are currently no other field friendly serological diagnostic test for the other 
trypanosome species although a 2nd generation RDT designed to detect HAT is under 
development (140). In order to develop serological diagnostic assays for the other species of 
trypanosomes antibodies specific to these parasites need to be raised and then checked for 
cross reactivity with similar species. 
 
1.3.3 Molecular methods 
Molecular methods can be used to identify differences in the genomes of organisms as 
opposed to relying on morphological differences, which in the case of the salivarian 
trypanosomes are often limited. Another advantage of using DNA to distinguish 
trypanosome species is that unlike the morphology it does not change depending on the life 
stage of the parasite. The first molecular methods used to identify trypanosome species 
were based on DNA hybridisation probes (141). These were short sections of satellite DNA 
repeats that were specific for the intended species of trypanosomes. These non-coding 
repetitive DNA elements were used as they often had high copy numbers, which increased 
the sensitivity of the test and were poorly conserved between species increasing their 
specificity (142). These early assays were able to detect low levels of trypanosomes and 
distinguish between the morphologically similar species, including the three different strains 
of T. congolense, something that could not be done with microscopy methods (142). 
 
1.3.3.1 PCR 
The discovery of the polymerase chain reaction (PCR) in 1983 credited to Kary Mullis (143) 
superseded the DNA hybridisation probe method due to the copying of the target sequence. 
PCR uses two complementary short codes of DNA, called primers, to target a specific region 
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of the genome for amplification. One primer is upstream of the region of interest and the 
other is downstream. The temperature of the reaction is increased to the point at which the 
double stranded DNA is denatured and separates, as the reaction cools the primers are able 
to attach to their sequence on either one of the single strands of DNA. The complimentary 
strand of DNA is then generated when a DNA polymerase extends the primer sequence. This 
process is repeated each cycle so in 30 cycles, if the amplification is 100% efficient, a single 
copy of a double stranded DNA sequence will result in over 100 million copies. 
To visualise the results, the PCR the product is run out on a gel in a process called gel 
electrophoresis. The theory behind this is that the target of the primers will be a specific 
number of base pairs (bp) and different length products will move through a gel matrix at 
different speeds with smaller products moving faster than larger ones. The PCR product is 
added to a well at one end of the gel and an electric current is passed through the gel. DNA 
being negatively charged travels through the gel towards the anode, and it is during this 
process that any PCR product present in the gel gets separated by size. To gauge the size of 
the products, a molecular weight marker is run through the gel at the same time. The 
products produced during the PCR reaction are dependent on how well the reaction has 
been optimised and on the design of the primers for the purpose of the experiment. The 
specificity of the primers are dependent on the purpose of the assay. Some PCRs are 
designed to be highly specific, targeting only a single species, while others can be more 
generic, resulting in the amplification of DNA from multiple species. The choice of using 
either species specific or generic primers is part of the experimental design. 
 
1.3.3.2 Species specific primers 
These primers target variable regions within the parasites genome that are unique to the 
species of interest. The major salivarian species of trypanosome all have their own species 
specific primers, with the exception of T. b. brucei which cannot be positively identified as 
such due to a single gene difference between it and T. b. rhodesiense. Although being highly 
specific the disadvantage of species specific primers is that multiple reactions are required 
to screen a single sample for multiple trypanosome species resulting in an increase in cost. 
Another limitation of species specific primers is that they are unable to identify novel 
trypanosome species. 
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1.3.3.3 Generic primers 
Generic primers are designed to target conserved regions of the genome that flank a 
variable region. The conserved regions allow for a wide range of trypanosome species to be 
targeted while the variable region allows for species identification. There are several ways 
that the different species can be identified, the variable region between the two conserved 
sites can be of different lengths resulting in different sized PCR products for each species. 
These can then be separated out using gel electrophoresis and sized by using the molecular 
weight markers. A common region of the genome that has been targeted for development 
of generic primers for trypanosome is the spacer DNA between the small-subunit (SSU) and 
the large-subunit (LSU) ribosomal RNA (rRNA) genes. These are referred to as internal 
transcribed spacer (ITS) regions and in eukaryotes there are two ITS regions, ITS1 and ITS2, 
separated by the 5.8S rRNA gene. These rRNA and ITS genes occur in multiple copies 
separated by non-transcribed DNA named intergenic spacers (IGS) Fig 1.3.  
 
Figure 1.3 Diagrammatic representation of the positions of the ITS 1 and ITS 2 regions: 
in relation to the neighbouring genomic regions, image adapted from (144). 
 
ITS 1 and ITS 2 have become popular targets for phylogenetic and taxonomic studies as they 
have a high copy number and they are highly variable. There are several generic primer 
assays that have been designed to identify trypanosome species based on the size of the 
PCR product generated (145-147). These generic PCRs are advantageous as they can identify 
a wide range of trypanosome species in the same reaction, including novel species. 
 
1.3.3.4 Restriction fragment length polymorphism (RFLP) 
Another method that has been used to identify different trypanosome species is the use of 
PCR restriction fragment length polymorphisms (RFLP). This method uses PCR to amplify the 
18S variable region with the SSU gene, this stretch of DNA is then cut by restriction enzymes 
resulting in multiple fragments of varying sizes. When run out on a gel these different size 
fragments produce a banding pattern (148). This technique was able to distinguish all of the 
different salivarian trypanosome species transmitted by tsetse, however this method is less 
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accurate with multiple infections as some species share similar banding patterns, notably T. 
congolense and the non-salivarian species T. theileri  (149). 
 
1.3.3.5 Sequencing 
Alternatively, if it is not possible to distinguish the different species based on the size of the 
PCR product, they can be sequenced to determine the exact genetic sequence of a product. 
Sequencing has the advantage of being able to compare your sequence to published 
sequences available on online databases like GenBank (www.ncbi.nlm.nih.gov). Using 
bioinformatics software, it is possible to compare sequences generated by one study to 
those of other studies, this is especially useful if the generic primers amplify an unknown 
trypanosome species. Even if it has never been described before it would be possible to 
observe its phylogenetic relationship with the known species. The negative side to 
sequencing is that it adds an extra cost to the processing of samples and complications arise 
when there are mixed infections within one sample. 
 
1.3.3.5 Loop-mediated isothermal amplification (LAMP) 
An alternative molecular method to PCR is loop-mediated isothermal amplification (LAMP) 
developed at the start of the 21st century (150). Like PCR, LAMP is capable of replicating a 
specific DNA target, however unlike PCR LAMP uses up to six different primers and an auto-
cycling strand displacement Bst DNA polymerase. The six different primers are designed to 
target different regions of the replicating DNA resulting in a branching loop structure that is 
capable of continual amplification by the Bst DNA polymerase without the need for multiple 
heat steps. This isothermal property of the method means that an expensive thermocycler is 
not required for the reaction and instead a simple heat block is sufficient. The amount of 
DNA that is amplified using this method is enough for the turbidity of the reaction mix to 
increase when the target DNA is present, and it is this change that indicates a positive or 
negative result. This does away with the need to run the reaction out on a gel to determine 
the results and the addition of a fluorescent dye increases the sensitivity of detecting this 
changes in turbidity (151). 
A LAMP assay targeting the Trypanozoon sub-genus was developed in 2007 and the results 
showed that the assay was both highly sensitive and reproducible. The simplicity of 
detecting the results by checking for turbidity in the reaction mix and the simplicity of the 
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sample preparation makes this method a good candidate for use in a clinical setting (152). 
Subsequent investigations further developed the reliability of the visual detection system 
(153), demonstrated the superior sensitivity of the assay to PCR (154) and improved the 
clinical applicability of the assay by developing lyophilised kits and simplifying the sample 
preparation (155). 
 
1.4 The vector of African trypanosomaisis, Glossina s.l. 
1.4.1 Forests, rivers and savannas 
The biological vector of the African salivarian trypanosomes are members of the genus 
Glossina; these flies are commonly called tsetse. There are a total of 22 Glossina species 
that include five sub-species complexes (156) found discontinuously across ~10 million km2 
of sub-Saharan Africa (157). Tsetse are limited to Africa due to the Sahara desert to the 
North although a small population from Saudi Arabia was reported in 1910 (158). The 
limited range of the vector has prevented the spread of HAT and AAT beyond Africa, with 
the exception of T. vivax, which is currently being spread by mechanical vectors in South 
America. The tsetse species have been organised into three groups based on their external 
genitalia (Fig1.4), these are Morsitans (Glossina), Palpalis (Nemorhina) and Fusca 
(Austenina).  
 
Figure 1.4 Illustrations of the different morphologies of male superior claspers. 
The claspers of the Fusca male lack a membrane and end in claws, the Palpalis male’s claspers 
have a membrane and the claws are narrow. The Morsitans claspers are more specialised and no 
longer poses claws. Image taken from the FAO training manual for tsetse control personnel (159).  
 
The Palpalis, Morsitans and Fusca groups correlate roughly with the favoured habitats that 
the different groups can be found in. These three types of habitat are forest, savanna and 
riverine environments, the corresponding tsetse groups are Fusca, Morsitans and Palpalis 
(160). The correlation between genital morphology and habitat reflects the evolution of the 
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different tsetse species. The Fusca tsetse have the most primitive genital morphology, 
followed by the Palpalis group and the Morsitans are considered the most recently evolved 
(161). It follows then that the original environment was a forest habitat, from here the 
tsetse moved out to riverine and then savanna habitats, this adaptation to increasingly arid 
environments can also be seen in the ability of tsetse pupae to resist dessication (162). Of 
the 22 species of tsetse only 11 are known to transmit sleeping sickness, six from the 
palpalis group, five from the morsitans group and 0 from the fusca group, (Table 1.1). 
 
Table 1-1 Glossina species that are known to transmit HAT (163) 
Palpalis Morsitans 
Glossina palpalis  gambiense Glossina morsitans centralis 
Glossina palpalis palpalis Glossina morsitans morsitans 
Glossina tachinoides 
Glossina morsitans 
submorsitans 
Glossina fuscipes fuscipes Glossina Swynnertoni 
Glossina fuscipes quanzensis Glossina pallidipes 
Glossina fuscipes martinii   
 
 
 
The ecological niches that the different tsetse species occupy determines their geographical 
distribution, the Fusca and Palpalis groups are mainly found in West and central Africa 
whilst the Morsitans tsetse can be found mainly in East Africa (160) Fig1.5.  
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Figure 1.5 Distribution of the different tsetse groups across Africa: 
showing the concentration of Palapalis and Fusca species in West Africa and the Morsitans tsetse 
in East Africa. Image taken from medical ecology website (164). 
 
 
1.4.2 Host seeking 
The geographical distribution of tsetse species is also reflected in the vectors responsible for 
the transmission of the two types of HAT with the Palpalis group transmitting T. b. 
gambiense and the Morsitans group transmitting T. b. rhodesiense. 
The habitat a tsetse lives in influences the host seeking strategies that tsetse employ.  
Morsitans tsetse, typically found in savanna woodland, locate their hosts using a 
combination of visual and olfactory cues, particularly the latter (165, 166). Host odours 
include volatiles such as 1-octen-3-ol, ketones, acetone and products of respiration such as 
carbon dioxide (165-167). Tsetse use olfactory cues to locate the host from long range by 
flying upwind of the odour plume and visual cues to locate and land on the host at closer 
proximity (168, 169). In contrast, Palpalis group tsetse, typically found in riverine habitats, 
are less responsive to host odours and rely more on visual cues (170, 171). 
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Palpalis and Morsitans tsetse are attracted to different sized hosts with the savanna tsetse 
preferring larger hosts such as bush pig and kudu while the riverine tsetse are more 
attracted to smaller hosts such as monitor lizard (172). It has been hypothesised that these 
differences in behaviour can be attributed to the geometry of the habitat, whereby barriers 
to tsetse movement and host location could be formed from dense bushes (173) thus 
necessitating the tsetse to adopt different feeding patterns. The importance of 
understanding the interaction between the visual and chemical signals given off by the host 
is essential in designing effective control technologies that can mimic these to the point of 
passing as a valid target for hungry tsetse (171). The third group of flies, fusca tends to be 
considered of minor importance in the transmission of African trypanosomiasis as they are 
not recorded as feeding on humans and are only ever found in heavily shaded bush where 
cattle are rarely encountered (174, 175) although there has been some attempt to re-
evaluate their role as a vector(176). 
 
1.4.2.1 Blood feeding 
The tsetse fly  belongs to the superfamily Hippoboscoidea, all members of this family, both 
male and female, are obligate blood feeders and have been recorded feeding on birds, 
mammals and reptiles (177). Tsetse have previously been described as opportunistic 
feeders, however this is generally only true when selective pressure is placed on the tsetse 
through the reduction of host diversity (172, 178). A recent study by Harriet Auty, that 
compared identification of tsetse blood meals with host density, has confirmed that 
Morsitans-group tsetse are highly selective in their feeding (179).  Analyses of the diet of 
Palpalis-group tsetse suggests that they are less selective (172, 178).The identification of the 
host species that tsetse fed upon provides a better understanding of the transmission 
dynamics, especially with regards to reservoir hosts. It also provides the opportunity for 
intervention, such as treating the preferred domestic animal host with insecticide (180-182). 
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1.4.3 Blood meal analysis 
1.4.3.1 Direct observation of feeding 
The earliest and simplest method that was used to try and identify the origins of blood 
meals is to try and observe feeding behaviours of tsetse in the field. Directly observing 
tsetse feeding is difficult due to their small size and the short amount of time they spend 
feeding on the vertebrate host. This method is generally unreliable and is prone to bias 
based on what the researcher is able to track and observe and without extensive surveys it 
would be hard to determine the value of results generated (183-185). Although this method 
can be improved by having a range of bait animals to test the attractiveness of different 
hosts to tsetse (186) but even in this instance the presence of humans near bait animals has 
been shown to create a bias within experiments(187), although this can be negated with the 
use of electrical screens that catch flies as they approach and leave the hosts (188). 
 
1.4.3.2 Red cell morphology 
The analysis of fresh blood from the midgut of tsetse to determine the origin of the blood 
meal based on morphological features of the blood, such as nucleated erythrocytes found in 
birds and reptiles, (189) was used in the past. However this method lacks specificity and the 
morphology of erythrocytes can vary. The size of cells can be affected by digestive processes 
within the insect gut and there is often a range of cell sizes within the same species 
depending on the age of both the cell and animal (190). 
 
1.4.3.3 Serology 
It was in 1914 when the use of serology to identify the origins of blood meals in blood-
sucking invertebrates was first demonstrated (190) and by 1963 a massive collection of over 
22,000 tsetse blood meals from 15 species of tsetse spanning the years 1953-1962 had been 
collected and analysed using serological precipitation for 33 species groups(191). A larger 
serological study using an enzyme-linked immunosorbent assay (ELISA) to screen 29, 245 
flies confirmed previous findings (172). Serological methods of blood meal identification 
were a vast improvement on visual field observations and could even detect blood meals 
three days post feed(192). This method is limited when trying to increase the resolution 
down to the species level as more tests need to be conducted, and in order to identify each 
species a specific antiserum needs to be developed.  
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1.4.3.4 Polymerase chain reaction (PCR) 
PCR allows for the identification of blood meals to a far greater level of detail and with less 
laboratory work. Similar to the identification of trypanosome species, a number of 
molecular methods for the identification of blood meals have been developed, including 
RFLP methods targeting the hosts mitochondrial DNA (193-195). Allowing for multiple hosts 
to be identified with a single primer pair and restriction enzymes (196, 197). There are also 
multiplex PCR assays that combine multiple sets of species specific primers that each 
produce their own uniquely sized PCR product (198).  
An alternative method to the species specific primers are the generic primers that target 
conserved regions flanking areas of variability and rather than use product size or enzyme 
digestion to identify the organism, sequencing is used instead (199). This has the advantage 
of not needing to know what potential hosts are in the environment and if any unknown 
animal is detected it would be possible to identify it easily to the genus level due to the high 
number of DNA sequences of known animals available online from various databases. 
 
1.4.3 Trypanosome development in tsetse 
The tsetse fly, as a vector of the salivarian trypanosomes is also a victim of trypanosomiasis 
itself and as such they have evolved their own immunological defence (200, 201) and a 
physical barrier that surrounds the blood meal to protect the tsetse from blood borne 
pathogens (202). The majority of tsetse in a population are refractory to trypanosomes and 
this is evident in the low rates of mature infections found in wild tsetse (203). The age of an 
individual tsetse is an important contributor to its susceptibility to infection. A newly 
emerged tsetse that has not taken a blood meal is termed a teneral fly. These teneral tsetse 
are highly susceptible to infection due to a reduced immunological competency (204) and 
the peritrophic matrix (PM) is not yet fully formed (205). The PM is a protective sheath that 
lines the gut of the tsetse and serves as a protective barrier for the tsetse. The importance 
of the midgut environment is probably greater for both T. brucei s.l. and T. congolense than 
it is for T. vivax as they have different developmental cycles within the vector host. 
Both T. brucei s.l. and T. congolense establish an immature infection in the midgut, they 
then develop mature infections in the salivary glands and mouth parts respectively. T. vivax 
carries out its entire developmental cycle in the mouth parts of the tsetse(135) (Fig1.6). 
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Figure 1.6 Illustrations of the different developmental routes for salivarian trypanosomes 
 The development of African salivarian trypanosomes, within the vector, varies depending on the 
species of parasite. The three most important trypanosome species from both a veterinary and 
medical stand-point are T. brucei (A), T. congolense (B) and T. vivax (C). The figure divides the 
developmental cycle into four stages, ingestion of blood-stream form parasites (1); the passage of 
trypanosomes to the midgut (MG) of the tsetse and subsequent development into procyclic form 
(this step is absent in T. vivax development); anterior migration of trypanosomes and 
differentiation into epimastigotes in the proventriculus (PV) (T. congolense) or salivary glands (SG) 
(T. brucei); the final stage is inoculation of metacyclic forms into a vertebrate host during feeding 
(4). Image taken from Jackson 2015 (206). 
 
1.4.4 Reproductive cycle 
The Hippoboscoidae share a reproductive cycle that is characteristic of their superfamily and 
plays an important role in the susceptibility of tsetse to vector control. The tsetse fly differs 
from the other major vectors of medical and veterinary diseases in that they do not lay eggs 
but rather give birth to a single 3rd instar larva every nine days with the mother providing all 
the nutrition required by the larva while it grows within the mother and for subsequent 
pupal development.  This large maternal investment and low rate of reproduction – an 
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example of a K-selected reproductive strategy (207) – contrasts with the much higher rates 
of reproduction and r-selected reproductive strategies displayed by most other vectors.  
The larva is nourished by ‘milk glands’ within the tsetse uterus that produces a milk-like 
substance which the growing larvae feeds from. It normally takes 9-10 days for the 
complete development of the 3rd instar larvae in the uterus of the tsetse, after which the 
larva is deposited on loose sandy soil. Having been deposited the larva burrows into the 
ground where it then pupates to form a puparium. The developmental time within the 
puparium for the larvae to transform into an adult tsetse is dependent on temperature; at 
24ᵒC it takes 30 days for the adult tsetse to emerge. Whilst ensconced underground the 
developing tsetse is relatively safe from predators and inclement weather, barring flooding 
the puparium remains safe. Once fully developed the young tsetse emerges from the 
puparium and burrows to the surface using its ptilinum, a sac like structure that when 
pumped expands and contracts helping the tsetse move through the soil. Following 
emergence from the soil females are fully fertile but males will take three days to fully 
mature (208). This reproductive cycle is represented diagrammatically in Fig.1.7. 
 
Figure 1.7 Diagrammatic representation of the life cycle of the tsetse fly 
Image taken from Tsetse Biology and Ecology: Their Role in the Epidemiology of Trypanosomiasis (161). 
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1.4.5 Tsetse control 
One of the earliest tsetse control efforts was successfully conducted on Principe Island off 
the coast of West Africa in the Gulf of Guinea. This early campaign against Glossina palpalis 
was successful in eradicating the vector from the island through a combination of methods 
that would become the blue print for sleeping sickness control Across Africa during the early 
and mid-20th century. The methods employed to control the tsetse included bush clearing, 
the extermination of wild animal hosts and the use of a sticky trap to catch adult tsetse (82). 
 
1.4.5.1 Bush clearing 
The rationale behind bush clearing was that tsetse are known to favour different habitat 
types and the destruction of these habitats makes the area unsuitable for tsetse. There 
were two forms of bush clearance selective and sheer clearing. In the case of selective 
clearing it was found to be not as effective as the wholesale destruction of the tsetse habitat 
depending on the species of tsetse involved (Nash 1940, Harley and Pilson 1961). Due to the 
ecologically destructive nature of bush clearing it has fallen out of favour and is no longer 
used as a method of tsetse control. 
 
1.4.5.2 Animal destruction 
The destruction of wild host animals was carried out on the island of Principe and later 
would be carried out on a large scale after the observation was made that tsetse numbers 
correlated with those of wild animals (Da costa 1916, Jack 1914). Initially this involved the 
destruction of all large wild mammalian species but following the development of blood 
meal identification techniques are more selective approach was used. By destroying the wild 
hosts the intention was to starve the tsetse by limiting their likelihood of finding a blood 
meal. Despite its obvious success this strategy became increasingly unacceptable especially 
as general recognition of the value of biodiversity emerged in the 20th Century. Moreover, 
the long-term value of this approach became less obvious as it became clear tsetse would 
switch their feeding from wild animals to domestic ones, increasing the risk of nagana and 
East African sleeping sickness being introduced to the local communities.  Despite both 
habitat and wild animal destruction no longer being an intentional method of tsetse control 
the encroachment of the human population into wilderness areas means that this process 
still impacts on tsetse populations. 
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1.4.5.3 Traps 
The use of traps or targets for tsetse control can be traced back as early as 1906 when 
Senhor Bulhões Maldonado invented the sticky traps worn by the workers on Principe island 
(Fig.1.8.A). Over the course of 21 months, from April 1906 to the end of 1907, 133,778 
tsetse were caught by this method on the Maldano estate. It was observed that two men 
wearing a sticky trap each whilst working in the plantation caught 1,500 – 2,000 tsetse at 
the start of the week and by the end of the week this number had dropped to 20 (82). 
 
The success of the sticky traps on the island of Principe was enhanced by the reduction of 
alternative hosts through the destruction of local pigs, dogs and civet cats.  
Screens had been used to attract tsetse by Swynnerton since 1922 (Fig.1.8.B) and following 
the development in 1930 of a trap for Stomoxys attempts were made to turn the screens 
into traps with the addition of a “non-return” wire cage(Fig.1.8.C) (168). 
Later in the 1930s a trap was developed by Harris that was used to control the tsetse 
population in Zululand (Fig.1.8.D). From 1931 to 1938 it is estimated that over 10.5 million 
tsetse were caught using the Harris trap, resulting in the reduction of nagana in the local 
cattle populations (209). Harris traps were used in a variety locations such as in the Congo 
where 12 traps reportedly reduced the number of new HAT cases from 20 to 0 (161). 
Despite the success of the Harris trap it was not widely deployed, this could be due to the 
fact that it did not perform equally well with all tsetse species (168).  
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Figure 1.8 Images of early tsetse traps and targets: 
Sticky targets used for the control of tsetse on the island of Principe (A). The original targets used by 
Swynnerton, including plain oblongs as well as animal shaped targets (B), Swynnerton’s target with non-
return cage attached (C) and the Harris traps (D). Images taken from (82) and (168) 
 
 
Different tsetse trap designs were developed throughout the 20th century with the 
development of the biconical trap (Fig.1.9.A) by Challier and Lavissiere (210, 211) The 
biconical trap was further developed into the Lancien trap (Fig.1.9.B) (212), pyramidal trap 
(Fig.1.9.C) (213) and the Vavoua trap (Fig.1.9.D) (214). The biconical trap and its variants 
were developed to target the Palpalis group of tsetse in West and Central African.  
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Figure 1.9 Images showing modern tsetse traps derived from the biconical design: 
(A) The original biconical trap and the three traps that subsequently derived from it, (B) the 
Lancien trap, (C) pyramidal trap and (D) Vavoua trap. Images taken from (215). 
 
 
Trap development designed to target the Morsitans group of tsetse was also being 
developed during this period. In Zimbabwe the F3 trap was developed, this design was 
improved to make it easier to setup, resulting in the epsilon trap (Fig.1.10.A) (216). The F3 
and epsilon traps were again re-designed to produce the M1, M2 and M3 series of traps of 
which the M3 performed the best (217).  Other traps designed for savanna tsetse include 
the H-trap (Fig.1.10.B) (218) and NGU trap (Fig.1.10.C) (219, 220). 
 
Figure 1.10 Traps designed to catch the savanna tsetse: 
(A) the epsilon trap, (B) H-trap and (C) NGU trap, images taken from (215) 
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The design of the traps work by taking advantage of the tsetse’s attraction to particular 
wavelengths of light (221) in particular to combinations of black and a specific shade of blue 
called phthalogen blue (221, 222). Alongside the visual cues artificial odours have been 
developed that mimic those of a host animal. These artificial odour baits mimicked breath, 
urine (165, 223, 224) and skin secretions (225). These odours do not work equally well 
amongst the different tsetse groups as they are very effective in attracting the Morsitans 
tsetse but have little effect on the Palpalis group (161). 
 
The deployment of traps can be used purely for control or they can be used as a method of 
collecting live tsetse from the wild populations for study. If the traps are being used as a 
control device the lethality of the trap can be enhanced by the application of insecticides 
(226, 227). Another form of control that developed in parallel with the trap technology is 
the development of the targets or screens. This method of control works in a similar way to 
the traps in that the targets attract the tsetse primarily through visual cues based on a 
contrasting blue and black pattern. However whereas the traps can still operate without 
insecticide, albeit with a lower lethality, the targets killing power comes from being 
impregnated with a fast acting contact insecticide (227-229).  
 
1.4.5.4 Targets 
The combination of visual and odour attractants is more effective against the savanna group 
of tsetse, requiring four targets per km2 (166) in order to control the population. Riverine 
tsetse are less attracted to the artificial odours and the visual targets developed by 
Laveissière (230) resulting in a far higher number of targets needing to be deployed in order 
to control their numbers (231). The high number of targets needed to control the vectors of 
West African sleeping sickness has for a long time made this prohibitively costly.  This 
difference in vector behaviour, in combination with the respective zoonotic and 
anthropophilic life histories of the parasite, has contributed to the different control 
strategies for HAT in East and West Africa. The West African disease is controlled mainly 
through the screening and treatment of the human population whilst vector control plays a 
bigger role in East Africa. 
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This hurdle of cost effective West African tsetse control methods has now been overcome 
after experimentation with target sizes revealed that a 90% reduction in the target area led 
to a 50% reduction in catch numbers (231). It was found that the number of tsetse caught 
per m2 of fabric is optimum with 25 cm2, targets flanked by an equal area of netting (231). 
The difference in size between the East African tsetse target and the new West African tiny 
target can be seen in Fig1.11. 
 
Figure 1.11 Comparison of Tiny Target and a larger East African target 
Image used for the tiny target was taken from (232) and the image for the large tsetse target was taken 
from (233) 
 
Due to their smaller size the reduction in the cost of the fabric offsets the number of targets 
required for effective control resulting in an economically viable strategy (234, 235). Initial 
studies, conducted on islands on Lake Victoria, showed that the optimum number of Tiny 
Targets  to be deployed was 20 per linear km (236). The Tiny Targets  reduced the tsetse 
population by >90% and this result was replicated when the Tiny Targets  were deployed on 
a larger scale in NW Uganda in 2013 (236). 
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1.4.5.5 Insecticide treated cattle 
Treatment of cattle with insecticide turns the domestic animals susceptible to nagana into 
natural bait for the control of tsetse. This control technology was first tested in the 
Tanganyika territory, in what is today Tanzania, in the 1940s with DDT treated cattle (180). 
The effectiveness of this method was limited by persistency of the DDT as in order to kill 
95% of tsetse that landed on the cattle the DDT needed to be applied twice a week (180). 
Later trials using the pyrethroid insecticide, deltamethrin, were able to kill 95% of tsetse 
landing on the cattle without the need for re-application (237). The efficiency costs of 
treating cattle with deltamethrin can be reduced by 80% with restricted application of 
insecticide to the belly and legs where >95% of G. pallidipes land (182). 
 
1.4.5.6 Insecticidal spraying of resting sites 
Just prior to the Second World War in 1939 DDT was discovered to be lethal to insects by 
the Swiss chemist Paul Müller (238). Following the success of its use by the US Army in WW2 
the newly formed WHO established the global malaria eradication program (GMEP) in which 
adult vector control was to be achieved through application of DDT to the indoor resting 
sites of malaria mosquitoes (239). The use of DDT, and other organochlorines, to control 
adult tsetse by spraying trees and bushes followed from the initial success of the GMEP 
(240, 241). In the 1970s when environmental concerns regarding the toxicity of DDT to the 
ecosystem were raised (161) DDT was replaced by other synthetic compounds of which the 
pyrethroids were to play a significant role in tsetse control. 
 
The application of the insecticides to resting places was carried out with the use of 
pressurised knapsack sprayers. Ground spraying was highly effective but also labour 
intensive as it required selection and spraying of individual resting sites by an army of 
technicians. To help cover larger areas mistblowers and unimogs were introduced into some 
control campaigns (242) (161). Although better than spraying with the knapsacks these 
methods were still limited by terrain and accessibility issues, limiting the size of the areas 
that could be controlled. 
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1.4.5.7 Aerial spraying 
Aerial spraying with either residual or non-residual contact ultra-low volume (ULV) 
insecticides has been used to cover larger areas of terrain inaccessible to the ground based 
spraying methods. The earliest aerial spraying campaign against tsetse was in 1947 in South 
Africa (161) using DDT. Pyrethroids were also used in some aerial spraying interventions 
(243). ULV insecticide spraying involves multiple cycles of insecticide spraying that uses an 
atomiser to create a fine spray. Multiple cycles are required as the ULV spraying targets the 
adult tsetse only as the pupating tsetse are safe below ground. The cycles need to coincide 
with the emergence of new tsetse and were typically spaced 19 days apart. This method of 
timing meant that the tsetse that had emerged the day after the spraying were killed before 
they had a chance to deposit their 3rd instar larvae. 
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1.5 Thesis objectives 
Since the early 2000s the number of sleeping sickness cases has been declining in both East 
and West Africa due to the implementation of successful control strategies. The number of 
reported West African Gambiense HAT cases has dropped by 89% from 25,865 in 2000 to 
2,733 in 2015 (244). Similarly the number of East African Rhodesiense HAT cases has 
dropped by 90% from 709 in 2000 to 71 in 2015 Fig 1.12 (245). 
 
Figure 1.12 The number of reported cases of sleeping sickness from 1990 to 2015 
WHO global health observatory data repository 
 
The success of HAT control has resulted in sleeping sickness being included in the London 
declaration as one of the 10 diseases earmarked for eradication by 2020. To date only two 
diseases have been eradicated, small pox and rinderpest. This reflects the difficulty of 
complete disease eradication, this is often due to the difficulty and cost of identifying the 
remaining transmission sites. As the success of disease control increases it can be harder to 
justify expending the same cost and efforts to maintain control, especially in resource 
limited environments. It is therefore important to explore alternative strategies to maintain 
the pressure on diseases being brought to eradication (246). It is in light of the goals of the 
London declaration that this thesis will study several aspects of the transmission dynamics 
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and control of  T. brucei s.l. in a historic focus of Gambiense sleeping sickness in NW 
Uganda. 
 This thesis will examine four research questions that relate to the transmission and control 
of T. brucei s.l. in the historical HAT foci of the West Nile region of Uganda within the 
context of the elimination goals of the London declaration. 
 
The fours questions addressed are: 
1. What is the prevalence of T. brucei gambiense in the tsetse population? 
This question is to be answered in two parts across two chapters using traditional 
entomological methods as well as a novel multiplex PCR reaction to assess the 
prevalence of T. brucei s.l. as well as two other salivarian species of trypanosomes, T. 
congolense and T. vivax. The study was conducted over 16 months and included 
physiological, (age) and environmental (rainfall estimates and temperature) factors. 
The source of bloodmeals was investigated, in order to determine host preference. 
This data is explored in Chapters 3 and provides a context for the following chapters. 
The samples positive for T. brucei s.l.  were then re-screened using sub-species 
specific primers that target the T. b. gambiense specific TgsGP gene, these result are 
detailed in Chapter 6. 
 
2. Can commercially available LAMP kits, designed for human screening, be used to 
screen tsetse for the presence of T. brucei s.l. DNA? 
The previous question answers if T. brucei s.l. is present in the local population. This 
question looks at adapting a pre-existing tool for human surveillance to screen the 
vector population as an alternative to active screening of people. The current 
methods used to identify T. brucei s.l. in tsetse either rely on classical entomological 
techniques or molecular methods, such as PCR. Both of these approaches require 
highly skilled technicians, are time consuming and can be expensive. The recent 
development of the LAMP technology has the potential to provide the sensitivity and 
specificity of a molecular assay but without the need for a fully furnished molecular 
laboratory. This question is fully explored in Chapter 4. 
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3. How does the successful deployment of ‘Tiny-Targets’ effect the prevalence of 
pathogenic trypanosomes in the local cattle population of the West Nile region of 
Uganda? 
The answer to this question is sought by comparing the incidence of three 
pathogenic trypanosomes, T. brucei s.l., T. congolense and T. vivax in cattle from two 
sites in NW Uganda. The first site, Arua, has had Tiny Targets deployed since 2011, 
the second site, Koboko, has had no tiny target deployment. To identify 
trypanosome positive cattle both traditional microscopy and standard molecular 
methods will be used. The analysis of the two cattle populations will also include 
comparison of relative packed blood cell volumes to identify any relationship 
between anaemia and infection. 
 
4. Is T. b. gambiense present in the cattle and pigs from the gHAT foci in NW Uganda? 
There are two sources of sample that are potentially positive for T. b. gambiense 
those samples derived from the vector and those from the vertebrate host. The 
tsetse samples processed in Chapter 3 are the first source of samples and were 
screened for T. b. gambiense. The second set of samples to screen, vertebrate hosts, 
are comprised of the cattle sampled in Chapter 5 and pigs from Arua and Moyo. The 
reason why pigs were selected is that in other studies they have been found to be 
positive for T. b. gambiense, were shown to have a higher prevalence of T. brucei s.l. 
and based on the bloodmeal analysis from Chapter 3 we know that the local tsetse 
feed on pigs. Currently gHAT is inderstood to be an anthroponosis however there is 
theoretical and empirical evidence that suggests there may be a role for non-human 
reservoir hosts in the transmission of the disease. If true, the existence of an animal 
reservoir host could reduce the chance of reaching the elimination goal set out by 
the London declaration. The results of screening tsetse for T. b. gambiense will be 
given in Chapter 3 and the results for both the cattle and pig screening assays will be 
given in Chapter 5. 
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 : Molecular methods 
 
 
2.1 Background 
This chapter reports the development and/or refinement of molecular methods used in 
subsequent chapters. These include DNA extraction methods used in Chapters 3 and 5, as 
well as the different PCR reactions used in Chapters 3, 4 and 5. There are two primary 
sources of sample that are used in this thesis: tsetse flies and blood samples taken from 
cattle or pigs that have been collected from the field and stored on Whatman Fitzco/Flinder 
Technology Agreement (FTA) card. Both the tsetse and blood spot samples were screened 
for trypanosomes using PCR with either (i) generic, (ii) species-specific and (iii) sequencing 
to identify the species of Trypanosoma. 
 
2.1.1 DNA extraction 
FTA cards were chosen as the best means of storing the blood samples of both the cattle 
and pigs as the technology allows for the safe storage and transportation of DNA at room 
temperature. The cards are impregnated with four chemicals that lyse cells, denature 
enzymes, inhibit microorganism growth and protect the DNA from UV damage (247, 248). 
Previous work has investigated the distribution of trypanosome DNA in blood spotted on 
FTA cards and found that the DNA is not distributed evenly across the blood spot but rather 
is only present in specific areas (249). This uneven distribution of trypanosome DNA on the 
card means that when screening the blood spot the more hole-punches taken increases the 
likelihood of sampling from an area where trypanosomes DNA is present. The sensitivity of 
PCRs using processed FTA card samples increases the more hole-punches used, this is 
especially true for samples with low parasite load. The optimum number of hole-punches 
taken from a sample depends on whether or not whole blood or lysed blood was applied to 
the FTA card. With whole blood samples, as used in this study, the sensitivity of the PCR 
starts to plateau with the processing of 10 hole-punches (250). The use of blood as a sample 
source is further complicated by the fact that within blood there are inhibitors that can 
affect the performance of the PCR reaction (251). To reduce the number of inhibitors the 
hole-punch samples were washed in a solvent. Other inhibitors present in human blood are 
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heavy metals, which can also be removed with the addition of a chelating agent, such as 
Chelex, which bind with the heavy metals and remove them from the suspension (248, 252). 
 
2.1.2 Species-specific primers 
Since the late 1980s, PCR primers have been developed and used to identify trypanosome 
species by targeting unique regions of the trypanosome genome that are a signature for the 
species of interest. Ideally, the target genes would have a high copy number to increase the 
sensitivity of the primers, as is the case with the Tbr primers, mentioned in Chapter 1. These 
primers target a 10,000 copy satellite repeat sequence unique to the T. brucei sl sub-species 
group (253) resulting in a highly sensitive and specific PCR assay. 
By 1996, a range of species-specific primers had been designed to recognise the most 
important parasite species which include T. brucei s.l., T. congolense, T. vivax, T. godfreyi 
and T. simiae (254). These species-specific primers worked well in furthering our 
understanding of epidemiology and proved that mixed trypanosome infections in tsetse 
were more common than previously thought (255-257). However, the design and validation 
of species-specific primer sets is time consuming and expensive as many screening reactions 
can deplete the DNA template. A way to reduce the number of reactions, particularly when 
screening individual samples for different trypanosome species is to run a multiplex PCR.  
This assay includes more than one primer pair in the PCR reaction allowing several PCR 
reactions contained within one tube. However, attempts at creating a multiplex primer set 
for a more varied range of species caused problems due to reductions in sensitivity and 
specificity (258). 
The limit of detection of the species-specific primers varies between species as it is 
dependent on the genes being targeted by the primers, their copy number and cross 
reaction with other primer sets. This is especially true for the primers used to differentiate 
the T. brucei sub-species as these reactions rely on the TgsGP and SRA single copy gene 
regions to distinguish between T. b. gambiense and T. b. rhodesiense. Other limitations that 
can arise from using species-specific primers depend on how specific the primers were 
designed and also the inherent genetic variability of field strains of the different species. A 
good example of this is the T. vivax species complex, which has a large number of different 
strains with varying degrees of genetic diversity. When species-specific primers were first 
designed to detect T. vivax, the DNA template used to design the primers was subsequently 
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discovered to be specific for strains from West Africa and consequently the primers 
performed poorly with East African strains (136). Species-specific primers are designed to 
detect known species of trypanosomes, not unknown species, and this can lead to an 
inability to identify microscopy-positive samples (259). This presents a challenge: how do we 
target unknown trypanosome species when we lack genomic information? Fortunately, we 
are able to deal with these knowledge gaps by mining known trypanosome genomes for 
regions that are highly conserved between a wide range of trypanosomes species, which 
assumes conservation in the unknown species. The resultant primer sets are termed 
‘generic primers’ and their use has helped identify novel trypanosome species in previous 
surveys (260) and can detect multiple species at the same time reducing time and costs. A 
good candidate region for generic primer design is the ITS region. 
 
2.1.3 Generic internal transcribed spacer (ITS) primers 
The ITS region of the genome is relatively small and highly variable, but it is flanked by 
conserved regions that are ideal for primer annealing. The ITS variable region differs in size 
between species and has a relatively high copy number of 100-200 depending on the 
species. The primers designed in previous studies have been generic so as to successfully 
amplify known and potentially unknown trypanosome species (144, 145, 147, 261). To 
increase both specificity and sensitivity, nested PCR assays have been designed that use 
outer and inner primer sets simultaneously.  The product amplified by the outer primers 
acts as the template for the inner primers (Fig.2.1).  If this reaction is performed within the 
same PCR reaction, it is termed one-step nested PCR, and when using two separate PCR 
reactions, it is called two-step nested PCR. 
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Figure 2.1 Diagram of a nested PCR reaction: 
depicting how the outer primers relate to the original DNA template (A) and the inner primers 
relate to the PCR product generated by the outer primers (B). OP denotes outer-primers, IP inner-
primers and F or R refer to the primer position, either forward or reverse. 
 
2.1.4 Sequencing trypanosomes 
To check what has been amplified in the PCR reaction and gain further information to 
differentiate species and sub-species groups, involves a separate technique called DNA 
sequencing.  Primers can be designed specifically for sequencing but it is also possible to 
have the PCR product sequenced to confirm the predicted identity based on the band size of 
PCR product.  
 
Two sites commonly targeted for sequence analysis are the 18S ribosomal RNA and the 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) genes. Both of these genes have a 
high copy number and because they are essential for eukaryotic cell function they contain, 
short, highly conserved regions as well as variable regions under evolutionary pressure, 
resulting in genetic variation. The conserved 18S and GAPDH regions permit the design of 
generic primers to amplify novel trypanosome species.  Using phylogenetic software it is 
then possible to position the new species in relation to current phylogenetic models. 
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2.1.5 Limitations of microscopy 
The traditional diagnostic microscopy methods used prior to the rise of molecular 
techniques have been essential for the study of African trypanosomiasis in animals and 
humans.  Microscopy has a very low false positive rate because it requires the identification 
of live or stained trypanosomes, as opposed to serological and molecular methods, which 
could be detecting antibodies or DNA from a previous infection which has been cured. 
Microscopy also has the advantage of being a low cost diagnostic method as it does not 
necessarily require an electricity source or cold chain, making it ideal for field use, especially 
in remote rural areas. Microscopy does have several limitations although it can be improved 
by methods such as the quantitative buffy coat concentration technique (262), however 
these extra steps increase the resources required and so restrict its use. 
 
The weakness of microscopy is that traditional examination of blood, lymph or 
cerebrospinal aspirates still have a low sensitivity (263), which can be compounded by low 
parasitemia in infected individuals. Typically T. b. gambiense infections produce fewer 
parasites than T. b. rhodesiense infections, which makes identification of West African 
sleeping sickness difficult (264). Like many lab-based diagnostic procedures, the skill and 
knowledge of the technician also greatly influences assay accuracy.  This was illustrated in a 
recent investigation where 50.4% of the laboratories tested failed to identify trypanosomes 
in a positive blood film (137).   
 
In addition to the problems of sensitivity, microscopy methods cannot morphologically 
distinguish between sub-species, such as T. b. brucei, T. b. gambiense and T. b. rhodesiense.  
Addition of serological methods to microscopic examination can help distinguish some 
trypanosome infections, such as the development of the card agglutination test for 
trypanosomiasis (CATT), which is specific for identifying T. b. gambiense sero-positive 
individuals.  However, unlike microscopy, this test is limited in that it cannot distinguish 
between a recently cured person and someone with an active infection (265). 
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2.1.6 Chapter objectives 
The specific aims of the work described in this chapter were to: 
1) Evaluate pre-existing molecular techniques for the generic identification of 
trypanosomes from mammalian blood and tsetse midguts 
 
2) Design new multiplex ITS PCR assays that target a more limited range of 
trypanosome species compared to the current generic ITS primers in order to better 
discern between target and non-target species of trypanosome. 
 
3) Quantify the sensitivity and accuracy of the new methods and demonstrate that they 
are able to three major trypanosome species of interest, T. brucei s.l., T. congolense 
and T. vivax. 
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2.2 Methods 
2.2.1 DNA extraction from FTA cards 
Blood samples were collected from 2,877 cattle and 766 pigs via a venous ear puncture 
using a 50mm heparinized capillary tube that holds 35µl of blood. The blood was then 
spotted onto Whatman FTA cards and processed using a modified version of the method 
described by Ahmed (250). For each blood spot ten hole-punches (2 mm diameter) were 
taken using a Harris Micro-PunchTM and placed into a 1.5 ml Eppendorf tube. Between 
taking each sample, the tip of the Harris Micro-Hole punch underwent three washes, first it 
was washed in 10% NaClO followed by a wash in distilled water and finally in 100% EtOH, 
each wash step took five seconds. The tip underwent a final cleaning step by punching 10 
holes from clean filter paper to ensure there was no cross contamination between samples 
and that the tip was dry after being washed. The samples were processed in batches of 72 
as this was the maximum number of samples that could be run out on the large gel tanks 
needed to determine the size of the different trypanosome species when using the generic 
ITS primers. These 72 samples included three negative hole punch controls, one reagent 
negative control, one positive hole punch control and one reagent positive control and 66 
blood spot samples. The positive hole punch control consisted of 200 µL of T. b. brucei (J10) 
stabilate that had been added to five mL of horse blood, spotted onto FTA cards and left to 
dry. 
 
Components of blood, such as heme, are known to inhibit the activity of the Thermus 
aquaticus derived DNA polymerase, therefore it was necessary to wash the samples in the 
following manner.  To the hole punches, 1ml of distilled water was added, after sealing the 
tubes the samples were then rotated using a, Reax 2, overhead shaker (manufactured by  
Heidolph) for 30 mins at 20 rpm. Following the first wash, two more wash cycles were 
carried out where the supernatant was decanted and another 1ml of distilled water added, 
the samples were rotated for a reduced time of 20 mins and 15 mins respectively at 20 rpm. 
After the final wash the supernatant was removed and the tubes were centrifuged at 10,000 
rpm for 15 sec before adding 130µl of a 10% Chelex® (Sigma)-TE suspension and 1.3 µl of 
proteinase K (20mg/ml, Bioline). Using a Star-Lab Dry Bath System   the samples were then 
heated for one hour at 56°C to allow for proteinase K digestion, which was followed by a 
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quick vortex. A second heat step at 92°C for 30 minutes to allow for the elution of DNA was 
done, after which 100µl of the eluted DNA was transferred to a separate tube. 
 
2.2.2 DNA extraction from tsetse tissues 
The DNA extraction of the tsetse tissues was modified from the FTA DNA extraction 
described above. The tsetse tissues were transported in 60µl of 100% ethanol (EtOH) in 96 
well PCR plates. To remove the alcohol, the samples were spun down at 10,000 rpm for 30 
seconds and the caps removed. The open plates were then placed in a Bio Rad T100TM 
thermal cycler for two to three hours at 56˚C in order to evaporate the ETOH. Having 
removed all the alcohol 135 µl of a solution of 1x TE buffer with a 5% Chelex solution and 
1.3µl Proteinase K (20mg/mL) was added to each sample. Fresh caps were then placed on 
the plate and it was once more centrifuged at 10,000 rpm for 30 seconds. The plates were 
then incubated in a thermal cycler at 56˚C for one hour to allow for the digestion of the 
tsetse tissues. This was followed by incubation at 93˚C for 30 minutes to elute the DNA and 
halt the enzymatic reaction. 
 
2.2.3 Blood meal analysis 
Having extracted the DNA from tsetse tissues it is possible to screen the samples not only 
for trypanosomes but also for DNA from blood meals the tsetse fly has recently ingested. To 
screen for the vertebrate host DNA sequencing primers that target the Cytochrome B 
(CytB)gene of mammals, reptiles and birds will be used (199), Table 2.1. 
The PCR conditions are the same as those described in section 2.2.5 with the exception that 
55ᵒC was used as the annealing temperature. 
Table 2-1 Vertibrate CytB primers used for the blood meal identification assay 
Primer Name Primer Sequence 5’-3’ Described by 
15_168 TACCATGAGGACAAATATCATTCTG (199) 
15_590 CCTCCTAGTTTGTTAGGGATTGATCG  
 
 
2.2.4 Limit of detection (LOD) assay 
To ensure that both the ITS and multiplex ITS had comparable sensitivity, both tests were 
assessed against a 10 fold dilution series of T. b. brucei and T. vivax DNA. The DNA dilution 
series (neat to 1/107) for each species ranged from 5 ng genomic DNA/uL to 0.0000005 
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ng/uL. Assuming that the DNA content of each T. b. brucei trypanosome is 0.1pg (266) then  
the dilution series described above ranges between the equivalent of 50,000,000 
trypanosomes/mL to 5 trypanosomes/mL. 
 
2.2.5 PCR reaction conditions 
The PCR reactions that used Bioline BIOTAQ Red  DNA polymerase were carried out at a final 
volume of 25µL each containing the following reagents: 2.5µl of 10X PCR Buffer (Bioline), 
200µM of each of the deoxynucleotide triphosphates (dNTPs) (ThermoFisher), 1.2mM of 
MgCl2 (Bioline), 0.4µM of both the forward and reverse primers and 10µL of BIOTAQ Red 
DNA Polymerase (Bioline). The first reaction of the two nested PCRs and standard PCR used 
5µL of DNA template. For the nested PCRs second reaction 1µL of the PCR product from the 
first reaction was used as the template. 
For the T. brucei s.l. multiplex and T. b. gambiense reactions DreamTaq Green was used in a 
final volume of 25µl consisting of:  12.5µl of DreamTaq Green was used with 0.2µM of each 
primer and 2µl of DNA template for the T. brucei s.l. multiplex; and: 12.5µl of DreamTaq 
Green with 0.4µM of each primer and 2µl of DNA template for the T. b. gambiense specific 
primers. 
 
The following PCR cycle was used for all three generic ITS primer sets and for the Tbr 
Trypanozoon, T. congolense and T. vivax  species-specific primers: initial denaturation step 
at 95ᵒC for 5 min, 35 cycles of 95ᵒC for 30 sec, 55ᵒC for 30 sec and 72ᵒC for 30 sec followed 
by a final extension step of 72ᵒC for 3 minutes. The PCR reactions were carried out on a 
BioRad T100TM thermal cycler. 
 
For the T. brucei s.l. multiplex reaction and the the T. b. gambiense species specific primers 
the following cycling conditions were used respectively: 95ᵒC for 10 minutes followed by 40 
cycles of 95ᵒC for 30 s, 63ᵒC for 90 s, 72ᵒC for 70 s with a final extension step for 10 minutes; 
and 95ᵒC for 3 minutes followed by 40 cycles of 95ᵒC for 30 s, 63ᵒC for 90 s, 72ᵒC for 70 s 
with a final extension step for 10 minutes. 
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2.2.6 Evaluation of current PCR methods 
2.2.6.1 ITS PCR evaluation 
There are a number of generic primers available that target the trypanosome internal 
transcriber regions (ITS). Three of these (145-147) were compared with each other to 
determine their suitability to screen the blood samples collected on FTA cards (Table 2.2).  
Primer LOD was compared using the dilution series described in section 2.2.3. The primers 
were also tested with T. b. brucei and T. congolense serial dilutions applied onto FTA cards. 
The PCR reactions were carried out as described in section 2.2.5. 
 
Table 2-2 Generic ITS primers tested 
Primer Name Primer Sequence 5’-3’ Described by 
Tryp 1R AAGCCAAGTCATCCATCG (147) 
 
 
 
Tryp 2F TAGAGGAAGCAAAAG 
Tryp 3F TGCAATTATTGGTCGCGC 
Tryp 4R CTTTGCTGCGTTCTT 
ITS1 GATTACGTCCCTGCCATTTG (146) 
ITS2 TTGTTCGCTATCGGTCTTCC  
ITS3 GGAAGCAAAAGTCGTAACAAGG  
ITS4 TGTTTTCTTTTCCTCCGCTG  
CF CCGGAAGTTCACCGATATTG (145) 
BR TTGCTGCGTTCTTCAACGAA  
 
 
2.2.6.2 Species-specific primers limit of detection 
Species-specific primers were used to help confirm the trypanosome species identified using 
the generic ITS assays. The species-specific primer sets and the target species are listed in 
Table 2.3. 
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Table 2-3 List of species-specific primers used throughout this thesis 
 
Primer name Target Species Primer Sequence 5'-3' 
Expected 
product 
size 
Reference 
Tbr F Trypanozoon CGAATGAATATTAAACAATGCGCAGT 
173 (267) 
Tbr R Trypanozoon AGAACCATTTATTAGCTTTGTTGC 
Tbr-FIND F Trypanozoon TGCGCAGTTAACGCTATTATACA 
117 (268) 
Tbr-FIND R Trypanozoon AAAGAACAGCGTTGCAAACTT 
TCS1 T. congolense Savannah CGAGAACGGGCACTTTGCGA 316 
(269) 
TCS2 T. congolense Savannah GGACAAACAAATCCCGGGCACA   
TCK1 T. congolense Kilifi GTGCCCAAATTTGAAGTGAT 
294 (269) 
TCK2 T. congolense Kilifi ACTCAAAATCGTGCACCTCG 
TCF1 T. congolense Forest GGACACGCCAGAAGGTACTT 
350 (270) 
TCF2 T. congolense Forest GTTCTCGCACCAAATCCAAC 
TVMF T. vivax TCGCTACCACAGTCGCAATCGTCGTCTCAAGG 
399 (51) 
TVMR T. vivax CAGCTCGGCGAAGGCCACTTCGCTGGGGTG 
PLC 657 T. brucei s.l. CTTTGTTGAGGAGCTGCA 
324 (271)  
PLC 658 T. brucei s.l. CACCGCAAAGTCGTTATT 
SRA 02 T. b. rhodesiense AGCCAAAACCAGTGGGCA 
669 (271) 
SRA 03 T. b. rhodesiense TAGCGCTGTCCTGTAGACGCT 
VSG 651 T. brucei s.l. GAAGAGCCCGTCAAGAAGGTTTG 
>1Kb (271)  
VSG 651 T. brucei s.l. TTTTGAGCCTTCCACAAGCTTGGG 
TgsGP F T. b. gambiense GCTGCTGTGTTCGGAGAGC 
308 (272) 
TgsGP R T. b. gambiense GCCATCGTGCTTGCCGCTC 
 
With the exception of the PLC, SRA, VSG and TgsGP primers the species-specific primers 
were tested to determine their LOD using the serial dilution described in section 2.2.3 with 
the addition of a T. congolense Savanna dilution gradient covering the same ng/µL range. 
The species-specific PCR reactions were carried out using the conditions described in section  
 
2.2.5. 
2.2.7 Novel PCR assay development 
2.2.7.1 ITS multiplex development 
The strength of a generic ITS PCR can also be its weakness as it can be too generic.  For 
example, if it can amplify non-salivarian trypanosome species, this will cause additional 
complications when trying to identify the species based on banding patterns in an agarose 
gel. A potential contaminating source of non-tsetse transmitted trypanosomes are the 
cattle-associated Trypanosoma theileri species group (273). The ITS region is variable in size 
between different strains of T. theileri. This results in a range of PCR product band sizes, 
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approximately 220bp-380bp, which overlap with bands from salivarian trypanosome 
species, creating false positive identification.  Free living flagellates closely related to 
trypanosomes, such as Bodo saltans, can also be amplified. 
 
The ITS-based multiplex primers (mITS) used in the present study were designed to amplify 
the following three key trypanosome species: T. vivax, T. congolense and the Trypanozoon 
species group, which includes both the human and animal parasites. The primers bind to the 
inner region of the ITS 1 gene between the internal forward and reverse primers described 
by Adams 2006 (147) as this was the primer set selected to be used in the study.. This design 
allows for comparable levels of sensitivity between the generic ITS assay and the mITS 
assay. The outer primers remain the same to retain the sensitivity between the mITS 
primers and the generic ITS primers and to use the PCR product from the first nest to be 
useable with both the multiplex and generic primers. The mITS primers were designed by 
aligning the ITS 1 region from within the inner primers using Mega 6 software (274). The 
primers were designed to have a universal forward primer and a species-specific reverse 
primer. The following sequences from the NCBI database were aligned to test forward 
primer specificity: T. congolense Kilifi (TCU22317), T. congolense Forest (U22319), T. 
congolense Savannah/IL1180 (U22315), T. brucei s.l. (JX910373), T. vivax (U22316), T. 
godfreyi (ZWA6307), T. simiae (AB742533), T. theileri (JX853185) and Bodo saltans 
(AY028452). Reverse primer specificities were tested with the NCBI Primer-Blast tool (275) 
against other trypanosome species. The primers were also screened against human, cow, 
pig, tsetse and three tsetse symbionts (Wolbachia, Wigglesworthia and Sodalis) genomes to 
test for cross reactivity. 
 The identification of T. brucei s.l., the three T. congolense strains and T. vivax was based on 
each species having its own expected band size on amplification with mITS primers. To test 
potential cross reactivity and specificity, the selected primers were then screened against a 
library of trypanosome DNA: T. b. brucei, T. congolense Savannah, T. congolense Forest, T. 
congolense Kilifi, T. vivax, T. godfreyi, T. simiae and T. simiae Tsavo. 
 
2.2.8 18S and GAPDH sequencing 
The sequencing primers targeting the trypanosome GAPDH (276, 277) and 18S (278) genes 
were tested with the DNA library and four Tryp 1-4 positive cattle blood spots collected 
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from the field. Despite using DNA samples that had previously yielded reliable results, there 
were failures in DNA amplification when working with the field samples.  Protocol 
improvements by 1) cleaning the DNA using Qiagen DNeasy Blood and Tissue Kit (279), 2) 
concentrating the DNA by precipitation, 3) modifying temperature gradients 4) re-ordering 
and testing primers and 5) testing different taq-polymerases failed to increase primer 
performance. Consequently, new primers were designed to target the same variable regions 
as the original 18S and GAPDH primers, but with a smaller product size to ensure that if any 
DNA degradation was present, particularly in field samples, there would be a better chance 
of amplification. 
 
These alternative primers were designed by separately aligning the variable regions of both 
the 18S and GAPDH genes, from a range of trypanosome species, not just the African 
salivarian species, to help identify the most conserved regions. Where possible the same 
species were used but there was not a 100% concordance between the species used to 
design the 18S and GAPDH primers due to what was available on the NCBI online database.  
To increase their sensitivity, inner and outer sets of primers (nested) were developed. To 
design the new 18S primers, sequences from T. b. rhodesiense (AJ009142), T. congolense 
(AJ009146), T. godfreyi (AJ009155), T. grayi (KF546526), T. lewisi (GU252209), T. grosi 
(AB175623) and T. otospermophili (AB175625) were aligned and the primers designed to 
amplify the 500-600 bp variable region. To design the GAPDH primers the following 
sequences were aligned, T. b. rhodesiense (AJ620284), T. congolense (AJ620291), T. simiae 
Tsavo (FM879137), T. vivax (AF053744), T. grayi (FM164795), T. lewisi (AJ620272) and T. 
grosi (AB362557). The primers were then tested using the NCBI Primer design tool (275) to 
check for kinetoplastid specificity. The new primers were again screened against human, 
cattle, pig and tsetse genomes, including the bacterial tsetse symbionts. 
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2.3 Results 
2.3.1 Evaluation of current PCR methods 
2.3.1.1 ITS PCR evaluation 
Three primer sets were tested with the trypanosome DNA library kindly supplied by 
Professor Wendy Gibson from Bristol University. All three primer sets performed well and 
produced PCR products with bands of the expected size (Table 2.4). 
 
Table 2-4 The band sizes (bp) produced by each of the ITS trypanosome primer sets. 
Primer set Trypanosome species Final product size (bp) 
Tryp 1-4 
(nested) 
  
  
  
  
  
  
  
  
T. congolense Savannah 640 
T. congolense Forest 640 
T. congolense Kilifi 560 
Trypanozoon 430 
T. simiae 370 
T. simiae Tsavo 350 
T. grayi 350 
T. godreyi 240 
T. vivax 180-200 
ITS 1-4 
(nested) 
  
  
  
  
  
  
  
  
T. congolense Savannah 1413 
T. congolense Forest 1513 
T. congolense Kilifi 1422 
Trypanozoon 1207-1224 
T. simiae 850 
T. simiae Tsavo 980 
T. grayi 940 
T. godreyi 650 
T. vivax 611 
 
 
 
ITS CF-BR 
  
  
  
  
  
  
  
  
T. congolense Savannah 700 
T. congolense Forest 700 
T. congolense Kilifi 620 
Trypanozoon 480 
T. simiae 396 
T. simiae Tsavo 370 
T. grayi 370 
T. godreyi 300 
T. vivax 240 
 
 
 
The sensitivity of the different Generic PCRs was tested with a 10 fold dilution series of T. b. 
brucei and T. vivax DNA. The two nested primer sets (Tryp 1-4 and ITS 1-4) had a higher 
sensitivity than the simple PCR primers (CF-BR); the latter started to lose sensitivity after 0.5 
52 
 
ng/μL and only produced a very faint band with 0.05 ng/μL of template, whereas both 
nested PCRs produced strong bands at this concentration and only failed to amplify the 
target DNA after 0.005ng/µL  
 
Once these primers were validated, they were tested on DNA extracted from blood spots 
preserved on FTA cards where varying concentrations of trypanosomes had been added (1 x 
102 trypanosomes/mL to 1 x 106 trypanosomes/mL). The simple ITS CF-BR PCR assay again 
had reduced sensitivity and was unable to identify the lowest concentration of T. 
congolense trypanosomes. The nested primer set, ITS 1-4 also failed to amplify the lowest 
concentration of the T. b. brucei and T. congolense sample. Only the Tryp 1-4 (nested) 
primers correctly identified all the trypanosome-spiked samples, including the lower 
concentrations of T. congolense and T. b. brucei. Based on these results, the generic ITS 1 
primers described by Adams et al 2006 would be used to screen all future blood samples 
(Fig2.2). 
 
 
 
Figure 2.2 Gel image of the relative sizes of the salivarian trypanosomes: 
(1) T. vivax, (2) T. godfreyi, (3) T. grayi, (4) T. simiae, (5) T. simiae Tsavo, (6) T. brucei s.l., (7) T. 
congolense Kilifi, (8) T. congolense Savannah, (9) T. congolense Forest and (M) marker 
 
 
2.3.1.2 Species-specific primers 
Compared to the Tryp 1-4 and mITS nested primers, the limit of detection for the species-
specific primers varied. The species-specific primers for T. congolense and T. vivax were less 
sensitive than either of the nested primers failing to detect any DNA beyond 0.05ng/µL, 
however both the T. brucei s.l. specific primers (Tbr and Tbr-FIND) were more sensitive than 
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the nested primers with the ability to amplify 0.000005ng of DNA/μL, the equivalent of 50 
trypanosomes/mL. 
 
2.3.2 Novel PCR assay development 
2.3.2.1 Multiplex ITS primers (mITS) 
Having aligned the sequences for T. congolense Kilifi (TCU22317), T. congolense Forest 
(U22319), T. congolense Savannah/IL1180 (U22315), T. brucei s.l. (JX910373), T. vivax 
(U22316), T. godfreyi (ZWA6307) and T. simiae (AB742533), the primers in Table 2.5 and Fig 
2.3, were designed and tested using the NCBI Primer-basic local alignment search tool 
(BLAST) (275) against the Genome database (from all organisms). 
 
Table 2-5 Novel multiplex ITS 1 sequences and PCR product sizes 
Primer name Sequence 5'-3' Target organism Product size Tm˚C 
MpMk2F TAGCTGTAGGTGAACCTGCAGC  Trypanosomatidae - 63 
MpMkTcR GCGTCAGGCGGCRWAAGAA T. congolense 392, 433* 63 
MpMkTbR ATGCGAGGTTGATATACACATAGCA T .brucei sl 342 63 
MpMkTvR GCCGTGCTCCACCTG T .vivax 139 63 
 
*two different sizes of product due to T. congolense Kilifi having a shorter ITS 1 region than T. congolense 
Savannah and T. congolense Forest. 
 
 
 
Figure 2.3 Gel image showing the relative sizes of the mITS PCR reaction: 
(1) T. congolense Savannah, (2) T. vivax and (3) T. b. brucei. Lanes 4-6 comprised of two negative reagent 
controls and a single T. b. gambiense positive control respectively. The nucleotide weight marker (M) used 
was the 100bp ladder from Invitrogen 
 
 
The following in silico conditions were used to design the primers: product size = 100 bp +/- 
the target product size, primer melting temperatures (Tm) 61˚C - 65˚C with a max Tm 
difference of 2˚C. The remaining test conditions were left as the default settings. 
There was some cross priming detected with other species, most notably with the T. vivax 
reverse primer, however these products were beyond the size range specified, (max 100 bp 
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+/-) of the target product size. Dilution assays of T. b. brucei and T. vivax demonstrated that 
both the original generic ITS 1 primers designed by Adams (2006) and the new multiplex 
primers have a similar detection range with a lower limit of 0.05 ng/uL for the trypanosome 
species tested. 
 
2.3.2.2 18S and GAPDH 
The new 18S and GAPDH primers are listed in Table 2.6. They were tested against the 
trypanosome DNA library and produced the expected sized products. These were sent for 
sequencing and BLASTed to confirm identity. Both sets of primers were able to amplify the 
18S and GAPDH regions correctly for each trypanosome species they were tested against. 
When tested against the specified non-target organisms, no products with 100 bp +/- pf the 
expected product size were produced. 
Table 2-6 Novel sequencing primers for Trypanosoma 
Primer name Sequence 5'-3' Target organism Product size* Tm˚C 
GAPDHFout TACTTYGCVTAYCAGATGMRSTACG Trypanosoma 789 55 
GAPDHRout GCTKCGRYTGTCRYTGATGA Trypanosoma 789 55 
GAPDHFin CACCAYGTBGTGTCSAACG Trypanosoma 349 55 
GAPDHRin CRATCTCCTTGATGCBTGTGT Trypanosoma 349 55 
18S Fout TAATTCCAGCTCCAAAAGCG Trypanosoma 713-814 55 
18S Rout CGTGCTGAGGAYATTCCCGT Trypanosoma 713-814 55 
18S Fin TCGTAGTTGAAYTGTGGGC Trypanosoma 515-599 55 
18S Rin GCAGTGTGGACTACAAT Trypanosoma 515-599 55 
 
*there is a size variation amongst the products produced by the 18S primers depending on the species of 
trypanosome being amplified. 
 
Both sets of sequencing primers were also tested with a serial dilution of T. b. brucei and T. 
vivax DNA. The GAPDH primers had a higher sensitivity than the ITS 1 and mITS primers 
when tested against the T. brucei DNA with a lower limit of 0.005 ng/µL and a comparable 
sensitivity when tested against the T. vivax DNA. However the 18S primer was more 
sensitive than the ITS 1 and mITS primers by a factor of two when tested against the T. b. 
brucei concentration gradient and by a factor of one against the T. vivax assay with lower 
limits of 0.0005 ng/µL and 0.005 ng/µL, respectively, Fig 2.4. Due to the difference in 
sensitivity, only the 18S sequencing primers were taken forward to be used in the rest of the 
thesis. 
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Figure 2.4 Gel image of the GAPDH (1-18) and 18S (19-36) limit of detection assay: 
(1-8, 19-26) and T. vivax (10-17, 28-35). Negative controls were included (9, 18, 27 and 36) plus molecular 
weight markers (M). 
 
2.4 Discussion 
2.4.1 Generic ITS primer set 
Of the three generic ITS-based primer sets screened, the primers named Tryp 1-4 proved 
most promising due to their higher sensitivity and absence of non-specific DNA 
amplification. The lower detection limit of Tryp 1-4 was 0.05 ng/μl of trypanosome DNA 
based on dilution series of T. b. brucei and T. vivax. 
 
2.4.2 Multiplex ITS (mITS) primers 
A set of multiplex primers was designed to amplify the specific subset of trypanosome 
species of medical and veterinary importance. This was done using a universal forward 
primer and species-specific reverse primers for the Trypanozoon group, T. congolense and T. 
vivax. The mITS primers were designed for use with the Tryp 1-4 ITS outer primers to ensure 
that the sensitivities between the two primer sets were the same, thus permitting 
comparison between the two sets. The outer Tryp 1-4 primers can be used with the original 
inner primers and the mITS primers as both have equivalent sensitivity. When tested against 
non-specific gene targets, the mITS did not amplify non-target salivarian trypanosomes, T. 
theileri and B. saltans, which confirms that the presence of these non-target organisms in 
samples will not confound the multiplex assay. 
 
2.4.3 Sequencing primers for 18S and GAPDH 
Primers designed to amplify the 18S and GAPDH gene sequencing regions successfully 
amplified all nine trypanosomes in the DNA library. When tested against field isolates, the 
primers amplified DNA products of the correct size and of suitable quality for sequencing. 
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The sensitivity of these sequencing primers are equivalent to the nested ITS primers used to 
initially identify samples of interest.  Sequencing primers can be used to confirm the identity 
of amplified samples by quickly sending products off for sequencing without delay.   GAPDH 
and 18S primer sets also help confirm sample identities made with Tryp 1-4 and mITS 
primers.  Furthermore, when unknown trypanosome species are identified, these primers 
are crucial for getting sequence data that can place new species in the correct phylogenetic 
position relative to currently known trypanosomatids. 
 
2.4.4 Species-specific primers 
Species-specific primers can identify trypanosomes without the added complication and 
expense of sending PCR products for DNA sequencing. However, of the eight species-specific 
primer sets selected for parasite identification, only the TBR primers (that target the T. 
brucei sl sub-species) had a greater sensitivity than the nested ITS primers. This difference in 
sensitivity is due to the nested nature of the generic ITS primers and a difference in copy 
number of the genomic sequence that the ITS and Tbr primers target. Therefore, the Tryp 1-
4 and mITS primers, because of the high copy number of target gene, are more likely to 
detect lower amounts of trypanosome DNA than the species-specific primers, with the 
exception of the Tbr primers. Additionally, the generic nature of Tryp 1-4 primers enhances 
the amplification of local strains that may not react with the more precise species-specific 
primers.  However, using species-specific primers offer a more convenient and affordable 
means to quickly confirm most positive samples identified by generic PCR assays than 
sequencing. 
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2.4.5 Final primer selection 
Having assessed the primers described in this chapter the following primer selection was 
made, Table 2.7, to be used throughout the rest of the thesis. 
 
Table 2.7 Final selection of primers to be used throughout the rest of the thesis for the identification and 
detection of trypanosomes 
Primer set Target species Final product size (bp) 
LOD 
ng/µl 
Tryp 1-4 
(nested) 
T. congolense Savannah 640 
0.05 
T. congolense Forest 640 
T. congolense Kilifi 560 
Trypanozoon 430 
T. simiae 370 
T. simiae Tsavo 350 
T. grayi 350 
T. godreyi 240 
T. vivax 180-200 
mITS (nested) 
T. congolense Savannah 433 
0.05 
T. congolense Forest 433 
T. congolense Kilifi 392 
Trypanozoon 342 
T. vivax 139 
18S (nested) Trypanosoma 349 
0.005-
0.0005* 
Tbr-FIND Trypanozoon 117 0.000005 
TCS T. congolense Savannah 316 0.5 
TV T. vivax 399 0.5 
PLC T. brucei s.l. 324   
SRA T. b. rhodesiense 669   
VSG T. brucei s.l. >1Kb   
TgsGP T. b. gambiense 308   
*These values are only applicable to T. vivax and T. brucei s.l., LOD for T. congolense was not determined. 
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 : Prevalence of T. brucei s.l. and other Trypanosoma spp. in 
G. f. fuscipes 
 
3.1 Background 
3.1.1 Tsetse as vectors of HAT and AAT 
The tsetse fly, genus Glossinidae, is the sole vector for the two trypanosome sub-species 
responsible for human African trypanosomiasis.  They are also the most important vectors 
of Trypanosoma spp. which cause animal African trypanosomiasis, albeit horseflies 
(Tabanidae) are able to act as mechanical vectors for veterinary important species of 
trypanosomes (280, 281). Due to their ability to act as mechanical vectors, tabanids have 
been able to spread T. vivax outside of Africa amongst South American cattle populations 
(282).  
 
The study of the vector population is important in understanding the transmission of 
disease as key aspects of vector biology have been shown to affect disease transmission, 
these include the species of local tsetse present (120, 283-285),  the age structure of the 
tsetse population (203, 286-288), sex (289)  and host preference (290, 291) . 
There are 30 species of tsetse and these are assigned to one of three species groups, 
Mositans (Glossina), Palpalis (Nemorhina) and Fusca (Austeni) Table 3.1. Of these 30 species 
only six are responsible for the majority of sleeping sickness cases, Glossina palpalis, 
Glossina fuscipes, Glossina tachninoides, Glossina morsitans, Glossina pallidipes and 
Glossina swynnertoni (156, 292). These six species all belong to only two of the species 
groups Palpalis and Morsitans. The third group of tsetse flies, Fusca is not considered a 
vector of HAT as it rarely feeds on humans and typically occupies habitat that is removed 
from urban and agricultural lands. The species of tsetse responsible for the spread of 
nagana include the five associated with HAT as well as Glossina austeni and Glossina 
longipalpis and the following members of the Fusca group: Glossina brevipalpis, Glossina 
fusca, Glossina tabaniformis and Glossina vanhoofi. 
The susceptibility of tsetse to infection with T. brucei is primarily dependent on the age of 
the tsetse, newly emerged flies, termed teneral flies, are more susceptible to infection from 
trypanosomes compared to older flies although starvation can also render older flies 
59 
 
susceptible to infection (293). Other factors that can contribute to a mature trypanosome 
infection establishing in tsetse are the vector species (120) , the sex of the tsetse (294), 
temperature (295), the specific strains of trypanosome parasites (296, 297) and even the 
microbiome of the tsetse with special significance placed on the presence of the symbiont 
bacteria Sodalis glossinidius (298). 
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Table 3-1 A list of all 30 species of tsetse detailing their respective habitats 
 
Group Glossina species Habitat 
Morsitans 
G. longipalpis 
Woodland savannah 
G. pallidipes 
G. morsitans morsitans 
G. morsitans submorsitans 
G. morsitans centralis 
G. swynnertoni 
G. austeni 
Palpalis 
G. palpalis palpalis 
Riverine and swamp vegetation 
G. palpalis gambiensis 
G. fuscipes fuscipes 
G. fuscipes martinii 
G. fuscipes quanzensis 
G. tachinoides 
G. pallicera pallicera 
G. pallicera newsteadi 
G. caliginea 
Fusca 
G. nigrofusca nigrofusca 
Rain Forest and Riverine Forest 
G. nigrofusca hopkinsi 
G. fusca fusca 
G. fusca congolensis 
G. fuscipleuris 
G. haningtoni 
G. schwetzi 
G. tabaniformis 
G. nashi 
G. vanhoofi 
G. medicorum 
G. severini 
G. brevipalpis 
G. longipennis* 
 
 
*G. longipennis differs from the other Fusca species in that it is found in savannah habitats and not in forest 
habitats. 
 
Salivarian trypanosomes take varying amounts of time to establish a mature infection in 
their respective tsetse hosts, this is temperature dependent with T. vivax taking between 
five days at 29ᵒC to 13 days at 22ᵒC (295).  T. brucei s.l. has been shown to take between 17 
to 45 days (299) to establish a mature infection with a study on T. b. rhodesiense showing 
that at temperatures of 28ᵒC and 30ᵒC it took 23 and 12 days respectively to establish 
salivary gland infections (300). Studies on T. congolense have shown at 23ᵒC to 24ᵒC it takes 
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15 to 20 days for a mature infection to establish (285) although other studies have shown 
that it can take 19 to 53 days for T. congolense to establish an infection (299). The sex of the 
tsetse is another aspect of the biology that has been shown to affect the ability of 
trypanosomes to establish an infection. Male tsetse are more susceptible to the 
establishment of mature salivary gland infections in the species G. m. morsitans and a 
similar difference between the sexes was seen in G. pallidipes however it was less 
pronounced (294). 
 
3.1.2 Identification of infection 
The Lloyd and Johnson method of assessing infection of tsetse with trypanosomes (135) is a 
traditional technique for identifying three of the major trypanosome sub-genera based on 
the tissue type that trypanosomes are found in after dissection (Fig 3.1). The identification 
of trypanosomes in either the salivary glands, midgut or mouthparts of the tsetse are used, 
in theory, determine whether the trypanosomes are either Trypanozoon, Nannomonas or 
Duttonella. The Lloyd and Johnson technique which was developed to identify the species of 
trypanosome in the tsetse has limitations (259) as it cannot identify mixed infections or 
distinguish between species that invade the same organs, e.g., infections of T. brucei and T. 
congelense in the midgut.  However, the traditional dissection technique can inform on 
whether the fly has a mature infection and the location of the parasites can provide a 
preliminary overview of what to expect in later, more sensitive, molecular assays.  
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Figure 3.1 Trypanosome development in the tsetse 
Image adapted from FAO handbook for tsetse control (159). Using this method trypanosomes found in the 
mid gut would be classed as either T. congolense or T. brucei s.l., those found in the mouthparts would 
either be T. vivax or T. congolense whilst those found in the salivary glands would be indentified as T. brucei 
s.l.. 
 
 
As previously mentioned (Chapter 1) the use of molecular methods for identifying 
trypanosomes greatly increases the resolution of prevalence of different trypanosome 
species with regards to the sensitivity and specificity. 
 
3.1.3 Ageing tsetse 
As well as identifying infected flies, classical dissection methods also allow the age of flies to 
be estimated either through the wing fray method (301) or through ovarian dissection (302). 
The importance of understanding the ages of the vector population allow for assessment of 
transmission risk, with older flies more likely to have a mature infection (303, 304). The two 
ageing methods that can be used vary in their application and accuracy, the wing fray 
method can be applied to both male and female tsetse but is considered less accurate as it 
is dependent on the activity of the individual fly, which may vary not just between 
individuals but between seasons and the sampling method  (305). 
 
The ovarian method used to determine the physiological age of tsetse was adapted by 
Saunders (302) from the methods developed by Soviet scientists for determining the age of 
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mosquitoes (306).   To carry out this method the ovaries and uterus of the tsetse are 
removed, once removed it is possible to observe the different developmental states of the 
four oocytes found in the ovaries. These four oocytes are termed the left inner, right inner, 
left outer and right outer due to their relative position within the female, with the inner 
oocytes located more anteriorly than those termed outer oocytes (Fig 3.2). 
 
Figure 3.2 Female tsetse reproductive system: 
(A) diagram of the female tsetse reproductive organs, with the four oocytes labelled as follows: (i) Right 
inner oocyte, (ii) Left inner oocyte, (iii) Right outer oocyte, (iv) Left outer oocyte. (B) an example of an 
ovarian dissection showing the correct orientation with the spermathecae overlaid on top of the ovaries. 
The developing larvae can be clearly seen in the uterus. (C) the right outer oocyte has been removed from 
the right ovarie and here we are able to see the follicular tube with a relic attached (v) and the germarium 
(vi). Image adapted from the FAO training handbook (159) 
 
 
This method takes advantage of the sequential development of the oocytes and the known 
time it takes for the completion of a gonotrophic cycle (Fig 3.3). This method can only be 
used with fertilised females and any delay in fertilisation would skew the physiological age 
of the tsetse from the chronological age. The extent of this skewing is slight as the 
probability of finding un-inseminated females a week after emergence is very low (307). 
Research conducted with G. pallidipes and G. m. morsitans found the probability of finding a 
virgin female seven days after emergence was 10% and 0% respectively (308). 
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Figure 3.3 Ovarian categories (0-7) and their age estimates 
Image adapted from the FAO training handbook (159) showing the relative development of the ovaries and 
their corresponding age estimation. 
 
3.1.4 Host blood meal identification 
Blood meal analysis in the study of disease transmission allows the researcher to identify 
the main hosts of the hematophagous insect vectors. The ability to identify what animals 
the tsetse are feeding on provides information on the range and relative importance of 
hosts. Monitoring tsetse feeding in the field and observing them feeding on host animals 
can be problematic as the presence of a field worker trying to observe this behaviour may in 
itself attract or repel flies depending on the species (187, 309). An alternative to observing 
the active feeding of tsetse on animals is to analyse their gut contents in order to identify 
which animal species they have fed upon. The basis of analysing the gut contents of 
hematophagous insects relies on the identification of markers that are specific to the hosts. 
These markers must be stable so as not to degrade to quickly over time and they must occur 
in relatively high amounts so that they can be detected in the low volume of an insect blood 
meal. The two most commonly used types of markers for blood meal identification are 
proteins and DNA.  
 
The detection and identification of different host specific proteins relies on the antigenic 
relationship of different animal sera with their phylogenetic classification. This principle was 
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first demonstrated in 1904 by Nuttall (310) with his experiments into blood precipitation 
tests. In these experiments, he was able to demonstrate that, when mixed, the serum of 
two different species formed a precipitate and that this reaction was more distinct the less 
related the two species were. This method was adapted for use in the investigation of 
arthropod blood meals (311, 312). The precipitin test is not commonly used as it lacks 
specificity due to cross-reaction between phylogenetically close species and it is expensive 
as it requires a large volume of antibodies (313).  
 
Due to the poor sensitivity of the precipitin test a more sensitive serological test was 
developed by Weitz (314) known as an inhibition test. Despite being more sensitive than the 
precipitin test (315), it still resulted in cross reactions and was technically more complex 
making it ill-suited for field work. In 1986, the enzyme-linked immunosorbent assay (ELISA) 
was developed for the identification of blood meals in haematophagous insects by Service 
(316). The ELISA test uses immobilised antibodies that had been raised against specific host 
species. The ELISA tests were less complex and could be used in a kit form making them 
more suitable for field work. A study by Clausen in 1998 using the ELISA technology was 
used to screen 29, 245 wild caught tsetse blood meals. In total, 62.8% of the blood meals 
were identified down to either host-group, (e.g. ruminant), family or species (172).  These 
antigenic methods require the screening of the blood samples against pre-prepared host 
immune sera, therefore the more potential hosts there are the larger the number of 
immune sera that need to be prepared, making these methods labour intensive. These 
serological methods have a low specificity when distinguishing between closely related 
species such as species of antelope (172).  
 
The use of molecular methods to identify vector blood meals has been used since the early 
1990s and has the advantage of being able to not just distinguish between different host 
species but is also able to use genetic markers to discriminate between individuals within a 
village (317) or group of animal hosts (318) The other advantage of molecular methods is 
that it is possible to amplify the DNA allowing for greater analysis from a smaller starting 
volume, making the process highly sensitive(319). As discussed previously (Chapter 2, 
section 2.2.3), the cytochrome b region of the genome can be used to identify the source of 
blood meals. This gene is conserved across genera and is often used as a target to identify 
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the origins of blood meals in haematophagous arthropods (198, 320, 321). There have been 
various assays developed targeting this region, designed to be read on a gel or submitted for 
sequencing (322, 323). 
 
3.1.5 Objectives 
North Western Uganda is a historic hot spot for gambiense sleeping sickness (56). Using 
both classical entomological methods and molecular methods this chapter describes studies 
conducted to assess the prevalence of T. brucei s.l., T. congolense and T. vivax in the tsetse 
population. As mentioned in section 3.1.1 the prevalence of trypanosome infection in tsetse 
populations is dependent on physiological and environmental factors, which this chapter 
will assess. The overall aim of the work described in this Chapter was to assess the 
prevalence of Trypanosoma spp. in the tsetse population of the Koboko focus in NW 
Uganda.  To achieve this aim, the the specific objectives were: 
1. Using traditional and molecular methods, assess the prevalence of T. brucei s.l., T. 
congolense and T. vivax in the local tsetse population 
2. Quantify variation in the age structure, sex ratio and relative abundance of tsetse 
across a period of 16 months from April 2013 to July 2014. 
3. Assess the impact of temperature and rainfall on the abundance, age structure and 
sex ratio of the tsetse population 
4. Using the molecular methods to screen for vertebrate cytochrome b DNA estimate 
the diet of the tsetse population. 
5. Screen the Tbr positive tsetse samples for T. b. gambiense using the T. brucei s.l. 
multiplex primer assay and the TgsGP primers. 
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3.2 Methods 
3.1.5 Study site 
The study site was located along the Kochi River in the Koboko district of NW Uganda. The 
Kochi is a perennial river that flows through Koboko allowing for tsetse sampling throughout 
the year. Traps were deployed between 3.451ᵒ-3.465ᵒ N and 30ᵒ58’-31ᵒ03’E. This is an 
agricultural area where crops such as cassava, tobacco, millet and sesame are grown. The 
human population of Koboko was 204,048 in 2014 (324). The most recent census on the 
livestock numbers raised in Koboko (325) are given in Table 3.2. Of the mammalian livestock 
animals, the low number of pigs is a reflection of Islam being the predominant religion in the 
area. 
Table 3-2 Census numbers from 2008 of the different domestic animals present in Koboko 
Livestock Number Percentage of total livestock population 
Cattle 54204 13.2 
Goat 101602 24.8 
Sheep 33250 8.1 
Pig 275 0.1 
Chicken 209513 51.2 
Ducks 9742 2.4 
Turkeys 648 0.2 
Total livestock population 409234   
 
 
 
The NW of Uganda is a historic focus for Gambiense sleeping sickness cases, with the 
disease being reported from 1905 (326) to the present day. The number of gambiense-HAT 
(gHAT) cases reported from the area has decreased from 948 in 2000 to only four cases in 
the first 10 months of 2016 (327). This makes the NW of Uganda a good example of a gHAT 
focus close to elimination. The main vector of T. b. gambiense in NW of Uganda is G. f. 
fuscipes (159, 236, 328), a member of the palpalis group and one of the six species of tsetse 
responsible for the majority of sleeping sickness transmission.  
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3.2.1 Tsetse catches 
A total of 6,664tsetse flies were caught along the Kochi River in the district of Koboko over 
16 months from April 2013 to July 2014, Fig 3.4. These flies were caught at a total of four 
different trap sites (KO16, KO19, KO20 and KO21) using standard pyramidal traps (329) Fig 
3.5.  
 
Figure 3.4 Tsetse catch numbers from the Kochi river from April 2013 to July 2014 
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Figure 3.5 A map of the tsetse study site: 
Trap sites used are denoted by a red tsetse symbol, B. pyramidal trap set up along the Kochi River. 
 
 
 
The traps were deployed <2m from the river and grease was smeared on the branch 
supporting the trap to prevent ants getting into the trap and carrying off any caught flies. 
The traps were checked twice a day, once in the morning at 7:30 h and again in the 
afternoon at 15:30 h, traps with tsetse were removed and replaced with a fresh trap. The 
tsetse-laden traps were transported back to the field laboratory in chilled cooler boxes with 
a damp cloth to reduce heat stress and mortality. 
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3.2.2 Dissection 
On arrival to the laboratory, the traps were emptied and the live and dead tsetse were 
sorted based on eye colour and we also took this opportunity to sex the flies based on their 
external genitalia. The tsetse were dissected by trained laboratory technicians using a Zeiss 
Stemi 2000 dissection microscope equipped with the C LED stand. The three tissues of 
interest, mouthparts, salivary glands and midgut, were then screened using one of two 
compound microscopes, either a Zeiss Primo Star or a Leica DM500. Both these microscopes 
were fitted with a dark-field filter to increase contrast when screening samples for living 
trypanosomes. 
 
The dissection first required the removal of the head and salivary glands by carefully pulling 
the head off from the thorax, the salivary glands still being attached to the head are then 
pulled out of the body. The head and salivary glands were then transferred to a separate 
drop of saline on the same slide and here the salivary glands are separated from the head. 
Having removed the salivary glands, the body of female flies was further dissected by 
making two small incisions either side of the second abdominal segment after which the 
ovaries, spermathecae and uterus were then pulled out. Categorising of the ovaries 
followed the method described by Saunders (302) described in section 3.1.3.  
Having been aged, the female flies then had their midguts dissected out by removing the 
abdomen from the thorax and drawing out the midgut. The midgut was then macerated 
with the dissecting forceps and screened using one of the two compound microscopes at 
200x and 400x using the dark-field filter in order to check for trypanosomes. The salivary 
glands were left intact and screened at the same magnification as the midgut tissue. Finally, 
the mouthparts were removed and dissected separately on the slide and again screened for 
infection as the midguts and salivary glands were screened. 
 
A tissue was deemed infected if living trypanosomes were seen within the tissue and 
negative tissues were devoid of any visibly motile trypanosomes. All tissues were stored in 
60µl of 100% ethanol (ETOH) including those that were trypanosome negative using 
traditional microscopy methods. The tissues from each fly were stored separately on a 96 
well PCR plate sealed with strip caps, so that each plate comprised 32 flies divided up into 
mouth parts, salivary glands and midgut. 
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3.2.3 DNA extraction 
A subsample of 2,184 of the 6,664 dissected tsetse were selected for further analysis using 
the mITS primers described in Chapter 2 (section 2.2.6). Prior to extraction of DNA tissues 
from each fly were preserved separately in 60µL of 100% ethanol. The DNA extraction was 
carried out on each individually preserved tissue so that for each tsetse its midgut, salivary 
glands and mouthparts would have their DNA extracted and stored. The DNA extraction 
followed the protocol described in Chapter 2 section 2.2.2. 
 
3.2.4 Trypanosome PCR 
The tsetse samples were to be processed with the generic ITS primers however the 
presence of a Bodo sl contamination cross reacted with ITS primers producing a product of 
similar size to T. vivax. This led to the development and adoption of the mITS primers for all 
work in this chapter as the specificity of the mITS primers resulted in no cross reaction with 
Bodo s.l.. The analysis of the tsetse samples followed a two-step process.  First, 2µL aliquots 
of the different tissues for each fly were pooled together and these were screened with the 
mITS for any positive tsetse. Second, upon identifying any positive pools of tissues the 
midgut, salivary glands and mouthparts from the positive pool were then re-screened 
individually to identify which organ of the tsetse was infected, and therefore to determine if 
the infections were mature or immature. The samples identified as positive for T. brucei s.l. 
would be screened with the T. brucei s.l. multiplex primers designed by Kim Picozzi (271) 
and with the TgsGP primers specific for T. brucei gambiense (272). The T. brucei s.l. 
multiplex included universal Trypanozoon primers that target a single copy gene, 
phospholipase C (PLC), (330-332) and primers that amplify the serum resistance associated 
(SRA) gene. Amplification of the PLC gene indicates that there is enough material in the 
template for the detection of single copy genes, such as the T. b. gambiense specific 
glycoprotein (TgsGP) primers. The mITS PCR and T. brucei sub-species PCR followed the 
methods described in Chapter 2 (section 2.2.5). 
 
3.2.5 Identification of T. brucei s.l. sub-species 
There is a difference between the sensitivity of the primers used to identify samples positive 
for T. brucei s.l. and those used to identify down to the sub-species level. The Tbr primer 
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targets a copy region of several thousand (267) and the mITS primers target a ~200 copy 
region (333) whereas the T. b. rhodesiense and T. b. gambiense species specific primers 
target a single copy region of the genome. Consequently, it may be that while samples can 
be unequivocally identified as being from T. brucei s.l. the quality and/or quantity of the 
DNA extracted is insufficient to identify the sub-species. Accordingly, the following 
methodology was used to quantify whether samples contained sufficient DNA to allow the 
TgsGP primers to detect presence of genomic material from T. b. gambiense unequivocally. 
 
Having identified the Tbr positive samples the same samples were then screened with the T. 
brucei s.l. multiplex primers designed by Kim Picozzi (271) and with the TgsGP primers 
specific for T. brucei gambiense (272). The T. brucei s.l. multiplex included universal 
Trypanozoon primers that target a single copy gene, phospholipase C (PLC), (330-332) and 
primers that amplify the serum resistance associated (SRA) gene. Amplification of the PLC 
gene indicates that there is enough material in the template for the detection of single copy 
genes, such as the T. b. gambiense specific glycoprotein (TgsGP) primers. The primers used 
in the T. brucei s.l. multiplex are shown in Table 6.1.. Primers 657 and 658 amplify a single 
copy trypanozoon PLC gene. The SRA gene is similar to variable surface glycoprotein (VSG) 
genes, to help distinguish SRA amplification from VSG amplification two primer sets were 
designed, which when run together, produced SRA products of 669bp and VSG products of 
>1Kb (271).  
 
3.2.6 Blood meal analyses 
Of the 2,184 tsetse that had undergone DNA extraction, 768 tsetse midguts were tested 
with a universal vertebrate cytochrome B primer to screen for host DNA (199). The 768 
subsamples analysed comprised 384 tsetse from each of the wet (September 2013-
November 2013) and dry (December 2013-February 2014) seasons and were selected 
randomly from tsetse samples processed in the middle period of each month (10th  to the 
20th). It was necessary to make a one in ten dilution of neat tsetse midgut DNA elution to act 
as the DNA template as some of the samples had a large blood meal that inhibited the PCR 
reaction, either through over saturation of DNA or due to a higher proportion of inhibitors in 
the blood. 
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3.2.7 Weather data 
The importance of the weather on tsetse populations has been critical in understanding 
tsetse ecology and distribution (334-336). The knowledge generated by such studies has 
contributed to the development of various predictive models designed to assess the effects 
of weather changes on tsetse populations (337). 
 
To better understand the data generated by this study it is essential to relate the tsetse data 
to meteorological data. As local weather data were unavailable, rainfall estimates (rfe) were 
derived from the tropical applications of meteorology using satellite data (TAMSAT) online 
model developed by the meteorological department of Reading University (338). A 
rectangular area of Koboko (N:3.8, W:30.8, E:31.5 and S:3.2)(338) was used as the area of 
interest for the model, this area covered the study area of Koboko. Alongside rfe the 
maximum, minimum and average temperatures for each month were obtained from 
climate-data.org (339). The monthly temperatures were average temperatures generated 
from a climate model with 220 million global data points from 1982-2012.   
 
3.2.8 General statistical methods 
All statistical analyses were carried out using R (340).  Catches (n) were not Normally 
distributed and so the use of classical statistical tests and standard estimates of means and 
error estimates based on an assumption of a Normal Distribution are inappropriate.  
Accordingly, a number of approaches were therefore adopted.  First, to provide simple 
estimates of relative abundance the median catches and their respective inter-quartile 
ranges and the 5% and 95% centiles are reported.  Second, to analyse the statistical 
significance of differences in the catch of tsetse, catches were Normalised using a log10(n+1) 
transformation and then subjected to an Analysis of Variance (ANOVA).  Third, in some 
cases raw (i.e., not transformed) catch data were analysed using Generalized Linear Models 
(GLM) or Generalized Linear Mixed Models (GLMM, using the glmmADMB package) with 
either a Poisson or Negative Binomial error structure. Several types of data comprised 
proportions.  For example, the proportion of the catch that was a particular sex (male or 
female), various ovarian categories (0-7) or infected with trypanosomes.  These data are 
also not Normally distributed and were therefore analysed using a GLM or GLMM with a 
Binomial error structure.  For instance, to analyse differences in the proportion of males (or 
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females) in a catch, the number of males was specified as the response variable and the 
total catch (males+females) as the Binomial denominator.  Further details of the statistical 
methods and models as applied to particular types of data are reported in the Results 
section below. 
 
3.3 Results 
3.3.1 Tsetse catch data 
Across the sampling period from April 2013 to July 2014, traps were deployed at the four 
sampling sites for 287 days and a total of 12,532 tsetse with 930, 2857, 3543 and 5092 
tsetse caught at trap sites KO16, KO19, KO20 and KO21, respectively. The median daily catch 
of tsetse caught from the four trap sites, varied between a peak of 14 in November 2013 
and a low of 4.5 in April 2013. To assess whether there was a significant difference in catch 
between months, a GLMM was fitted to the data with sites and days specified as random 
effects and months as a fixed effect.  The best fit to the data, as judged by having the lowest 
Akaike information criterion (AIC), was obtained by specifying a Negative Binomial error 
structure with zero inflation.  There was a significant (Deviance=84.8, df=15, P<0.001) effect 
of month on the catch.  Pairwise comparison of the catches (Tukey multicomparison test) 
showed that there were significant differences between, on the one hand, months (April 
2013; January, February and April 2014) with relatively low catches (5.0-7.4 tsetse/day) and 
November-December 2013 when the mean daily catches ranged between 19.4 and 17.9 
tsetse/trap (Fig. 3.6). 
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Figure 3.6 Median catch of tsetse per month between April 2013 and July 2014 
males+females pooled (boxes=interquartile range, whiskers=10 and 90 centiles). In this figure the outliers 
are represented by the black dots. 
 
 
The relationship between male and female tsetse was studied by analysing the variation in 
proportion of females across the year. Overall, 78.% (9749/12422) of the catch was female 
and there was no clear or significant variation in the proportion of females (Fig. 3.7B)  
between months (Tukey multiple comparison test). 
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Figure 3.7 Mean tsetse daily catch and female percent 
(A) Mean (±95%CI) daily number of tsetse and (B) percentage female caught from traps operated 
between April 2013 and July 2014 
 
3.3.2 Interaction between catch numbers, temperature and rainfall estimates 
To assess the potential causes of the intra-annual variation in the apparent density of tsetse 
(Fig. 3.7A), the effects of temperature and rainfall on the catch of tsetse was assessed by 
regression analysis of the mean for each month (Fig. 3.7A) against monthly rainfall and 
temperature.  There was no significant effect of temperature (Fig. 3.8) but analyses of the 
rainfall data (Fig. 3.9) showed that while there was also no significant effect of rainfall 
during the month that the tsetse were collected, there was a significant relationship with 
the rainfall in previous months. In particular, the rainfall in one month (m) was a stronger 
predicter of relative abundance three months later (m+3).   For instance, there was no 
significant correlation (r2=0.002, Fig. 3.9A) between catch in a month and the rainfall for 
that month whereas there was a strong correlation (r2=0.618, Fig. 3.9D) between catch and 
the rainfall three months previously. 
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Figure 3.8 Scatterplot of mean daily catch against mean monthly temperature: 
 
Dotted line indicates regression line (not significant) 
 
 
Figure 3.9 Scatterplot of mean daily catch for that month against: Scatterplot of mean daily catch for that 
month against:  
(A) that month or (B) 1, (C) 2 or (D) 3 months previously.  Solid and dotted lines indicate significant and non-
significant regression lines respectively. 
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3.3.3 Age structure 
The distribution of age categories was not Normally distributed.  To assess the significance 
of changes in age structure, the proportion of tsetse old enough to have developed a 
mature infection of trypanosomes (Ovarian category >2) was calculated for each month.  
The results (Fig. 3.10) showed that there was a significant decline in the proportion of 
mature flies from a mean of 79% in April 2013 to 54% in July 2014.  This change in age 
structure is likely to have an impact on the overall prevalence of trypanosome infections in 
the tsetse population since the proportion of tsetse old enough to harbour a mature 
infection was lower during the dry season (Jan-Feb 2014) and highest during the wet season 
(May 2013, May 2014). 
 
 
 
 
Figure 3.10 Proportion of 'mature' female tsetse for  each month 
Inset graphs show age structure for months when the proportion of mature flies was the greatest (May 2013) 
or smallest (January 2014). 
 
3.3.4 Trypanosome prevalence 
Of the 12,532 tsetse caught 6,664 (53%) were dissected, of which 89 (1.34%) were midgut 
positive, seven (0.11%) were salivary gland positive and 84 (1.26%) were mouthpart 
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positive. A sub sample of 2,184 tsetse, from September 2013 to February 2014, were then 
screened using the mITS primers to identify tsetse positive for T. brucei s.l., T. congolense 
and T. vivax. In comparison to the classical dissection results for these samples the PCR 
detected three times as many midgut positives, seven times as many salivary gland positives 
and twice as many mouthpart positives (Fig.3.11). The PCR assay consistently detected a 
higher number of positive tsetse across the sampling period than the traditional microscopy 
method (Fig 3.11), there were a total of 106, 34, and 64 midgut, salivary glands and 
mouthpart positives, respectively. 
 
 
 
Figure 3.11 Comparison of microscopy and PCR positive results  
The PCR method has been able to identify a greater number of samples positive for salivarian trypanosomes 
than the microscopy methods employed. 
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3.3.4.1 Comparison of microscopy and qPCR results 
Mircoscopic examination of the 2,184 tsetse samples screened with the mITS PCR primers 
showed that 62 tissues were infected comprising: 30 midguts, 4 salivary glands and 28 
mouth parts. The mITS primers identified infections in 48 of the 62 tissues detected by 
microscopy, Table 3.3.  
 
Table 3-3 The mITS results of the microscopy positives 
   Midgut Salivary glands Mouth parts 
  Microscopy positive 30 4 28 
m
IT
S 
re
su
lt
s 
T. brucei s.l. 4 2 0 
T. congolense 10 1 7 
T. vivax 0 0 15 
T. brucei s.l. +T. vivax 0 0 1 
T. brucei s.l.+T. congolense 6 1 1 
No ID 10 0 4 
 
 
 
The mITS assay was used to screen 2, 184 tsetse flies, the initial screening of pooled samples 
identified 173 trypanosome positive tsetse. The midguts, salivary glands and mouthparts of 
these positive tsetse were then re-screened individually to determine which tissues were 
positive. Of the 173 pooled samples that were positive, it was possible to identify the 
individual positive tissues in 125 (75%). Of the three tissue types, midguts produced the 
greatest number of positives followed by mouthparts and then salivary glands with 106, 64 
and 34 positives respectively. T. congolense was identified as the most prevalent 
trypanosome with 81/125 (64%) positive tissues, followed by T. vivax with 72/125 (58%) and 
T. brucei s.l. proved to be the least common with only 46/125 (37%) positive tissues. There 
were also five positive samples that produced a PCR product of a size that did not correlate 
with the three species of interest (Table 3.4). For all three of the species of interest there 
were instances where tissues not associated with their life cycle produced positive results. 
For T. vivax, there were four salivary gland positives and 34 midgut positives, T. congolense 
produced 16 positive salivary glands and T. brucei s.l. produced 10 positive mouthparts. 
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Table 3-4 The tissue positives for T. vivax, T. brucei s.l., T. congolense and unknown 
                                Single tissue positives  
  Midgut Salivary glands Mouthparts 
T. vivax 9 2 10 
T. brucei s.l. 19 9 8 
T. congolense 31 3 6 
Unknown 3 0 0 
  Multiple tissue positives 
  Midgut/mouthparts Midgut/salivary glands 
Salivary 
glands/mouthparts 
Midgut/salivary 
glands/mouthparts 
T. vivax 23 1 0 1 
T. brucei s.l. 0 2 0 2 
T. congolense 4 4 2 7 
Unknown 0 0 1 0 
 
 
 
 
Detection of trypanosomes in particular tissues is the classical method of distinguishing 
between the three main groups of salivarian trypanosomes, Trypanozon, Nanomonas and 
Duttonela. The advantage of microscopy analysis is that it allows for positive tissue and flies 
to be identified as live trypanosomes need to be observed. Of the 6,664 tsetse dissected and 
screened with microscopy 158 were positive for live trypanosomes in the three tissues 
screened. The prevalence of infection was greatest in older flies with OvC 6 producing the 
highest percentage of positive tsetse caught, (4%) Table 3.5 
 
Table 3-5 The infection rates for all females by Ovarian categories, and males, per tissue type. 
 
 
 Infection numbers per ovarian category (OvC)    
  OvC 0 OvC 1 OvC 2 OvC 3 OvC 4 OvC 5 OvC 6 OvC 7 Females Males Total 
Total tsetse caught 505 812 565 437 1312 1098 424 254 5407 1257 6664 
Infected tsetse 4 20 11 14 37 25 20 7 138 20 158 
Midgut 4 14 7 9 18 12 8 4 76 13 89 
Salivary glands 0 0 0 0 3 1 2 0 6 1 7 
Mouth parts 0 7 6 6 24 15 14 4 76 8 84 
Total tissue positives 4 21 13 15 45 28 24 8 158 22 180 
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3.3.5 T. brucei species multiplex and TgsGP assay 
3.3.5.1 T. brucei species multiplex 
Of the 46 T. brucei s.l. positive tissue samples identified with the mITS primers 25 (56%) 
tested positively for the single PLC gene respectively. Of the 25 positive tsetse samples 13 
were from midguts, 10 from the salivary glands and two were from the mouthparts. No 
samples were positive for the 669 bp sized band specific for the SRA gene which would 
indicate the presence of T. b. rhodesiense. The multiplex assay would produce different 
sized bands depending on the T. brucei s.l. sub-species. If there is sufficient genetic material 
for single gene copy amplification then all three sub-species would produce the 
phospholipase C band(PLC) (324bp); some strains could produce a VSG gene band (>1Kb); 
however only T. b. rhodesiense would produce the SRA band (669bp). In our study we found 
that our T. b. gambiense positive control and some of our field samples also produced a 
third band of >700bp in size. This band persisted despite increases in annealing 
temperature, Fig 3.12 
 
Figure 3.12 Representative results of the T. brucei s.l. multiplex assay 
with positive controls for all three T. brucei sub-species. Samples 1-10 are tsetse midgut samples that were 
identified as positive for T. brucei s.l. using the mITS primer set. Sample 2 has a strong 324bp PLC band and a 
band >1Kb VSG band. This indicates that there is enough genetic material for the detection of a single copy 
gene. It is also easy to observe the difference in sizes between the SRA band at 669bp and the third band of 
approximately 700bp in size that appears in all three T. brucei s.l. sub-species, albeit faintly for T. b. 
rhodesiense. M denotes the molecular weight markers. 
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3.3.5.2 TgsGP assay 
The samples were then tested with the TgsGP primers to screen for T. brucei gambiense. Of 
the cattle and pig samples none was positive for T. b. gambiense however eight midgut and 
eight salivary gland samples produced faint PCR products of approximately 308bp Fig.3.13. 
 
 
 
Figure 3.13 T. brucei s.l. positives 
Results of tsetse samples processed with the TgsGP showing the presence of a ~308bp sized product after 
amplification with the TgsGP primers. The numbers given are the tissue sample reference numbers and ‘+’ 
denotes a positive samples, the PCR ladders are labelled as M. 
 
 
The bands produced by the TgsGP primers were very faint and only three bands from the 
midgut samples were sent for sequencing (samples 3861, 3923 and 4280) as these bands 
showed three different levels of brightness. The PCR products were purified using the 
ExoSap PCR clean-up kit. The samples were sent to SourceBioscience for sequencing using 
both the forward and reverse primers. The positive T. b. gambiense control was also purified 
and sent for sequencing. 
 
3.3.5.3 TgsGP sequencing results 
The sequencing results allowed for a more accurate measurement of the size of the 
products produced. The T. b. gambiense control product measured 308bp and was a 100% 
query cover and identity match with the T. b. gambiense sequences from the NCBI 
nucleotide collection data base. The three samples from the midgut produced a sequence 
that found no similarity when searched against the nucleotide collection database and 
measured 281bp. Fig.3.14 shows an alignment with the three sequenced midgut samples, 
the T. b. gambiense positive control and an NCBI blast reference sequence, accession 
number FN555990. 
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Figure 3.14 Aligment of the products generated by the TgsGP primers 
These were aligned against the T. b. gambiense positive control and a reference sequence for the T. b. gambiense 
glycoprotein gene (accession number FN555990) from the NCBI nucleotide collection database. 
 
 
3.3.6 Blood meal analysis 
Following on from the molecular analysis targeting trypanosomes, a subsample of 384 flies 
were taken from the wet and dry season each, giving a total of 768 (36%) of the mITS 
screened tsetse. From these 768 tsetse, 131/768 (17%) blood meals were identified, 63 
(48%) from the wet season and 68 (52%) from the dry season. The blood meals were 
comprised of the following host species: 48/131 (37%) Homo sapiens (humans), 51/131 
(49%) Bos taurus (cow), Varanus niloticus (Nile monitor), 5/131 (4%) Naja melanoleuca 
(forest cobra), 2/131 (1.5%) Capra hircus (goat), 4/131 (3%) Sus scrofa (pig), 1/131 (0.8%) 
Ovies aries (sheep) and 1/131 (0.8%) unidentified species of passerine bird. Only the first 
four hosts were found in both the wet and the dry season the remaining host species were 
only identified in the dry season Fig 3.15. 
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Figure 3.15 Blood meal identification from tsetse caught in wet and dry seasons 
Of the 131 blood meals identified 63 (48%) came from the wet season and 68 (52%) came from the dry season.
  
The source of blood meals across the two seasons was analysed using the chi-squared test 
and found no significant difference between host feeding from the two seasons (P- 0.5), 
although the range of different host animals fed upon was greater in the dry season. In total 
eight different host species were identified by cytochrome B sequencing primers from the 
midguts of the tsetse screened. There was no statistical significance in the proportion of 
blood meals from humans and cattle in the wet versus dry season. The next biggest source 
of blood meals was taken from the Nile monitor (Fig 3.16).  
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3.4 Discussion 
3.4.1 Tsetse population 
3.4.1.1 Tsetse catch numbers 
The number of tsetse caught along the Kochi from all traps was 13,876, averaging 867 flies 
per month, the male and female catch numbers differed significantly with the ratio of 
females to males being 3.6:1, but this ratio remained stable through the sampling period. 
This difference in numbers between the sexes may not be an accurate reflection of the sex 
ratio of the population as Fisher proposed that in a randomly mating population an equal 
sex ratio will be maintained (341).  The differences in the numbers of males and females 
may reflect a sampling bias and/or differences in mortality rates.  It is likely that both are 
true as the mortality rates in males have been estimated to be higher than females (342) 
and previous studies have shown that different tsetse catch methods attract male and 
female tsetse in different quantities. For example more males than females are caught with 
‘fly rounds’ and the opposite is true with several designs of trap (343, 344). The number of 
tsetse caught did not vary markedly through most of the sampling period except for a dip 
two months after the end of the dry season in April 2014. This is in keeping with the finding 
that tsetse catch numbers were correlated with rainfall estimates 2-3 months prior to the 
catch date. Prior studies of tsetse populations have found a high degree of seasonal 
variability in the number of tsetse caught in traps (335, 345). The relative stability in tsetse 
catch numbers from our study site likely reflects the proximity of the study site to the 
equator and subsequent stable weather patterns compared to, say, the populations studied 
by Hargrove in Zimbabwe. 
 
3.4.1.2 Tsetse age structure 
The age structure of the tsetse population varied across the sampling period. Although 
there was no significant change in proportion of tsetse in different ovarian age categories in 
relation to rainfall, the average age of the tsetse population decreased during the dry 
season from December-February. There are no comparable studies of G. fuscipes 
populations.  However, studies of G. pallidipes have shown an increase in the average age of 
the tsetse population and a drop in catch numbers during the dry season. It was concluded 
that this was due to an increase in the mortality of young tsetse and pupae (345). Present 
data shows the opposite, with an increase in the number of tsetse caught during the dry 
87 
 
season and a simultaneous decrease in the average age of the tsetse population. The reason 
for this difference could be that the higher catch numbers and younger flies are the result of 
a higher productivity of offspring during the end of the wet season. These larvae would be 
secure in the mother’s uterus for two weeks and following deposition they would be 
protected within their puparium buried in the soil for a further three to four weeks. If during 
the rainy season there were less environmental pressures on the female population then it 
would follow that a greater number of larvae would be deposited only to emerge weeks 
later during the dry season. It has also been speculated that during dry seasons the 
frequency of feeds increases due to a shorter larval period and this increase in feeding rates 
brings with it an increased risk of mortality (346). Therefore, during the dry season there 
could be a large number of teneral flies emerging and at the same time older flies are dying 
off due to increased feeding, causing a lowering of the average age of tsetse catches. 
 
3.4.2 Trypanosome positive tsetse 
3.4.2.1 Dissection results 
Microscopic examination of tsetse showed that 158 (2.5%) were infected with at least one 
species of Trypanosoma, which is lower than previous microscopy examinations of wild 
tsetse, which ranged from 5 to 17% (147, 259, 347). However the number of salivary gland 
positives, indicative of a mature T. brucei s.l. is in keeping with previous studies (135, 203). 
 
Analysis of microscopy positive tsetse in Table 8 showed that the females with the highest 
infection rates were in ovarian categories 3, 6 and 6 for midgut, salivary glands and mouth 
parts respectively. Infected salivary glands were only found in tsetse in 4-6 in accordance 
with previous studies showing that older tsetse are more significant in the active 
transmission of salivarian trypanosomes (161). The traditional microscope-based method 
for the identification of trypanosome species based on infected tsetse organs (135) closely 
matched the results from the same samples  screened with the mITS primers. Of the 2,184 
tsetse screened with PCR, 62 (2.8%) were microscopy positive. The microscopy positives 
comprised of 30 midgut, four salivary gland and 28 mouthpart positives. The Lloyd and 
Johnson method would identify the midgut positives as immature infections of either T. 
congolense or T. brucei s.l., the salivary gland infections as a mature T. brucei s.l. infection 
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and mouthpart infections as being either a mature T. congolense infection or a T. vivax 
infection.  
 
The PCR-based method identified 48 (77.4%) of the microscopy positive samples, 21 (66.7%) 
from the midgut, four (100%) from the salivary glands and 24 (85.7%) from the mouthparts. 
The lower performance of the midgut samples is most likely down to an increased number 
of inhibitors in this tissue type as has been found in previous studies (348, 349). The 21 PCR 
positive midgut samples comprised 10 T. congolense, four T. brucei s.l.  and six mixed 
positives of T. brucei s.l. and T. congolense. Of the four positive salivary glands, the PCR-
based method identified two as single T. brucei s.l., one mixed T. brucei s.l. and T. 
congolense and the remaining salivary gland positive was identified as a single T. congolense 
infection.  T. vivax was not identified in either the microscopy positive salivary glands or 
midguts by PCR. The 24 PCR positive mouthparts consisted of 15 single T. vivax positives, 
seven single T. congolense positives, a mixed positive of T. vivax and T. brucei s.l. and a 
mixed positive of T. congolense and T. brucei s.l.. The congruence of the PCR results with 
what would be expected with the Lloyd and Johnson method is 100% for the 20 midgut 
positives and 91.7% for the mouthpart results. The salivary gland results deviated more 
significantly from the expected results with only 2 of the 4 microscopy positives being 
identified as single T. brucei s.l. infections. The final tally of PCR results that correlated with 
the traditional method for trypanosome identification in tsetse was 44 (91.7%) out of 48. 
 
3.4.2.2 mITS PCR results 
A total of 6,547 tissues were screened with the mITS PCR (2,183 midguts, 2,181 salivary 
glands and 2,183 mouthparts) first as pooled samples where the three tissue types for each 
fly were screened together and then later individually. The pooled samples detected 194 
(8.9%) infected tsetse. When individual tissues of infected tsetse were screened, only 126 
(5.6%) tsetse were found to have at least one tissue positive for either T. brucei s.l., T. 
congolense or T. vivax. The pooled samples produced 3x as many positives as microscopy 
while the individual tissue screening identified 2x as many positives as microscopy. The 
midgut samples produced 106 positives with 46 T. congolense, 34 T. vivax and 23 T. brucei 
s.l. plus three unknown products. The mouthparts contributed 64 positive results comprised 
of 19 T. congolense, 34 T. vivax and 10 T. brucei s.l. positives and one unknown. The salivary 
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glands produced 34 positive samples comprising of 16 T. congolense, four T. vivax and 13 T. 
brucei s.l. plus one unknown.  
 
Single T. brucei and T. congolense positives were mainly identified in tsetse midguts, single 
salivary gland positives were predominantly T. brucei s.l. and single mouth part positives 
were predominantly T. vivax, with T. brucei s.l. and T. congolense occurring in near equal 
numbers. The correlation between different tissue positives per trypanosome species, Table 
3.4, showed a T. vivax positives had a strong correlation between positive midgut and 
mouthparts. This is most likely due to trypanosomes from an infected mouth part being 
passed into the midgut during feeds resulting not in a midgut infection but rather the trace 
DNA of these parasites being picked up by the PCR. The high number of T. congolense 
salivary gland results are at odds with the known developmental cycle of the parasite. This 
could be explained by the dissection method employed, if the mouthparts are gripped prior 
to removal of salivary gland it is possible that saliva and trypanosomes could be forced back 
into the salivary glands. Alternatively, the development of T. congolense involves a stage in 
the cibarium, and here the salivary glands meet the mouthparts, so it is possible that the 
salivary gland could have T. congolense at the apical end. A limitation of the PCR method 
compared to microscopy is that it is unable to determine whether these positives are an 
active infection or relic DNA left over from dead trypanosomes that failed to establish an 
infection. This is especially true of midgut samples where trypanosomes could be taken up 
with a blood meal, including non-salivarian species. 
 
3.4.2.3 Identification of T. b. gambiense in local tsetse 
When screened with the Trypanozoon sub-species multiplex assay, 56% of the Tbr-FIND 
positive tsetse samples reacted successfully, indicating sufficient DNA being present for 
single-copy gene detection. Of these samples, 16 tsetse produced faint bands of 
approximately 308bp in size. A subset of these were then sent for sequencing alongside a T. 
b. gambiense positive control. The sequencing results showed that the size of the product 
generated by the samples was smaller than the expected size at only 281bp compared to 
the expected 308bp sized product. There was also significant variation in the 281bp sized 
sequences compared to T. b. gambiense sequence. Based on the sequencing results these 
positive samples cannot be considered to be T. b. gambiense and without further analysis it 
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is not possible to determine the origin of the bands produced by the TgsGP primer set as the 
sequence failed to match any known sequence in the NCBI databases. What can be said is 
that of the 25 tsetse samples that possessed enough genomic material to amplify single 
copy genes none was found to be positive for T. b. gambiense. This lack of positive samples 
reflects the overall low prevalence of the disease and the continued decrease in the number 
of cases in Uganda (350). Despite not finding T. b. gambiense in the tsetse population of 
Koboko vector control has been calculated to being essential to reach the elimination goal 
of 2020 (351). 
 
3.4.3 Bloodmeal analyses 
The analysis of the bloodmeal results show no differences across the two seasons between 
the top three sources of bloodmeal, cattle, human and Nile monitor lizard. The biggest 
difference in the feeding behaviour in the dry and wet seasons was that a greater variety of 
animals were fed upon during the dry season than in the wet season. Comparing the 
bloodmeal results with the data in table 3.2 shows that despite chickens and goats being in 
greater numbers cattle, nile monitor and forest cobra are fed upon more. Similarly, despite 
being the least common domestic animal pigs were fed upon in greater numbers than either 
sheep or goats which occur in 80x and 250x greater numbers. Other studies looking at the 
feeding habits of G. f. fuscipes found that cattle comprised 30%-40% of total blood meals 
(352), this study has a similar level of cattle blood meals comprising 39%. However, in this 
study levels of human blood meals were close the those of cattle at 37% which is far higher 
than those of the Waiswa study and is probably related to the fact that the area in this study 
is a gHAT foci. 
 
3.4.4 Conclusions 
Overall the tsetse catch numbers remain stable during the wet season and drops in the dry 
season. This probably relates to the relative stability of the equatorial climate compared to 
the more extreme climate of tsetse-infested areas of southern Africa.  While the fluctuation 
in numbers is relatively slight, there is some intra-annual variation in apparent density and 
this seems to be related to rainfall in preceding months.  There was also a significant 
variation in the age structure of the population during the 16-month course of the study.  
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These changes in tsetse numbers and age structure will affect the transmission potential of 
the tsetse population.   
 
Microscope and PCR-based analyses of trypanosome infection in tsetse showed that both 
methods identified T. brucei s.l., T. congolense and T. vivax positive tsetse. However, the 
PCR-based method had a higher sensitivity and identified three times as many positives as 
the microscopy method. The finding that T. brucei s.l. was only detected in older tsetse 
(Ovarian category 2) is in accordance with expectation and underlines the likely impact of 
changes in the age structure of tsetse populations on transmission of this species of 
Trypanosoma. 
Lastly and most importantly, the study identified salivary gland positive tsetse both through 
microscopy and PCR, implying the active transmission of T. brucei s.l. species in Koboko. The 
blood meal analysis helps to identify the most likely hosts of T. brucei s.l., T. coongolense 
and T. vivax in the area with a heavy predation of cattle. Despite the area being a 
predominantly Muslim, pigs were also identified as a blood meal source and recent studies 
have suggested pigs may serve as a reservoir for Gambiense HAT. It would therefore be 
worthwhile sampling members of the pig population in NW Uganda when searching for T. b. 
gambiense.  These data suggest that potential hosts of T. brucei are humans, cattle and pigs. 
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 : Loop-mediated isothermal Amplification (LAMP) for field 
based xenomonitoring 
 
4.1 Introduction 
4.1.1 Background 
Detection of Gambiense HAT relies largely on active or passive screening of the human 
population at risk. Active screening is difficult; screening >70% of a target population is 
seldom achieved  (353) and the most common method of active screening, the card 
agglutination test for trypanosomiasis (CATT)(138)  is insufficiently specific <96% (354). This 
lack of specificity means that the CATT assay is followed up by a series of tests including 
lymph node puncture, fresh blood and thick blood film examination (355-357).  The 
sensitivity of the other tests vary as they use microscopical examination and therefore 
depend on the skill of the technician (137). Therefore the sensitivity of lymph node aspirates 
varies from 40-80% and blood microscopy methods have a sensitivity that varies from 39-
80% (53) 
 
The CATT test also has a low positive predictive value when used for screening populations 
in which the prevalence of gHAT is low (354, 358, 359). This means that the current method 
of screening for sleeping sickness may become unsuitable as the prevalence of the disease 
continues to decrease, making elimination less likely. Moreover, as the prevalence of HAT 
decreases, the cost of detecting each case increases, leading to active screening 
programmes being scaled down or abandoned as other health priorities take precedent 
(246, 360, 361) An alternative to screening people is to screen vectors for the presence of 
the pathogen.  This approach, termed xenomonitoring,  has proven useful in the control of 
other vector transmitted diseases such as lymphatic filariasis (362).  Rather than screening 
people, tsetse flies might be caught using simple traps and subsequently analysed for 
presence of T. brucei s.l.. By monitoring trypanosomes in tsetse, xenomonitoring would 
measure current rates of transmission in a defined area.  By contrast, the chronic nature of 
Gambiense HAT and the mobility of humans mean that cases are detected months, if not 
years, after infection, and, potentially, in places far removed from sites of transmission (59).  
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4.1.3 Xenomonitoring of tsetse 
There is a need for a simple yet highly sensitive and specific surveillance system for HAT, 
designing a xenomonitoring protocol that combined a simple DNA extraction method with a 
LAMP assay could fill this gap in resource poor settings (263, 363) . The screening of vectors 
for parasites is a standard practice in understanding disease transmission, however as 
shown in Chapter 3 the prevalence of different trypanosome species can be extremely low 
with T. brucei s.l. being the lowest. Through classical dissection techniques (135) the number 
of salivary glands found to be positive from the 6,664 tsetse dissected was seven (0.1%). The 
use of the mITS PCR assay had a higher sensitivity identifying 13 out of 2,587 (0.5%) salivary 
glands as T. brucei s.l. positive. Sceening based on use of microscopy or PCR require skilled 
technicians, specialised equipment and overheads (364). Out of the two methods the PCR is 
more costly in both time and money, however it is more sensitive and specific than the 
microscopy method (349). The advantages of LAMP over PCR is two-fold, first it is a 
relatively simple assay to perform, secondly it requires less resources than PCR such as it has 
no need for thermocyclers, gel electrophoresis and gel imaging equipment. LAMP assays are 
also very sensitive and specific (365, 366). The LAMP test for HAT used in this study 
amplifies the repetitive insertion mobile element (RIME) of the Trypanozoon group (152). 
 
Studies of trypanosome infection in tsetse flies are generally concerned with quantifying the 
prevalence of pathogens in the vector population.  For this purpose, the status of infection 
in individual flies must be quantified; only tsetse with a mature infection where T. brucei s.l. 
are observed in the salivary glands are infectious (367).  For xenomonitioring however, the 
aim is to detect the presence or absence of pathogens in a vector population.  This specific 
aim offers two opportunities to improve the cost-effectiveness of screening.  First, pooled 
groups rather than single individuals might be screened for the presence of pathogens. 
Second, a molecular method may be able to detect trypanosomes that have been recently 
ingested but which will not lead to a mature infection.  Older tsetse flies are much less 
susceptible to infection with T. brucei (368). However, flies that are refractory to infection 
will nonetheless ingest trypanosomes from infected hosts and a sensitive method may be 
able to detect these transient trypanosomes in recently-fed flies (369).  
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4.1.2 Loop-mediated isothermal amplification (LAMP) 
LAMP is carried out at a constant temperature, thereby removing the need for 
thermocyclers, and results are read visually (150). The LAMP reaction uses a series of six 
primers that produce a DNA product with multiple annealing sites and results in continuous 
target DNA replication. The reaction is so efficient that the amount of DNA produced 
changes the turbidity of the reaction, causing the reaction mix to change from clear to 
cloudy. It is therefore possible to use this as a means of assessing a positive reaction without 
the need for post reaction processes such as gel electrophoresis. A diagrammatic 
representation of the LAMP reaction is depicted in Fig 4.1. 
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Figure 4.1 Depiction of the loop-mediated isothermal amplification (LAMP) reaction 
The LAMP assay uses six primer pairs specific to the target DNA sequence, which include inner and outer primer 
sets. 4.1a Amplification initiates from strand invasion from one of the inner primers, strand displacing DNA 
polymerase then extends the primer and separates the template DNA duplex.  4.1b The first product is then 
displaced by the synthesis of a secondary product initiating from an outer primer located on an upstream target 
region. 4.1c As the first product is displaced by the DNA polymerase it forms a self-hybridising loop structure, 
similar to a hair pin, due to the inclusion of a reverse complementary sequence in the primer design. A reverse 
inner primer is able to anneal to the 3’ end of the hairpin. 4.1d Cycles of annealing and displacement repeat 
from the opposite end of the target sequence on the hairpin structure resulting in a self-hybridising loop at 
both the 5’ and 3’ end, this dumbbell structure forms the seed for exponential LAMP amplification. 4.1e There 
are now multiple annealing sites located at the 3’ end of the open loops for both the inner and loop primers. 
The amplification proceeds from these sites and the product grows repeating the target sequence into a long 
continuous DNA molecule. This concatemer has itself multiple annealing sites causing a rapid increase in double 
stranded DNA that far exceeds the amount of DNA produced in a PCR assay (370). Image adapted from (150). 
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4.1.4 Aims 
Previous work has demonstrated the ability of LAMP to detect T. brucei in laboratory-
infected tsetse and in pooled groups of tsetse (154) however these studies have not tested 
commercially available LAMP kits.  The aims of this study were 
 
1) Design a field friendly DNA extraction protocol 
2) To assess the sensitivity of the commercial LAMP kits against pooled tsetse samples 
and dilution gradients 
3) Determine how long after an infective blood meal can T. brucei s.l. DNA still be 
detected 
4) Test the specificity of the LAMP kits against laboratory infected tsetse and also field 
caught tsetse 
 
4.2 Methods 
Tsetse samples were tested using the LoopampTM kit to determine the presence of 
trypanosome DNA, and the limit of detection of LAMP. DNA extraction methods were 
optimised for field settings and tested with the LAMP kits in pooled fly assays. The 
specificity of the kit was tested against laboratory (G. m. morsitans) and wild tsetse (G. f. 
fuscipes) infected with non-target species of trypanosomes likely to co-infect tsetse in areas 
where T. brucei s.l. occurs. 
 
4.2.1 DNA Extraction 
Tsetse flies were dissected and their midguts stored in 60µl of 100% ethanol (EtOH). At the 
Liverpool School of Tropical Medicine (LSTM) a standard DNA extraction procedure, 
hereafter referred to as the Chelex method, was followed: 70µl of distilled water was added 
to the midgut sample followed by centrifugation at 13,000rpm (15sec) and removal of 100µl 
of supernatant. Tissue samples were washed three times by adding and removing 100µl of 
distilled water. To the washed tissue, a 100µl suspension of Chelex and Proteinase K 
(20mg/ml) was added to give a final concentration of 1% Chelex, and incubated at 56˚C for 1 
h. The sample was then incubated for 30 minutes at 93˚C, centrifuged at 13,000rpm (15sec), 
the supernatant removed, and stored at -20C. 
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4.2.2 Simplification of DNA extraction 
The current Chelex DNA extraction method, although robust, is not field-friendly and takes 
~2 h to complete with a number of steps and components, some of which require a cold 
chain. To use this kit in the field, the current method needs to be optimised to ensure it is 
rapid, robust and simple. Five alternative DNA extraction methods aimed at reducing the 
time and complexity of the current Chelex extraction method for use in field studies were 
designed (Table 4.1). 
 
Table 4-1 Details of five alternative field-friendly DNA extraction methods. 
Method Spin 
13,000 
rpm 
Wash 
x3 
Spin 
13,000 
rpm 
5 % Chelex 
or 1% TE 
Proteinase 
K 
 
Incubation Total Time 
(Min) 
56˚C 93˚C 
Chelex Y Y Y Chelex Y 60 m 30 m  120 
1/2 time chelex Y Y Y Chelex Y 30 m  15 m  50 
1/4 time chelex Y Y Y Chelex Y 15 m  7.5 m  30 
TE wash off alcohol Y Y Y TE 
  
15 m  45 
TE with chelex Y * 
 
Chelex 
  
15 m  15 
TE leave in alcohol Y 
  
TE 
  
15 m  22 
 
*The alcohol was not washed off, instead the samples were transferred out of the EtOH and into a clean empty 
tube 
 
These different DNA extraction methods were tested against two sets of trypanosome 
concentrations at 102 and 104 trypanosomes per ml, with each of these concentrations 
being spiked into midguts and whole tsetse abdomens in four replicates of each 
concentration. In total each DNA extraction method would be tested against 16 samples, 
Table 4.2.  
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Table 4-2 Overview of samples used in assessment: 
Showing the number of samples spiked with different concentrations of trypanosomes to be processed with the 
different DNA extractions 
DNA extraction method 
Concentration of trypanosomes per 100ul 
Total number of 
samples 10^2 10^2 10^4 10^4 
Midgut Abdomen Midgut Abdomen 
DNA extraction method 4 4 4 4 16 
TE Leave in alcohol 4 4 4 4 16 
TE wash off alcohol 4 4 4 4 16 
Reduced Chelex 4 4 4 4 16 
Chelex 4 4 4 4 16 
TE with Chelex 4 4 4 4 16 
Reduced Chelex, 
reduced time 4 4 4 4 16 
 
 
The two concentrations of trypanosomes tested were produced by calculating the number 
of trypanosomes in a defrosted trypanosome stabilate using a haematocrit reader. The 
concentration of trypanosome in the stabilate was then used to calculate how much was 
required to be added to horse blood to produce the two final concentrations described 
above. 
 
To determine which DNA extraction method was best suited to the field three factors were 
considered: 
1. -Time- how long does each method takes to perform 
2. -Steps- how many steps are involved in each method; this is used as a proxy for 
complexity 
3. -Positives- the total number of positives identified 
The ideal method would produce a high number of positive results in a short amount of 
time, with as few steps as possible, to determine this efficiency the following formula was 
used: 
Time
Number of steps
 x Number of positives 
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4.2.3 LAMP 
The RIME LAMP test was performed using the LoopampTM Trypanosoma brucei Detection 
Kits manufactured by Eiken Chemical Co.,Ltd, Japan, according to the manufacturer’s 
specifications.  Briefly, 2.5µl of template DNA was added to 22.5 µl of nuclease-free water. 
LAMP reagents were reconstituted in the lids of the tubes, and after two minutes 
incubation, the tubes were inverted five times. A thermocycler was used to heat the 
samples for forty minutes at 65˚C and then at 85˚C for five minutes to stop the reaction. 
Results were determined by visualising presence or absence of fluorescence in the reaction 
tubes on a UV gel imager, and each sample was classed as positive or negative based on two 
separate blind screenings. A representative LAMP assay result is shown in Fig 4.2, this image 
shows a strip of eight sample tubes and a positive and negative control. 
 
Figure 4.2 Representative LAMP assay result 
This example shows eight samples (1-8) and a positive control (9) and negative control (10). Sample 5 and 6 are 
classed as positive while the remaining samples would be classed as negative. 
 
4.2.4 PCR 
Alongside the RIME LAMP assays, samples were also amplified using TBR primers(371) that  
target the same region of the gene as those designed by Moser(267) but are situated inside 
Moser’s primers, thus producing a smaller product of 117bp compared with the original 
product of 177bp and a nested universal trypanosome ITS primer set(147) (Table 4. 3). 
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Table 4-3 Primers used in this study 
 
Primer name Target species Primer sequence 5’-3’ Published/designed by 
TBR-FIND Forward T. brucei s.l. TGCGCAGTTAACGCTATTATACA Kazibwe 2008 
TBR-FIND Reverse T. brucei s.l. AAAGAACAGCGTTGCAAACTT Kazibwe 2008 
Tryp 1 Trypanosomatidae AAGCCAAGTCATCCATCG Adams et al. 2006 
Tryp 2 Trypanosomatidae TAGAGGAAGCAAAAG Adams et al. 2006 
Tryp 3 Trypanosomatidae TGCAATTATTGGTCGCGC Adams et al. 2006 
Tryp 4 Trypanosomatidae CTTTGCTGCGTTCTT Adams et al. 2006 
 
 
The PCR reactions consisted of 12.5 µl MyTaq Red Mix (Bioline), 1 µl of forward and reverse 
primer (25mmol), 8.5 µl of nuclease free water and 2 µl of DNA template. For the TBR 
primers the PCR cycles were: an initial denaturation step at 93˚C for 2 mins, followed by 35 
cycles at 94˚C for 10 s, 55˚C for 10 s and 72˚C for 10 s with a final extension step of 30 s at 
72˚C, for the nested PCR 1 µl of PCR product from the first nest was added to the second to 
act as the template. 
For both nests of the ITS primers the PCR cycle had an initial denaturation at 95˚C for 5 mins 
followed by 35 cycles of 94˚C for 15 s, 54˚C for 15 s and 72˚C for 10 s with a final extension 
step at 72˚C for 5 mins. 
 
4.2.5 Limit of Detection 
Colony-reared G. m. morsitans were dissected three days after their first blood meal, the 
midguts were collected into individual tubes and preserved in 100% EtOH.  A trypanosome 
dilution series was created by first making a stock concentration of 2x105 trypanosomes per 
ml using a haemocytometer (20).  The trypanosomes were then heated at 93˚C for 30 mins 
to lyse the parasites and extract the DNA. Using the eluted DNA, a tenfold dilution series 
was created equivalent to 2x105 trypanosomes/ml - 0.2 trypanosomes/mL.   
To prepare the samples for analysis, a modified version of the Chelex method was used. To 
remove residual EtOH from the preserved tsetse tissue, midguts were washed three times 
as previously described.  To each washed midgut, 50µl of a trypanosome DNA concentration 
was added. Following the addition of trypanosome DNA, 50µl of a Chelex suspension (10% 
Chelex with a 2% proteinase K concentration) was added to the midgut tissue for a final 
volume of 100µl.  The DNA concentration series was equivalent to 1x105/ml, 1x104/ml, 
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1x103/ml, 1x102/ml, 1x101/ml, 1/ml, 0.1/ml, 0.01/ml trypanosomes suspended in 5% Chelex 
suspension/1% proteinase K.  Each DNA dilution was processed according to the standard 
Chelex extraction method. Table 4.4 summarises the number of trypanosomes in the DNA 
dilution series per ml, per 100µl, and per reaction for both the LAMP (2.5µl of template) and 
PCR (2µl of template) assays. 
 
 
Table 4-4 Dilution gradient of trypanosomes expressed as trypanosomes/mL and as ng/µL. 
 
    Dilution gradient trypanosomes per mL: 
 
  1x10^5 1x10^4 1x10^3 1x10^2 1x10^1 1 0.1 0.01 
Tr
yp
an
o
so
m
e
s/
m
L Trypanosomes/ml 100000 10000 1000 100 10 1 0.1 0.01 
per 100µl sample 10000 1000 100 10 1 0.1 0.01 0.001 
per LAMP assay 250 25 2.5 0.25 0.025 0.0025 0.00025 0.000025 
D
N
A
 n
g/
µ
L ng/µl LAMP assay 2.5x10-2 
2.5x10-
3 
2.5x10-
4 
2.5x10-
5 
2.5x10-
6 
2.5x10-
7 
2.5x10-8 2.5x10-9 
per PCR assay 200 20 2 0.2 0.02 0.002 0.0002 0.00002 
ng/µl TBR assay 2x10-2  2x10-3 2x10-4 2x10-5 2x10-6 2x10-7 2x10-8 2x10-9 
 
 
 
4.2.6 Pooling 
Infected G. m. morsitans flies were generated by adding 200µl of thawed T.b. brucei GFP J10 
blood stabilates to five mL of defibrinated horse blood (TCS Biosciences Ltd). Teneral flies 
were fed through a silicon membrane placed over the blood which was heated to 37˚C. 
After seven days the flies were dissected and their midguts visually screened for infection 
using a compound microscope. Positive midguts were then stored individually in 100% EtOH 
and later they were processed using the chosen simplified DNA extraction method. Parallel 
to the infected flies a group of uninfected flies were also generated using the same method 
as the positive flies with the omission of 200µl of T. b. brucei blood stabilate being added to 
5 ml of horse blood. The midguts of negative flies were screened prior to being stored in the 
EtOH with microscopy and later, after DNA extraction using the Chelex method, with TBR 
PCR to ensure they were truly uninfected. 
Pools of tsetse flies were generated by adding 3µl of DNA template from a single positive fly 
sample to pools of four, nine and 19 uninfected fly samples, in which each fly contributed 
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3µl of DNA extract to the pool. A total of 9 replicates were performed per pool and each 
pool was tested with LAMP.  
 
4.2.7 Persistence of DNA in tsetse material  
To assess the ability of the LoopampTM kit to detect trypanosomes from a previous blood 
meal, 200µl of a 106 trypanosome/mL T. b. brucei blood stabilate was incubated for 15 
minutes at 54˚C to kill the trypanosomes and hence prevent establishment of an infection in 
the tsetse. The heat-killed trypanosomes were added to 5ml of defibrinated horse blood. 
The viability of the parasites was determined through microscopy and the use of the stain 
Trypan blue(372). If no living trypanosomes were observed, the blood was then fed to 
teneral flies. A similar volume of uninfected blood was heated and fed to a control group of 
flies. At 24 h intervals after the initial blood meal, three experimental flies and one control 
fly were dissected and the midgut removed and stored in 95% EtOH. During each dissection 
the midgut samples were screened visually for living trypanosomes using a compound 
microscope, at 250x magnification, as a secondary measure to ensure no trypanosomes had 
survived and had started to infect the flies. 
The midgut samples were processed using the Chelex method followed by LAMP and PCR 
assays as described. The experiments were repeated until the LAMP and PCR tests showed 
two consecutive days of negative results in all experimental fly samples. 
 
4.2.8 Mixed infections 
LAMP kits were tested for cross reactivity with single and mixed species infections of 
both T. congolense (1/148) and T.b. brucei (GFP J10). Flies were infected by artificial 
membrane feeding (373). Partially fed flies were removed. On the seventh day post-
infection all flies were dissected and their midguts screened for trypanosomes by 
microscopy. 
The four groups were processed using the Chelex method and analysed using the 
Trypanozoon specific TBR primers and the universal ITS primers alongside the RIME 
LAMP kits.  
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4.2.9 Wild-caught tsetse flies 
From NW Uganda, 449 G.f. fuscipes were caught using pyramidal traps and screened by 
microscopy, universal ITS primers and the LAMP kits. The flies were caught from April to 
June 2013 from eight trap sites along the Kochi River (Northings 381161-383674, Eastings 
276506-287545) in the district of Koboko.  The flies were dissected in the field and their 
mouthparts, salivary glands and midguts were separately screened for trypanosomes by 
microscopy. All samples were then stored individually in 100% EtOH and shipped at room 
temperature to LSTM where they underwent the Chelex extraction prior to PCR and LAMP 
analysis. 
 
4.3 Results 
4.3.1 Simplification of DNA extraction 
The results for the six different DNA extraction methods, tested with the LAMP kits, are 
shown in Table 4.5.  The method that produced the highest number of positive results was 
‘½ time Chelex ‘followed by ‘TE with Chelex’ detecting 13 and 12 positive samples 
respectively out of a total of 16 positives. The lowest scoring methods were ‘TE Leave in 
alcohol’ and ‘TE wash off alcohol’. Taking into account the number of steps involved for 
each method and the total time it takes ‘TE with Chelex’ was deemed the most efficient as it 
took half the time of ‘½ Chelex’ but only identified one less positive sample (Table 4.5 and 
Figure 4.2). 
 
Table 4-5 Overview of the results for the different DNA extraction methods. 
 
 
DNA extraction 
method 
LAMP positives per Trypanosome concentration 
Total  number of 
LAMP positives 
% of positive 
samples identified 10^2 10^2 10^4 10^4 
Midgut Abdomen Midgut Abdomen 
TE Leave in alcohol 2 0 3 2 7 44 
TE wash off alcohol 1 0 4 4 9 56 
½ time Chelex 4 2 4 3 13 81 
Chelex 3 1 4 3 11 69 
TE with Chelex 4 4 3 1 12 75 
¼ Chelex 3 2 3 3 11 69 
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Figure 4.3 Results of the efficiency formula for different DNA extraction methods: 
A= Chelex, B= ½ time Chelex, C= ¼ Chelex, D= TE leave in alcohol, E= TE wash off alcohol and F= TE 
with Chelex 
 
4.3.2 Limit of Detection 
The results (Figure 4.3) show that the LAMP kit was able to detect 100% of the spiked 
samples up until 104 trypanosomes per ml, after which there was a decline in the ability to 
detect the trypanosome DNA until 10-1  trypanosomes per ml. The sensitivity of the LAMP kit 
when compared with the TBR PCR, at the extreme limit of detection, was better by a factor 
of 100 as the TBR PCR had a limit of detection of 101 trypanosomes/ml. Although the 
template volumes for the LAMP and TBR assays varied slightly by 0.5 µl (or 25%) this 
variation is too small to explain the two fold, (or 100 x) greater difference in the sensitivity 
of the two assays. 
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Figure 4.4 Limit of detection results for LAMP and TBR primers: 
a total of six flies were used for each dilution gradient for both assays. 
 
4.3.3 Pooling 
Pooling experiments show that LAMP was able to amplify one positive midgut when pooled 
with four, nine and 19 uninfected midguts - this was repeated in nine independent tests. 
There were two kit failures, one in ratio 1:5 and the other in 1:20. The failure was caused by 
the dried reagents failing to properly dissolve and integrate into the reaction. 
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4.3.4 DNA persistence 
The number of tsetse that were able to give a positive LAMP results declined from 100% 
after 48 hours to just 11% by day six and zero by day seven(Fig 4.4). 
 
 
Figure 4.5 T. b. brucei DNA time series 
Tsetse were fed dead trypanosomes on day 1 and were sampled every 24 hrs, producing a time 
series of DNA persistance. The flies were fed every 48 hrs with a fresh blood meal. 
 
 
4.3.5 Mixed infections 
Thirteen out of sixteen surviving flies from single T.b. brucei infection were identified as 
positive by both microscopy and TBR PCR (Table 4.6). When the same samples were tested 
with LAMP, all 16 flies tested positive. Of the 17 surviving flies from the T. congolense single 
infection, 14 were positive by microscopy, 13 tested positive with the ITS primers, which 
amplifies and differentiates both T. brucei and T. congolense, and none were detected by 
LAMP, which is specific for T. brucei s.l.. Of the mixed infection group both LAMP and Tbr did 
not cross react with T. congolense and the present of non-target DNA did not inhibit the 
amplification of T. b. brucei DNA.  
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Table 4-6 Results from single and mixed infections of T.b. brucei and T. congolense. 
Groups of 25 tsetse were infected with T. b. brucei and T. congolense as mono and mixed 
infections. These groups were screened with microscopy, PCR and LAMP. A control group of 25 
tsetse was included. 
Infection Assay Positive Negative Lost Flies Total 
Single T. brucei infection 
LAMP 16 0 9 25 
TBR 13 3 9 25 
Microscopy 13 3 9 25 
Single T. congolense infection 
LAMP 0 17 8 25 
ITS 13 4 8 25 
Microscopy 14 3 8 25 
Mixed infection T. b. brucei and 
T. congolense 
LAMP 20 3 2 25 
TBR 17 6 2 25 
ITS 18 5 2 25 
Microscopy 15 8 2 25 
Negative control 
LAMP 0 16 9 25 
TBR 0 16 9 25 
ITS 0 16 9 25 
Microscopy 0 16 9 25 
 
 
 
4.3.6 Wild flies 
Of the 449 wild-caught tsetse, microscopic examination of tsetse identified one salivary 
gland positive T. brucei s.l. sample, the universal ITS primers identified two T. brucei sl. 
samples, including the microscopy positive, while LAMP identified six positives, including the 
microscopy positive tsetse but only one of the two samples identified by the universal ITS 
primers. The ITS assay identified 40 flies positive for non-Trypanozoon trypanosomes (T. 
vivax n:11, T. congolense s.l. n:5, T. grayi n: 22, T. simiae n:2) which the LAMP kits did not 
cross-react with.  
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4.4 Discussion 
4.4.1 Overview 
This study has demonstrated the potential of the Loopamp Trypanosoma brucei detection 
kit as a tool for identifying Trypanozoon DNA in tsetse. The LAMP kits showed a high degree 
of specificity, with no cross-reaction when non-target species of trypanosome are also 
preent. LAMP was more sensitive than standard PCR in both laboratory-infected and wild-
caught tsetse flies. Further it was shown that a single trypanosome-infected tsetse could be 
detected in a pool of 20 flies. Simplified DNA extractions were developed and the results 
show the ability to reduce the time of DNA extraction, although moderate equipment and 
skill is still required. The results suggest that LAMP may be a useful tool for epidemiological 
surveillance of T. brucei s.l. in HAT endemic regions to estimate the burden of the disease (in 
combination with species-specific PCR). This may be more cost-effective than active 
detection of human cases, and would allow control programmes to prioritise areas for HAT 
control. 
 
4.4.1 Simplification of DNA extraction and Pooling 
The field extraction methods tested here have been assessed by balancing the length of the 
process, reliability at detecting positive samples and the number of steps involved in the 
method, which is a proxy for its complexity. The most successful method at identifying 
spiked samples was the ‘½ time Chelex method’ but once the complexity and time was 
taken into account ‘TE with Chelex’ was decided as the most efficient DNA extraction 
method.  ‘TE with Chelex’ was also able to detect all the samples, both midgut and 
abdomens spiked with the lowest concentration of trypanosomes, although it was unable to 
do the same with the higher concentration of trypanosomes. This was especially true with 
the abdomens spiked with 10^4 trypansomes, where only 1 out of the four samples 
processed with this method was LAMP positive. This discrepancy could be due to inhibitors 
in the tsetse midguts or surrounding tissue. However, all of these extractions still require 
access to centrifuges, multiple reagents and handling steps and must be improved before 
implementation.   
In previous studies, LAMP assays on pooled samples showed a decline in sensitivity by 60% 
with a ratio of 1:15 (154). In the present study, the LAMP kit was capable of detecting one 
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infected tsetse amongst 19 uninfected flies 100% of the time when coupled with the TE 
Chelex extraction method. This demonstrates that both the kit and the TE Chelex extraction 
have good potential for use as tools in the xenomonitoring of tsetse. 
 
4.4.2 Limit of Detection 
The serial dilution experiment confirms that the LAMP kits have an extremely high 
sensitivity in detecting trypanosomes. Previous studies have reported limits of detection 
ranging from the equivalent of 100 to 0.001 trypanosomes per ml (152, 154, 364) using in-
house LAMP assays in accordance with results shown here. The advantage of using a 
commercially available, standardised LAMP kit would allow researchers to compare 
different settings with each other without differences in method confounding the results. 
The ability of the LAMP kits to detect such a low number of trypanosomes per ml is 
advantageous for its use in xenomonitoring as flies actively transmitting the disease can 
have infections ranging from <1 x 101 to 1 x 104 depending on the stage of infection(374). 
However, when viewing the results of the TBR and LAMP it is clear that the reliability of the 
two assays differ as although LAMP can detect lower concentrations of trypanosomes it also 
has a higher rate of false negatives at detectable levels of trypanosomes DNA, as is shown in 
Fig 4.3 where the Tbr PCR was capable of detecting six out of the six samples at 10^3 and 
10^2 trypanosomes per mL however the LAMP assay was only positive for five and four of 
the six samples respectively. This may be due to inhibitors in the DNA template and the 
nature of how the results are viewed post-reaction. The TBR results need to be run out on a 
gel and the gel is then read using a gel imager. By using the gel imager even very faint bands 
in the gel can be detected by adjusting exposure times, contrast and brightness levels 
whereas the LAMP results are viewed solely by the naked eye.  
 
4.4.3 DNA Persistence 
Another, less obvious, advantage with xenomonitoring is that the tsetse flies are 
continuously feeding on a wide range of local vertebrates (290) and could, in effect, act as 
an efficient source of blood for screening in order to detect Trypanozoon species in the 
environment. If tsetse are able to pick up T. brucei s.l. trypanosomes in blood meals and 
trypanosome DNA can be amplified, it would be possible to detect if HAT is present in a 
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region. The results for T. b. brucei DNA persistence are highly encouraging as they 
demonstrate that it is possible to detect DNA reliably from a blood meal for 48 h post-
feeding. This is despite the fact that the tsetse flies in the present study were not only 
digesting the initial infected blood meal, but they subsequently took on fresh blood, at later 
feeds, which helped flush their digestive system of previous meals. 
 
4.4.4 Mixed Infections 
The situation in the field may also be complicated by the presence of other trypanosome co-
infections in the tsetse flies (254). The results from the co-infection experiments 
demonstrate that even with co-infected flies it was still possible to identify those that had a 
T.b. brucei infection and in the one case where the fly cleared the T.b. brucei infection but 
maintained a T. congolense infection, the LAMP kit recorded this as a T.b. brucei negative 
fly, Table 4.6. The specificity of the LAMP kits was good when tested against single 
infections of T. congolense and T.b. brucei, with no cross-reaction with the flies infected 
with T. congolense.  In wild-caught flies, the LAMP test did not cross react with the wild 
populations of T. vivax, T. congolense, T. grayi and T. simiae. The LAMP kits only amplified 
one of the two T. brucei s.l. identified by the universal ITS primers. This could be due to 
inhibitors in the sample, although this is unlikely as the LAMP kits are capable of oricessing 
whole blood (375). An alternative explanation would be that an unknown strain or species 
of trypanosome was amplified from the tsetse producing a similar sized band to T. brucei 
s.l.. 
 
The LAMP kit used in the present study is only able to identify the Trypanozoon group, 
meaning that a species-specific PCR would still be necessary to differentiate human infective 
forms from the other trypanosomes in order to guide HAT control programmes effectively. 
Unfortunately, the species-specific PCRs used to differentiate the Trypanozoon group use 
single-copy gene targets (376, 377), making them significantly less sensitive than LAMP and 
other PCRs (e.g., TBR, ITS). In addition, it is currently not possible to conduct LAMP in a high-
throughput manner, and the cost of kits is still significant, at $2.60 per test. A larger study 
involving cost analysis of PCR vs LAMP should be conducted to verify that molecular 
xenomonitoring is a suitable tool for studying the epidemiology of HAT and is able to 
highlight hotspot areas of transmission.  
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4.4.5 Conclusion 
This study has demonstrated a robust detection limit of the DNA dilution equivalent to 1 
trypanosome/10mL for the Trypanozoon detection kit. The kit has been shown to have a 
high specificity, with no cross-reactivity in flies with multiple infections, including wild 
caught flies that had a greater variation of non-target species and provided a more realistic 
challenge. The kits could also detect T.b. brucei DNA 6 days after consumption of a 
contaminated blood meal, despite having fresh feeds every 48 hrs, which would be flushing 
their digestive system with clean blood. The sensitivity of the kits was high enough to allow 
for the detection of a single infected fly in a pool of 20 flies. The next step would be to test 
the DNA extraction and pooling methods in the field alongside a wider cost and feasibility 
evaluation of LAMP vs PCR and the ability to use xenomonitoring of HAT over time in the 
elimination campaign. 
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 : Impact of tiny target intervention on zoonotic 
trypanosome transmission 
 
5.1 Introduction 
The control of West African sleeping sickness has historically been reliant on case detection 
and treatment ever since it was successfully employed by Eugène Jamot in 1916-1917. 
Jamot termed his intervention “medical prophylaxis” and in the 18 months of this 
intervention close to 90,000 people were examined and over 5,000 people, identified as 
gHAT positive, were treated with atoxyl (378, 379). Active screening and treatment of 
populations at risk of gHAT by mobile teams however this has since been scaled back in the 
decades following de-colonisation (380) but has since been renewed in the 21st century 
(381). The role of vector control as a means of combating sleeping sickness is mainly a 
feature of combating East African sleeping sickness and has been used far less frequently in 
West Africa. The high number of targets needed to control the vectors of West African 
sleeping sickness has for a long time made this prohibitively costly.   
 
This hurdle of cost effective West African tsetse control methods has now been overcome 
after experimentation with target sizes revealed that a 90% reduction in target area led to a 
50% reduction in catch numbers (231). It was found that the number of tsetse caught per m2 
of fabric is optimum with 25 cm2, targets flanked by an equal area of netting (231). Due to 
their smaller size the reduction in the cost of the fabric offsets the number of targets 
required for effective control resulting in an economically viable strategy (234, 235). This 
increase in tsetse killed per m2 of fabric means that the cost of controlling tsetse with the 
new, smaller targets, is USD 55.7 per km2 (382) which is far below previous estimated costs 
for tsetse control which ranged from USD 179 to USD 556 (383, 384). 
 
This new, smaller, target technology has been dubbed “tiny targets” and with this new 
approach to vector control a major shortfall of case detection and treatment can be 
overcome, namely that the screening of the human population is never complete (385). 
Studies have shown that active screening coverage can vary from as low as 10% (386) and 
rarely exceeds 70% (387, 388) and it does not have an immediate effect on reducing the risk 
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of being infected via the bite of tsetse (236). The lack of 100% coverage is due to multiple 
factors from hard to reach communities to taboos associated with the screening process 
that involve fear of treatment, fear of being diagnosed as gHAT positive and the subsequent 
loss of work and a distrust of the mobile screening teams (387). Initial studies, conducted on 
islands on Lake Victoria, showed that the optimum number of Tiny Targets  to be deployed 
was 20 per linear km (236). The Tiny Targets  reduced the tsetse population by >90% and 
this result was replicated when the Tiny Targets  were deployed on a larger scale in N W 
Uganda in 2013 (236). 
 
5.1.1 Tiny targets intervention NW Uganda  
Full details of the Tiny Targets  trial in NW Uganda are described by Tirados et al 2015 and 
summarised here. The Ugandan study was carried out in two phases and lasted from 
September 2011 to December 2013. In the first phase, September 2011-December2012, the 
Tiny Targets  were deployed in five separate 7x7km blocks, in the historical HAT foci of Arua 
and Maracha, producing a total discontinuous intervention area of 250km2 (Fig. 5.1.A). 
Later, in the second phase from January 2013 to December 2013, the study site was 
increased in size to 500km2 by deploying Tiny Targets  between the five original intervention 
blocks to link them up into one large intervention zone (Fig. 5.1.B). The targets were 
deployed within the following co-ordinates: 3.053ᵒ-3.310ᵒ N and 30.838ᵒ-31.082ᵒ E. 
The impact of the Tiny Targets  on the tsetse population was assessed using pyramidal traps 
located in the centre and edges of the five original blocks; an additional 12 more traps were 
added in phase two when the intervention site was expanded. To the North of the study site 
a similar ecological environment was selected in the HAT foci of Koboko, along the Kochi 
River, from 3.451ᵒ-3.465ᵒ N and 30.058ᵒ-31.003ᵒ E. This site was selected as an 
experimental control site and no targets were deployed within this region. Within this non-
intervention zone fifteen monitoring sites were selected to assess the fly prevalence 
throughout the course of the study. 
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Figure 5.1 Tiny Target deployment sites 
The initial 7x7 km intervention blocks (A) were Ayi, Kubala, Inve, Aiyu and Arua. They were separated 
from each other by areas lacking tiny targets. These five sites were later linked up as new tiny targets 
were distributed between the intervention blocks, expanding the treatment area to a 500km2 site (B). 
Image provided by Tirados (389) 
 
The entomological survey in both sites showed that the Tiny Targets  had a significant 
impact on the tsetse numbers caught in the intervention zone whereas the tsetse 
population from Koboko showed little change across the intervention period (236). 
Although the impact of the intervention on the numbers of tsetse in the area is clear the 
effect on the transmission of salivarian trypanosomes has not been determined.  
The previous studies evaluating the effectiveness of the tiny target technology have 
concentrated on the effects the targets have on tsetse numbers. This is the first study to 
attempt to evaluate the effects of the Tiny Targets on the transmission of trypanosomes of 
medical and veterinary importance. In order to evaluate the impact the Tiny Targets have on 
the transmission of salivarian trypanosomes cattle from both the intervention and non-
intervention site will be screened for T. brucei s.l., T. congolense and T. vivax. Of primary 
interest is the effect of the intervention on the transmission of T. brucei s.l. as this species 
complex includes the pathogen responsible for gHAT. Any observable reduction in this 
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species complex across the intervention site will support the argument for this technology 
to be used to combat gHAT. The other two common salivarian trypanosomes, T. congolense 
and T. vivax will also be screened for due to the relative low prevalence of the T. brucei s.l. 
infections and help increase the chance of detecting a significant difference in transmission 
of trypanosomes between the two sites. 
 
5.1.2 Animal reservoirs of HAT 
The zoonotic nature of Rhodesian sleeping sickness has been proven for some time (390) 
and Gambian African sleeping sickness is widely accepted to be an anthroponotic disease. 
However, there is still a question over the importance of an animal reservoir host within the 
transmission cycle of T. b. gambiense. Studies have found domestic animals positive for T. b. 
gambiense in pigs, sheep and goats (64, 391) as well as numerous non-domestic animals 
(63). However, despite finding T. b. gambiense in non-human hosts there is no evidence that 
these animals are actively part of the transmission cycle. The elimination of T. b. gambiense 
from the island of Bioko through screening and treatment of the human population (392) 
would suggest that there was no animal reservoir.  Similarly, the success of the case 
detection and treatment approach in reducing the number of West African cases of sleeping 
sickness across large parts of the continent would also support the theory that this is an 
anthroponotic disease without an animal reservoir. Other studies seeking to find T.b. 
gambiense amongst domestic animals from historic HAT foci have failed to find any 
domestic animals positive for the gambiense sub-species (393). However, the potential of an 
animal reservoir cannot be overlooked if the push to elimination is to be achieved by 2020. 
Recent mathematical models have shown that the ability to eliminate the disease can be 
heavily influenced by non-human reservoirs of T. b. gambiense (394). The old transmission 
site at Bioko which once supported the notion of an anthroponotic disease has recently led 
credence to an animal reservoir argument as the parasite is still being found in the local 
tsetse population despite no evidence of it being in the human population. This suggests 
that there may be an animal reservoir maintaining transmission (60).  
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5.1.2.1 Cattle and pigs as potential reservoirs for T. b. gambiense in NW Uganda 
Having identified T. brucei s.l. in the local cattle populations from the HAT focus of Arua and 
Maracha, as presented and discussed in chapter 5, these Tbr-FIND positive samples would 
need to be identified down to the species to determine whether or not T. b. gambiense was 
present in any of the cattle.  To complement the study of cattle, pigs were also sampled for 
trypanosomes since they have previously been implicated as a potential reservoir host for T. 
b. gambiense (64, 65, 395-397) and since the mid 1980’s pig production has become an 
important income-generating activity in Uganda (398). A study carried out from 2004-2008 
screened domestic animals in NW Uganda and found that pigs had the highest percentage 
positive rates (21.7%) for T. brucei s.l. using the Tbr primers. This was despite only 161 pigs 
being screened out of a total of 3,267 other domestic animals. Cattle, goats and sheep all 
had a lower Tbr positive rate at 14.5%, 12.4% and 10.8% respectively (393). Although this 
study failed to find any animals positive for T. b. gambiense it is unclear precisely where the 
samples were collected. In this study, samples were collected close to areas where HAT 
cases had been recently reported. The results of the 2012 study are also unreliable as the 
Tbr positive samples were not tested with a single-copy Trypanozoon primer set, meaning 
that the absence of products from the TgsGP primers could be due to insufficient DNA 
present for the amplification of a single copy gene as opposed to a true negative result 
(271). 
 
5.1.3 Trypanosoma theileri 
Aside from the salivarian trypanosomes there are a number of non-tsetse transmitted 
species chief among these is Trypanosoma (Megatrypanum) theileri. This is a large 
trypanosome (Fig.5.2) that is found throughout the world’s cattle (128, 131, 249, 399). The 
vectors of T. theileri are tabanids (400) and generally cattle infected with this parasite show 
little to no clinical symptoms (400, 401). T. theileri infections can be significant amongst 
cattle populations reaching levels as high as 81-86% (249, 402).  
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Figure 5.2 Size difference between T. theileri and salivarian trypanosomes 
Comparison in size between an unknown salivarian trypanosome species (A) and Trypanosoma 
(Megatypanum) theileri (B) isolated from Ugandan cattle. The samples were stained with giemsa. 
Trypanosome A is most likely to be either T. vivax or T. brucei s.l. based on its size in relation to the red 
blood cells. Images taken during this study. 
 
 
The presence of the non-salivarian trypanosome Trypanosoma theileri may confuse the 
interpretation of both microscopy results and molecular analysis especially the ITS results 
due to its high genetic variability (273, 403) which results in a range of PCR product sizes.   
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5.1.4 Objectives 
As mentioned previously the impact of Tiny Targets  on the numbers of the local vector 
population has been well studied (236) however the impact of this novel vector control 
strategy on the transmission of salivarian trypanosomes and the health of local host animals 
has not been investigated. Therefore, the purpose of this chapter is to address these gaps in 
the current knowledge of the impact of the Tiny Targets in the wider context of 
trypanosomiasis transmission and morbidity.  
Aims: 
 
1. The prevalence of trypanosomiasis in cattle populations from the intervention and 
non-intervention sites will be quantified to determine the impact of vector control. 
2. Assess the presence of T. b. gambiense in local cattle and pig populations by: 
i. Determine the prevalence of T. brucei s.l. in the local pig populations from 
two sites in NW Uganda 
ii. Establish how many T. brucei s.l., cattle and pigs have enough genomic 
material to detect a single copy gene 
iii. Using the T. b. gambiense specific primers assess whether individual cattle 
and pigs that are T. brucei s.l. positive were infected with T. b. gambiense 
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5.2 Methods 
5.2.1 Cattle sampling 
To determine the effects of the intervention on the transmission of salivarian trypanosomes 
in the local cattle population a baseline for trypanosome prevalence was established by 
screening a total of 406 animals from the following five 7x7km intervention blocks: Aiivu 
(80), Arua (74), Ayi (70), Inve (65) and Kubala (117), a further 200 cattle were screened from 
the non-intervention zone in Koboko from two sites hereafter called Koboko East (100) and 
Koboko West (100). The selected cattle were treated with Albafas 10% de-wormer, main 
active ingredient albendazole, to encourage the co-operation of the local farmers, and the 
trypanocides Berenil or Veriben, main active ingredient is diminazene aceture. The de-
wormer was administered at 750mg of albendazole per 100kg of animal body weight and 
the trypanocide was administered at 350mg of diminazene aceture per 100kg of animal 
body weight.. To track the treated cattle, they were tagged with numbered ear tags of 
differing colours. This initial, pre-intervention, sampling will be referred to as round 0 (R0) 
and was used to inform the power calculations for the seven sampling rounds that followed 
(R1-R7)(Table 5.1). 
Table 5-1 Time frame of the sampling rounds and corresponding control operation. 
Sampling Round R0* R1 R2 R3 R4 R5 R6 R7 
Dates 
Start 01/08/11 15/12/11 30/04/12 01/08/12 17/01/13 02/05/13 20/08/13 26/11/13 
End 20/08/11 25/01/12 11/05/12 10/08/12 26/01/13 14/05/13 28/08/13 04/12/13 
Control operation   1st Phase 2nd Phase 
 
*R0 was carried out prior to the intervention. 
5.2.7.1 Power calculation 
Prior to carrying out the study the appropriate sample size of cattle for the intervention and 
non-intervention sites needed to be calculated in order to be sure that a large enough 
sample size has been used for the interests of the study. In this case our primary interest is 
to detect changes in the prevalence of trypanosomiasis in the cattle populations from the 
areas in which Tiny Targets  were deployed and the areas in which no targets were present. 
In theory a decrease in the vector population would impact the transmission of disease. 
To calculate the required sample sizes the following power calculation was used (404): 
𝑛 = (𝑡
√𝑃(1 − 𝑃)
𝑙
)
2
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Where: n= sample size, t= students T value, taken to be 1.96 for a 95% confidence level, P= 
prevalence, taken to be 15% from screening results, l= absolute level of power at 5%. 
 
 
These parameters were input into the equation to give: 
𝑛 = (1.96
√0.15(1 − 0.15)
0.05
)
2
= 196 
 
During each round, the same sampling sites were revisited and cattle that were treated in 
the previous round were re-sampled. If there was a short fall in the number of cattle, below 
196, new animals were recruited to the study. The trypanocide, veriben, was used as it 
remains effective for ~10 days and does not provide long-lasting protection, allowing the 
cattle to become re-infected. A reduction of tsetse numbers due to the vector control is 
expected to be reflected in the proportion of cattle that become re-infected. The cattle 
sampling lasted from August 2011 to November 2013, and on average each sampling round 
lasted 16 days with 105 days separating the end of one sampling round and the start of the 
next. The cattle sampling methodology is depicted in a diagrammatic form below (Fig.5.3.). 
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Figure 5.3 Sampling method employed covering two consecutive rounds: 
in the initial round (A), cattle are being re-sampled and any loss in numbers are replenished with new cattle 
to reach 196. Blood samples are then taken and the cattle treated with veriben to clear them of 
trypanosomes. (B) Between the two sampling rounds cattle are lost and are susceptible to re-infection. (C) 
The cattle from the previous sampling round are then re-sampled and new cattle recruited to replace those 
lost. 
 
5.2.2 Pig sampling 
The NW of Uganda has seven districts, Nebbi, Arua, Koboko, Yumbe, Moyo, Adjumani and 
Gulu, of which Arua, Koboko, Yumbe, Moyo and Adjumani have historic sleeping sickness 
foci (405). This study includes cattle data from Arua and Koboko and pig data from Arua 
(Fig.6.1.A) and Moyo (Fig.5.1.b). It was not feasible to sample pigs from Koboko as this is a 
predominantly Muslim area where there are very few pigs. 
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Figure 5.4 Distribution of the pig sampling sites: 
(A) Arua and (B) Moyo overlaid on the gHAT distribution sites from 2010-2014. Image adapted from the 
Atlas of HAT (406).   
 
5.2.3 Blood collection 
Blood was collected from individual cattle by first piercing a vein in the ear with a disposable 
lancet and collecting three, 35µl, samples of blood, using 50mm heparinised capillary tubes. 
One of these samples was directly spotted onto FTA card and left to air dry out of direct 
sunlight. The other two blood samples were then further processed to establish the PCV 
values and microscopy positive status as described below. 
 
5.2.4 Microscopy 
Following on from the PCV reading a wet slide was then prepared from the buffy coat layer 
of one of the tubes as initial screen for trypanosomes using a Leica DM500 microscope 
equipped with a dark field filter at 200x magnification. Using this method, it was not 
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possible to differentiate the species of trypanosome, so all positives were included in this 
section of the study. 
 
5.2.5 FTA DNA extraction 
The FTA cards were used to store individual blood samples from the study animals. The 
blood spots were left to air dry and then placed in a heat sealed foil pouch with silica beads. 
FTA cards were then transported back to the UK and processed at the Liverpool School of 
Tropical Medicine using the methods described in chapter 2 section 2.2.1 and is summarised 
below.   
 
5.2.6 Molecular analyses 
5.2.6.1 T. brucei s.l. 
All samples were screened with the T. brucei s.l. specific Tbr-FIND primers described in 
Chapter 2, these primers target a 10,000 copy region of the genome and have a greater 
sensitivity than the generic ITS primers. 
 
5.2.6.2 ITS 
In addition to the T. brucei s.l. specific primers generic ITS primers were also used to identify 
T. brucei s.l., T. congolense and T. vivax. Identification required running the PCR products 
out on a 1% agarose gel stained with ethidium bromide and measuring the band sizes. 
 
5.2.6.3 Species specific PCR and sequencing 
Putative T. congolense and T. vivax samples were re-tested with species specific primers 
described in Chapter 2 for the three strains of T. congolense and West African strains of T. 
vivax. 18S sequencing primers were used to help confirm the species and sub-species for 
samples of interest. The PCR products designated for sequencing were cleaned with the 
Qiagen PCR clean-up kit and sent for Sanger sequencing to Source-Bioscience. 
 
5.2.6.3 T. brucei s.l. multiplex PCR and T. b. gambiense species specific PCR 
As mentioned in Chapter 3 (sections 3.2.5) there is a difference between the sensitivity of 
the methods used to identify samples positive for T. brucei s.l. and those used to identify the 
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sub-species of Trypanozoon. The methods used to identify the sub-species are the same as 
those used in Chapter 3 and have been previously described in Chapter 2 (section 2.2.5). 
 
5.2.7 Statistics 
The impact of Tiny Targets on the infection status of cattle was assessed by comparing the 
proportions of infected cattle in areas with and without targets.  Proportional data are not 
Normally distributed and so standard statistical tests are inappropriate.  Moreover, herds 
were repeatedly sampled and hence allowance must be made for repeated measures.  
Accordingly, analyses were carried out using a Generalized Linear Mixed Model (GLMM) 
with a binomial error distribution.  Fixed effects included presence or absence of targets 
(two levels) and sampling round (seven levels) as fixed effects while the sentinel herd (seven 
levels) was a random effect.   Further details are provided in the Results below.  
 
5.3 Results 
5.3.1 Cattle loss and between rounds 
The proportion of cattle lost between rounds is shown in Fig.5.4, the most significant drop-
out of cattle occurred in the intervention site with a loss of 126 (63%) cattle from R1 to R2. 
On average the intervention site lost 67 (27%) animals between rounds and the control site 
lost an average of 54 (29%) animals.  
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Figure 5.5 Proportion of cattle lost between rounds: 
from the intervention (Arua-Maracha) and control (Koboko) sites. 
 
As mentioned in the cattle sampling description the loss of cattle between rounds meant 
that in order to meet the minimum sample size, new cattle were recruited to the study. 
New cattle were classified as any animal that had not been sampled in the previous round. 
This included cattle that had never been sampled and were completely new to the study 
and cattle that had been sampled in earlier rounds. Table 5.2 summarises the numbers of 
animals that were re-sampled or added to the sentinel herds. 
 
Table 5-2 Numbers of new cattle recruited into the study 
  Round pair 
Sampling site Sample status R1 R2 R2 R3 R3 R4 R4 R5 R5 R6 R6 R7 
Intervention 
re sampled 74 153 129 138 120 157 
Never sampled 127 1 50 5 44 23 
Previously sampled 0 28 33 24 49 17 
Total "new" cattle 127 29 83 29 93 40 
                
Control 
re sampled 180 143 99 100 116 90 
Never sampled 20 7 53 52 24 45 
Previously sampled 0 5 9 38 6 20 
Total "new" cattle 20 12 62 90 30 65 
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5.3.2 Microscopy 
The microscopy results were based on screening a wet slide prepared using the buffy coat 
layer of a centrifuged capillary tube in the field during sample collection. A total of 3173 
samples were screened, comprising of ‘new’ and ‘previously treated’ animals, 1784 (56%) 
from the intervention zone and 1389 (44%) from the control zone. Of these, 660 (21%) 
samples were microscopy positive, 304 (17%) from the intervention zone and 356 (26%) 
from the control zone (Fig 5.5). Logistic regression analysis of the data showed that there 
was no significant difference (GLMM, z=-0.155, ns) in the infection rate between herds in 
areas with (0.16, 95%CI=0.107-0.237) or without (0.21, 95%CI=0.155-0.275) targets.  
 
 
Figure 5.6 Proportion of cattle with Trypanosoma spp. 
 
The results shown in Fig.5.5 show that from Round 4 onwards the intervention site shows 
consistently lower microscopy positive cattle. However, there was a similar difference 
before the intervention (Round 0) and these percentages are confounded by new cattle 
recruited into the study that had not been treated in the previous round.  
 
The results for only those animals present in two consecutive sampling rounds are shown in 
Fig.5.6. These results show that there was again a reduction in the incidence of 
Trypanosoma infection in the area where targets were deployed (Arua-Maracha).   
Statistical analysis of the data showed that the difference was however not significant 
(GLMM, z=-1.49, ns) with the overall proportion infected in areas with and without targets 
being 0.19 (0.110-0.310, 95%CI) and 0.12 (0.053-0.240) respectively.  
127 
 
 
 
Figure 5.7 Proportion of cattle infected with Trypanosoma that were re-sampled 
The cattle were sampled three months after being treated with a trypanocide in the previous sampling 
round. Targets were present in Arua-Maracha only. 
 
 
The microscopy results show a decrease in the percentage of cattle infected with 
trypanosomes from round 4 onwards. However, these results include all trypanosomes 
present in the cattle including T. theileri which is not transmitted by tsetse and so would not 
be affected by the vector control.  Hence it is important to consider the salivarian 
trypanosomes alone. It was not possible to track animals sampled in Round 0 to Round 1 as 
no records were kept of tagged animals in Round 0. 
5.3.3 Tbr positive rate 
The primary interest of this study was to see the effects of the vector control on the 
transmission of T. brucei s.l. as within this species-group is the parasite responsible for 
gHAT. Using the highly specific and sensitive Tbr primers an accurate number of T. brucei s.l. 
infected cattle was produced from each sampling round (Fig.5.7). The total number of T. 
brucei s.l. positive cattle across all sampling rounds was 30 (1.9%) in the intervention site 
and 8 (0.6%) in the control site. These results show that the majority of T. brucei s.l. 
infections occurred in the intervention area (Arua-Maracha). The prevalence of T. brucei s.l. 
decreased in the intervention site from 4.5% in round one to 0.5% in round four. In the non-
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intervention site (Koboko), no cattle infected with T. brucei s.l. were detected in cattle until 
Round 5 whereafter it ranged from 0.5% to 3.8% across three sampling rounds (Fig.5.7). 
 
 
Figure 5.8 The proportion of cattle infected with T. brucei s.l. 
Positive cattle were identified using the Tbr-FIND primers across the control (Koboko) and 
intervention (Arua-Maracha) sites. 
 
As with the microscopy results, newly recruited cattle could be contributing positive animals 
to the total being detected resulting in inaccurate reporting of infections acquired between 
sampling rounds. In the intervention site, when considering only animals that were present 
in consecutive sampling rounds, there was no decrease in the percentage of T. brucei s.l. 
infections from rounds one to three (1.3%-1.3%). From Round three to four, no cases of T. 
brucei s.l. were detected but from Round 4 to Round 5 the percentage of cattle positive for 
T. brucei s.l. was 3.6%. From round five to six no cattle were detected as positive however 
from round six to seven 1.9% of the animals tested positive. T. brucei s.l. positive cattle were 
not identified in the non-intervention site until round five (1%), the positive percentage 
remained the same in round six and increased to 2.2% in round seven. The general trend in 
prevalence across the sampling round does not decrease and there is no clear or consistent 
effect. 
129 
 
 
Figure 5.9 Proportion of cattle infected with T. brucei s.l.: 
Cattle sampled from consecutive sampling rounds 
 
5.3.4 T. brucei s.l., T. congolense and T. vivax ITS positives 
A total of 2,877 cattle samples were screened with the ITS PCR of which 293 (10%), were 
positive for either T. brucei s.l., T. congolense or T. vivax in single and mixed infections. T. 
theileri was found in 1,189 (41%) of all cattle screened with the ITS primers and in 197 (67%) 
of the 293 cattle that were positive for either T. brucei s.l., T. congolense or T. vivax. The 
total number of cattle samples identified as being trypanosome positive, be it salivarian or 
T, theileri, was 1440 (50%). When comparing single and mixed positives, only amongst the 
293 salivarian positives, there were 275 (94%) single positives comprised of 125 (45%) T. 
brucei s.l. , 53 (19%) T. congolense and 97 (35%) T. vivax. A total of 17 (6%) samples had a 
double salivarian infection of which 13 were mixed T. brucei s.l. and T. congolense 
infections, 3 were mixed T. congolense and T. vivax infections and 1 mixed T. brucei s.l. and 
T. vivax mixed infection (Table.5.3). Only one animal was positive for all three salivarian 
trypanosomes. 
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Table 5-3 The number of single and double salivarian positive samples identified. 
 Infections 
 Single Double 
    T. brucei s.l. T. congolense T. vivax 
T. brucei s.l. 125   13 1 
T. congolense 53 13   3 
T. vivax 97 1 3   
 
 
 
Comparison of the ITS results for T. brucei s.l., T. congolense and T. vivax for all cattle across 
the sampling period shows variation in the percentage of positive cattle in both intervention 
and non-intervention sites (Fig.5.9). Logistic regression analyses for each species separately 
or all species combined showed that the targets had no significant effect on infection rate. 
 
Figure 5.10 Proportion of cattle infected with Trypanosoma spp. assessed using the ITS PCR: 
(a) T. brucei s.l., (b) T. congolense, (c) T. vivax, and (d) the combined infection rates for these three 
trypanosome species across all sampling rounds. 
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When comparing only animals that were present in consecutive sampling rounds (Fig.5.10) 
there was still no significant difference between the control and intervention sites for either 
T. brucei s.l., T. congolense and T. vivax or the combined salivarian species.  
 
 
Figure 5.11 Infection rates estimated using the ITS PCR: 
(a) T. brucei s.l., (b) T. congolense, (c) T. vivax, and (d) the combined positive rates for all three 
trypanosome species from consecutive rounds. 
 
5.3.5 ITS T. theileri positives 
The number of samples positive for T. theileri from the intervention site was 581 (37%) out 
of 1,595 from the intervention site and 525 (40%) out of 1302 from the control site 
(Fig.5.11). There was no significant difference in the number of positives between the two 
sites across the sampling period (Fig.5.11a). However, there was a significant difference 
(GLMM, z=-2.19, P<0.05) for animals sampled from consecutive sampling rounds (Fig.5.11s.) 
with the proportion infected in the areas with and without targets being 0.41 (0.291-0.532) 
and 0.33 (0.219-0.470) respectively.  
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Figure 5.12 The infections rates of cattle with T. theileri: 
(a) all cattle and (b) only cattle that were re-sampled at consecutive rounds 
 
5.3.6 Species specific primers for T. vivax and T. congolense 
Of the 103 cattle identified as positive for T. vivax with the generic ITS primers, 27 were 
confirmed with the species specific T. vivax primer set described in Chapter 2. Of the 73 
putative T. congolense positives identified with the generic ITS primers, none was confirmed 
with any of the three species specific primers used to identify the Kiliffi, Savannah and 
Forest/Riverine strains of congolense. This could either mean that the T. congolense 
samples identified by the ITS primers are not in fact T. congolense or that the lower 
sensitivity of the species specific primers is such that there is insufficient DNA present for 
them to work. 
 
5.3.7 Sequencing results 
To confirm the results from the species specific and ITS primers the single infections for 
trypanosome positive cattle were identified. For each species of interest, T. brucei s.l., T. 
congolense and T. vivax 10 samples were selected. This number was chosen as this was the 
maximum number of single T. congolense infections available. Of the 40 samples selected 
and processed with the 18S sequencing primers there was a total of 29 successful reactions 
(Table 5.4). The sequencing service was provided by Source Bioscience. As well as the 
salivarian species 11 suspected ITS T. theileri positives ranging in size from ~220-~380bp 
were also selected to confirm this parasite was as genetically diverse as suspected. 
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Table 5-4 Results of ITS and Tbr positives sequenced using 18S primers 
PCR   18S sequencing Results 
  
Species ID by ITS 
and Tbr T. brucei s.l. T. congolense T. vivax T. theileri 
Tbr T. brucei s.l. 4 1  1 
ITS 
T. congolense 3 2  2 
T. vivax 1  1 3 
T. theileri 1   10 
 
 
 
Although the species-specific primers had failed to identify the type of T. congolense 
present the sequencing primers amplified three T. congolense samples. When compared 
against the NCBI nucleotide collection database using BLAST search the T. congolense 
samples matched with T. congolense Forest with a 100% query cover and 99% identity. 
 
5.3.8 T. brucei s.l. multiplex PCR and T. b. gambiense species specific PCR results 
5.3.8.1 Tbr-FIND pig results 
A total of 766 pigs were sampled from 13 sites (Fig.5.4), 400 pigs from seven sites in Arua 
district and 366 from six sites in Moyo district. When the pigs were sampled their 
colouration was recorded as an indicator of their breed. The local breed is characteristically 
smaller and black in colour with exotic breeds being white or mixed white and black and 
larger. Arua’s local to exotic breed ratio was 3:1 and Moyo’s was 1:7. The seven sites from 
Arua averaged 57 pigs and the six sites from Moyo averaged 61 pigs, Table 5.5. 
 
134 
 
Table 5-5 The Tbr-FIND results of pigs sampled from Arua and Moyo 
District Site 
Easting Northing 
# pigs 
sampled 
Tbr-FIND 
positive 
Percent infected 
A
ru
a 
Wiliffi 288042 364383 67 1 0.01 
Duku 292384 361141 45 1 0.02 
Tondolo 290083 354060 25 0 0 
Ngalabia 286723 351690 68 0 0 
Muttee 290934 360741 51 7 0.14 
Drimveni 289931 362178 100 3 0.03 
Inia 288042 364383 44 13 0.3 
sub-total     400 25 0.06 
M
o
yo
 
Perego 359826 403404 37 0 0 
Opiro 359898 405066 109 0 0 
Moipi 357915 401930 67 0 0 
Kendi 357798 406514 113 0 0 
Goopi 363570 408774 32 0 0 
Kuleni  364337 407802 8 0 0 
sub-total     366 0 0 
  Total     766 25 0.03 
 
 
 
 
 
The number of pigs positive with the Tbr-FIND PCR assay was 25 (3.3%), all of these positives 
came from the Arua district; no pigs sampled from Moyo were found to be positive for T. 
brucei s.l.. Of the 25 positive pigs, 20 came from just two out of the seven sampling sites in 
Arua, these were Inia and Muttee. Sites Tondolo and Ngalabia produced zero positive pigs 
while Wiliffie, Duku and Drimveni produced the remaining five positive samples. 
 
5.3.8.2 T. brucei species multiplex and TgsGP results 
The T. brucei s.l.  positive pigs and cattle were screened with the brucei multiplex primers to 
determine how many samples contained enough DNA for the amplification of a single copy 
gene.  Of the cattle and pigs positive for T. brucei s.l., 24 (63%) and 15 (60%) tested 
positively for the single PLC gene respectively. No samples were positive for the 669 bp 
sized band specific for the SRA gene which would indicate the presence of T. b. rhodesiense. 
The samples were then tested with the TgsGP primers to screen for T. brucei gambiense. Of 
the cattle and pig samples none was positive for T. b. gambiense. 
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5.4 Discussion 
5.4.1 Effects of Tiny Targets  
In this chapter multiple methods were used to identify trypanosome infections in cattle 
from two sites in NW Uganda that were in areas with or without Tiny Targets.  The aim of 
the study was to assess the prevalence of Trypanosoma spp. in the cattle population and 
assess whether the deployment of Tiny Targets affected the incidence of infection in the 
local cattle population. 
 
The intervention and control sites both lost cattle between sampling rounds which 
complicated the analysis as new cattle were recruited which confounded efforts to assess 
re-infection rates. This meant that during the analysis a distinction had to be made between 
the cattle sampled in consecutive rounds and those that had not. Both microscopy and 
molecular methods were used to identify the trypanosome positive animals. Microscopy 
identified trypanosome infection in 20% of the animals screened however the methods used 
were not suitable for accurately distinguishing between species and included animals 
infected with T. theileri. There was a significant difference in the number of microscopy 
positives between the two sites for individual sampling rounds and animals present in 
consecutive sampling rounds. 
 
The results of the T. brucei s.l. specific primers identified 38 (1.3%) samples positive for T. 
brucei s.l. with an uneven distribution between the two sites. The intervention area 
contributed 30 Tbr positive cattle samples with only eight coming from the non-intervention 
sight. It was only in rounds five to seven that Tbr positive samples were found in the non-
intervention site. These low levels are consistent with previous studies that found the 
prevalence of T. brucei s.l. ranging from 1.4%-10% (407, 408). Due to the uneven 
distribution of T. brucei s.l. and the low prevalence it is not possible to use the non-
intervention site as a control to assess the impact of the Tiny Targets  on reinfection rates of 
T. brucei s.l.. 
 
Whereas microscopy identified trypanosomes in 20% of the samples, the generic ITS 
primers identified trypanosomes in 50% of all samples screened. The majority of these 
trypanosomes positives were T. theileri which was present in 41% of cattle samples. 
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Salivarian positives were found in 10% of cattle samples of which T. brucei s.l. was the most 
common. The generic ITS primers identified over three times as many putative T. brucei s.l. 
positives as the Tbr primers. The difference between the two PCR assays is unexpected as 
previous studies have shown that the Tbr PCR is more sensitive than the ITS PCR (253). A 
likely explanation for this is that the generic ITS primers amplified the ITS region of a 
trypanosome that shared a similar size to that of T. brucei s.l.. Subsequently when run out 
and read on a gel it can be difficult to distinguish bands of similar size resulting in mis-
identification. The species of trypanosome most likely to be producing these false positives 
is T. theileri as these trypanosomes, in this study, have produced ITS PCR products of 
~380bp in size, similar to the 430bp size of T. brucei s.l.. 
The ITS primers also identified T. congolense and T. vivax in which each contributed 24% and 
35% towards the total number of salivarian positives. The regression analyses conducted on 
the sampling rounds found no significant difference between the intervention and non-
intervention site with the exception of the analysis of animals from consecutive rounds 
positive for T. vivax. The result that T. vivax is the only salivarian trypanosome that differs 
significantly between the rounds is surprising as it has the shortest maturation time of the 
three salivarian species, 5-13 days, (295) and is known to be transmitted mechanically by 
tabanids (281). These life history traits make it less likely that T. vivax would be affected by 
tsetse control. Therefore, there is little evidence that the vector control implemented had 
any detectable impact on the reinfection rates of the study cattle. One explanation for this 
is that the majority of the T. brucei s.l. positives identified by the generic ITS PCR are 
potentially T. theileri wrongly identified as T. brucei s.l.. As T. theileri is not transmitted by 
tsetse but rather by tabanids, the Tiny Targets would have had little impact on the 
transmission of this parasite.  
 
The lack of any clear and consistent impact of vector control on the incidence of 
Trypanosoma infections in cattle may be because of the mobility of tsetse and cattle.  
Infected tsetse from outside the intervention area may have moved into the area where 
targets were deployed and conversely cattle may have moved out of the area for grazing 
and water.   
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The species-specific primers for T. congolense and T. vivax confirmed 25% of the ITS T. vivax 
and none of the ITS T. congolense positives. Previous studies have also shown similar results  
with one study showing that the T. congolense species specific primers gave a prevalence of 
0% compared to a prevalence 2.2% identified by the ITS primers (253). The results from the 
present study found an ITS T. congolense prevalence of 2.4% with a species specific primer 
result of 0%. The difference in prevalence of T. theileri between the intervention and control 
sites was found to be significant using binary logistic regression on animals present in 
consecutive sampling rounds. This difference is not due to the effects of the Tiny Targets but 
instead likely due to a pre-existing difference in the two regions.  
 
5.4.2 Assessment the presence of T. b. gambiense in local cattle and pig populations 
The second aim of this Chapter was to determine the prevalence of T. b. gambiense cattle 
sampled as well as in the local pig populations from two gHAT foci, Arua and Moyo. The 
identification of T. b. gambiense would show that transmission of sleeping sickness in the 
area is still on-going and the identification of the disease in either cattle or pigs would help 
resolve the role of animal reservoirs in the transmission of the disease. 
The Tbr-FIND PCR analysis of the pig samples identified a 3% prevalence of T. brucei s.l., this 
was double the percentage of cattle found to be positive with T. brucei s.l. (3%) using the 
same Tbr-FIND primers. All of the pig positives came from the Arua area, giving these 
samples a prevalence of 6%. A similar study, conducted in the same district in 2012, found 
pigs to have a higher prevalence (20%) of T. brucei s.l. (393). The results in this chapter have 
shown that T. brucei s.l. prevalences can be highly localised and this has been shown to be 
true in other studies (409). The method of blood collection and analysis between this study 
and that of Balyeidhusa was also different with the latter using venepuncture and 250µL of 
blood. It is therefore not possible to say that the difference in prevalence of T. brucei s.l. 
between this study and the study of 2012 is due to a decrease in overall prevalence of the 
disease. The lack of Tbr-FIND positives from Moyo district is harder to explain as the vector 
is the same as that found in Arua, G. f. fuscipes (328, 410) and it is an active foci of sleeping 
sickness transmission (406). One possible reason for the difference would be different 
animal husbandry techniques, although anecdotal, the pigs in Arua district were allowed to 
wander freely whereas the majority of pigs in Moyo district were kept in pig pens. The 
different methods of keeping pigs could reflect the fact that Moyo had recently suffered an 
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outbreak of swine fever and by penning their pigs they could limit the interaction the 
animals would have with each other. Another difference between the two sites was the 
proportion of local breeds with exotic breeds. Arua’s local to exotic breed ratio was 3:1 and 
Moyo’s was 1:7. 
 
5.4.2.1 Reservoir animals 
Previous studies from other parts of Africa had shown that a wide range of domestic 
animals were positive for T. b. gambiense (63-65, 395, 411). The importance of identifying 
the role these animals play in maintain transmission is critical if the goal of elimination by 
2020 is to be achieved (394).  To investigate this in the West Nile focus of Uganda, cattle and 
pig samples positive for T. brucei s.l. using the Tbr-FIND primers were screened with T.brucei 
s.l. sub-species specific primers and single-copy gene Trypanozoon primers. The single-copy 
gene primers were used to determine how many samples had sufficient DNA to detect 
down to a single-copy gene. This would allow the number of true T. b. gambiense and T. b. 
rhodesiense negatives to be identified, as opposed to those negative due to insufficient DNA 
for the PCR reaction to work (271). Of the cattle and pig Tbr-FIND positive samples, 63% and 
60% had sufficient DNA to detect a single copy gene respectively. Of the samples with 
sufficient DNA, none was positive for T. b. gambiense. This supports the current evidence 
that pigs and cattle are not acting as reservoir hosts in NW Uganda (393). Different sampling 
methods could produce higher or lower prevalence estimates depending on how suitable 
they are for detecting trypanosomes. Typically, blood samples have been used for collecting 
samples for trypanosome identification, however recent evidence suggests that 
trypanosomes may be found in other tissues such as skin (412, 413) or fat (414). It may be 
that future surveillance programmes will need to screen different tissues to determine the 
most reliable sample to take. 
 
 
 
 
139 
 
5.4.3  Conclusion 
It was not possible to detect any significant changes in the incidence of trypanosomiasis due 
to the deployment of Tiny Targets. This is most likely due not to the Tiny Targets  being 
ineffective as it has been shown that the tsetse population decreased by >90% (236) but due 
to the subject animals leaving the protection of the intervention zone. The presence of T. 
theileri in a high proportion of animals and the use of generic ITS primers contributed to the 
inconclusive results. This is due to the fact that the re-infection rates of T. theileri were not 
affected by the intervention as it is not transmitted by tsetse and the presence of the 
parasite contributed to false positives when screening for salivarian trypanosomes 
transmitted by tsetse. 
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 : Discussion 
 
6.1 Background 
There are currently no vaccines or prophylactic drugs to control African sleeping sickness 
and this limits interventions to treat the human population. In their absence, vector control 
will be an important component of the global effort to achieve the targets of the London 
declaration, which seeks elimination by 2020 (415). Specifically, elimination of Gambian HAT 
has been defined as <1 new case of gHAT per 10,000 people in at least 90% of the disease 
foci, with a global incidence of <2000 new cases (416).  
 
As the prevalence of disease decreases, cost-effective methods will be needed to identify 
areas of transmission to inform control efforts. Current strategies to control gHAT rely 
largely on active and passive screening and treatment of human population with relatively 
little vector control (417). By studying the tsetse population new control and monitoring 
methods could be introduced to supplement the current eradication efforts. Human 
screening and treatment clears the disease from local communities however without 
control of the vector the risk of re-infection remains the same, requiring constant 
surveillance and treatment. By targeting the vector population alongside treating human 
cases the disease is more effectively controlled. The vector population can also be used as 
an alternative to the human population, to identify areas of transmission (60).  
 
It is within this context that this study has taken place in order to better understand a gHAT 
foci in its last stages prior to elimination. The NW of Uganda is a historical gHAT focus 
currently undergoing active control campaigns utilising both the traditional test and treat 
strategy as well as vector control (236). As such the prevalence of disease in this area has 
been steadily decreasing, with only four cases of gHAT being reported in 2015 (418).  
 
6.1.2 Screening tsetse  
Traditional microscopy based methods for trypanosome identification in tsetse limit the 
practicality of xenomonitoring. These methods are unable to identify the trypanosome to 
the species level accurately, this is especially true for immature infections where 
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trypanosomes are present in the midgut but it is impossible to identify the species. Equally if 
xenomonitoring methods are to be used they must be as simple as possible in order for 
them to be suitable for the field. This desired field-friendly quality rules out PCR, as it 
requires a fully equipped molecular laboratory (419). However, the recent developments in 
LAMP technology provide a possible alternative means of screening tsetse, as it has a better 
sensitivity and specificity than PCR as well as a simpler operating procedure. 
 
6.1.3 Tsetse control 
A tsetse control operation that results in a daily mortality rate of 4% is enough to drive the 
tsetse population to extinction (420) but it has been calculated that it only takes a drop of 
72% in tsetse numbers to break gHAT transmission (236). Vector control has been 
successfully used to control Rhodesian HAT, where an effective vector control technology 
targets the Morsitan group (421). This same technology has performed poorly when used 
against the Palpalis group of tsetse. From 2007 to 2008 analyses of the responses of riverine 
species of tsetse to targets of various colour, shape and size, demonstrated that reducing 
the size of the traditional tsetse target increased its cost-effectiveness. This discovery 
resulted in the development of the Tiny Target, a novel control technology that successfully 
targets the Palpalis group of tsetse (231). The deployment of Tiny Targets in NW Uganda 
demonstrated the impact this technology has on the tsetse population, however the effect 
of this intervention on the transmission of T. brucei s.l., and to a lesser extent on other 
salivarian trypanosomes, has not been investigated. 
 
6.1.4 Animals as reservoirs 
One potential problem that could hamper the elimination attempts of sleeping sickness is 
the role animals may play as disease reservoirs. Animals are an important reservoir host for 
T. b. rhodesiense, the pathogen which causes Rhodesian HAT, however the role of animals in 
the transmission of Gambian HAT is not fully understood (61, 63, 64, 422). The two domestic 
animals of interest in this study are cattle and pigs, both of which have been found infected 
with T. b. gambiense in other studies (391). 
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6.2 Chapter summaries and findings 
6.2.1 Chapter 3:  Prevalence of T. brucei s.l. and other Trypanosoma spp. in G. f. fuscipes 
The vectorial competence of tsetse is dependent on a number of factors. These include: (i) 
host feeding preference, (ii) age structure of the populations and (iii) population size (423). 
Traditional dissection methods were used to estimate the age structure of the female 
population (424-426) as well as providing an initial assessment of the prevalence of 
trypanosome infection within the vector population. The species-specific ITS multiplex 
primers were employed to identify the prevalence T. brucei s.l., T. congolense and T. vivax in 
the vector population of Koboko. To assess patterns of blood feeding a subsample of tsetse 
midguts were screened with cytochrome B sequencing primers in order to identify 
vertebrate blood meals (199). Local weather data estimates were also used to try and 
identify their effects on the tsetse population. 
 
6.2.1.1 Results of tsetse study 
Tsetse were caught across a period of 16 months from April 2013 to July 2014. A correlation 
between rain fall estimates and tsetse catch numbers was observed when factoring in a lag 
time of two to three months between the rain fall data and tsetse catch numbers. The 
ovarian data revealed that the average age of tsetse across the sampling period fluctuated 
from a mean ovarian age category of 4.3 at the start of the wet season to 2.8 by the middle 
of the dry season.  
 
6.2.1.2 Microscopy 
Out of the 6664 flies caught from April 2013 to July 2014 along the Kochi river, 6,348 
(95.3%) midguts, 6,399 (96%) salivary glands and 6,403 (96.1%) mouthparts were screened 
with traditional microscopy methods. In total, 6,335 tsetse had all three tissue types 
screened with microscopy and a further 73 had at least one tissue screened and 158 (2.5%) 
were positive.  
 
6.2.1.3 PCR 
A subsample of 2,184 tsetse were selected from the sampling period of September 2013 to 
February 2014. This date range was selected to include three months of wet season 
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(September-November) and three months of the dry season (December-February). A total 
of 194 (8.9%) of the flies were positive for either T. brucei s.l., T. congolense or T. vivax when 
the three tissue types (midgut, salivary glands and mouth parts) were pooled together. 
When individual tissues were re-screened it was possible to identify positive tissues in 126 
(65%) of the 194 pooled positives. Of the 2,184 tsetse screened, 1.8% were T. brucei s.l. 
positive, 2.6% T. congolense positive and 2.2% T. vivax positive. The 126 positive tsetse 
resulted in 201 positive tissue samples of single or mixed infection. 
 
6.2.1.4 Midgut 
4.9% of 2, 183 midgut samples were infected with trypanosomes of which T. congolense was 
present in 2.2% samples, T. vivax in 1.6% and T. brucei s.l. was present in 1.2% of samples. 
The likely explanation of the relatively high number of T. vivax positive midgut samples is 
that this is due to trypanosomes from the mouthparts being flushed into the midgut with 
the bloodmeal as 67.6% of the T. vivax positive midgut samples had corresponding T. vivax 
positive mouthparts. Equally T. vivax trypanosomes could have been present in an ingested 
bloodmeal (268, 427). 
 
6.2.1.5 Salivary glands 
Salivary gland tissues were 1.5% positive comprising of 0.7% T. congolense, 0.6% T. brucei 
s.l. and 0.2% T. vivax positives. The most likely explanation for most of the salivary glands 
testing positive for T. congolense could be due to contamination, likely during the dissection 
of the tsetse fly. Evidence to support this is that of the 81% of T. congolense positive salivary 
glands occurred when T. congolense was also found in the midgut, mouthparts or both. This 
pattern of an increased likelihood of finding positive salivary glands when multiple tissues 
are positive does not hold with the T. brucei s.l. results. Of the 13 salivary glands found 
positive for T. brucei s.l. 62% came from tsetse where the salivary gland was the only 
positive tissue. 
 
6.2.1.6 Mouthparts 
Mouthparts had the second highest number of positives, after midguts, with 2.8% positive 
rate. The number of the mouthpart positives in this study per species were as follows: 1.6% 
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T. vivax, 0.9% T. congolense and 0.4% T. brucei s.l.. This distribution reflects what you may 
expect when using the Lloyd and Johnson method to determine the species. 
 
6.2.1.7 Blood meals 
Of the 768 midguts screened, with vertebrate cytochrome B primers (199), 17.1% produced 
a vertebrate host sequence, 8.2% from the wet season and 8.9% from the dry season. Cattle 
contributed 39% samples to the overall total. Human blood meals were second with 48 
(37%) positives. The third and fourth most common blood meals identified came from the 
Nile monitor lizard and forest cobra with a total of 19 (15%) and 5 (4%) respectively. These 
four host types made up 94% of the blood meals the remaining 6% of blood meals identified 
were pigs, goats, sheep and a bird. There was no significant variation in proportions 
between the two seasons with regards to feeding rates on different hosts. This lack of 
significant variation in blood feeding has been found in previous studies (428).  
 
6.2.2 Chapter 4: LAMP as a field based xenomonitoring tool  
There are currently no highly sensitive and specific techniques for identifying trypanosomes 
in tsetse that are suitable for xenomonitoring in the field. The advent of isothermal 
molecular assays have the potential to provide an alternative to dissection and PCR through 
technologies such as LAMP (150, 154, 155, 429, 430). A diagnostic kit designed to detect 
Trypanozoon infections in human patients was tested for its suitability in detecting T. brucei 
s.l. from tsetse tissues. 
 
6.2.2.1 Simplification of DNA extraction 
A simple boil and spin DNA extraction method using 5% chelex was developed and tested 
with T. brucei s.l. positive and negative tsetse samples pooled together. The ratio of positive 
to negative tsetse midguts tested was 1:5, 1:10 and 1:20. Apart from two instances of kit 
failures the LAMP kits were able to identify the positive midgut, even in a 1:20 ratio.  
 
6.2.2.2 LAMP kit limit of detection 
To test the limit of detection of the LAMP kits a 1 in 10 dilution gradient of lab cultured T. b. 
brucei (J10) was added to tsetse midguts. The dilution ranged from 1x105 to 0.01 
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trypanosomes per mL and the experiment comprised of six replicates for each of the eight 
dilutions. The results showed that the LAMP kits had a higher degree of sensitivity, with a 
third of the replicates being able to detect 0.1 trypanosomes per mL whereas the Tbr-FIND 
primers were unable to detect anything with a concentration of <10 trypanosomes/mL. 
 
6.2.2.3 Persistence of trypanosome DNA 
As the focus of the proposed Xenomonitoring method relied on the detection of DNA, it was 
important to ascertain how long after ingestion by the tsetse the target DNA could be 
detected. The experimental set up involved heat killing 200µL of trypanosome stabilate at 
54ᵒC for 15 minutes prior to adding them to 4.8mL of defibrinated horse blood. The final 
concentration of trypanosomes in the horse blood was 4x104 per mL (200uL at 1x106 added 
to 4.8mL). The average volume of blood consumed by tsetse from the colony at the LSTM is 
30µL, meaning that the average number of dead trypanosomes consumed by a single tsetse 
would be 240 (5,000µL divided by 30µL= 166.7, trypanosomes concentration of 4x104 
divided by 166.7 = 240.). After 48hrs it was still possible to detect T. brucei s.l. in all 
experimental flies, by 72hrs seven out of nine were positive. The number of positive tsetse 
decreased and after 144hrs post blood meal only one out of nine midguts tested positive for 
T. brucei s.l.. The DNA persisted in the tsetse midgut for a considerable amount of time 
despite the tsetse being fed a fresh blood meal every 48hrs.  
6.2.2.4 Specificity of the LAMP kit 
To test the specificity of the LAMP kits, tsetse from the colony at LSTM were prepared with 
single and mixed infections of T. b. brucei  (J10) and T. congolense (1/148). The infection 
status was checked with microscopy, Tbr-FIND primers and generic ITS primers. The LAMP 
kits showed no cross reaction with the single T. congolense infections and were still able to 
identify the T. brucei s.l. positive tsetse in the mixed infections. The cross reactivity of the 
kits was tested further with 449 wild caught tsetse that had been screened with the generic 
ITS primers which had identified a broader range of trypanosome species than just T. 
congolense and T. brucei s.l.. Once more the LAMP kits did not cross react with the non-
target species and identified both the ITS T. brucei s.l. positives plus four more. 
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6.2.3 Chapter 5: Impact of tiny target intervention on trypanosome transmission 
The implementation of a new tsetse control technology across 500km2 of NW Uganda has 
successfully reduced the tsetse numbers by >90% (236). Local cattle from both the 
intervention site and an ecologically similar control site were sampled from August 2011 to 
November 2013. The sampled cattle were treated with the trypanocide, Veriben, to clear 
them of infection in order to assess how many became re-infected between sampling 
rounds. The blood samples were initially screened in the field with microscopy using wet 
preparations and then subsequently screened using species specific Tbr primers, generic ITS 
primers and 18S sequencing primers at the LSTM. 
 
6.2.3.1 Microscopy results 
The microscopy work was carried out in the field using wet preps taken from the buffy coat 
layer of blood sample that had undergone centrifugation for PCV readings. A total of 3,173 
samples were screened using this method of which 21% were positive. The percentage of 
animals positive for the intervention and non-intervention sites was 17% and 26% 
respectively. There was no significant difference in the prevalence of Trypanosoma spp. in 
cattle from areas with or without Tiny Targets. 
 
6.2.3.2 T. brucei s.l.  positive results 
The results for T. brucei s.l. differed between the Tbr-FIND primers and generic ITS primers, 
with 38 detected by Tbr-FIND and 141 with ITS. The distribution of the Tbr-FIND positive 
cattle was not even between the intervention and control sites, with 30 positives being 
detected in the intervention site and eight in the control site. The distribution of ITS T. 
brucei s.l. was 79 in the intervention site and 62 in the control site. 
 
6.2.3.3 T. brucei s.l., T. congolense and T. vivax ITS positives 
The prevalence of the three salivarian species of interest for all cattle screened was 10% of 
which 94% were single infections. T. brucei s.l. positives were the most prevalent making up 
45% of single infections followed by T. vivax at 35% and T. congolense at 19%. Only 6% of 
the positive samples were double infections, the most common being mixed T. brucei s.l. 
and T. congolense (76%) followed by T. congolense and T. vivax (13%) and lastly T. brucei s.l. 
and T. vivax (6%). Only one animal was found to be infected with all three salivarian 
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trypanosomes. When comparing the result from the intervention and non-intervention sites 
there was no significant difference in the prevalence of the different salivarian species in all 
cattle sampled. When analysing only those animals present in consecutive rounds only T. 
vivax showed a significant difference between the two sites. 
 
6.2.3.4 T. vivax and T. congolense species specific primers 
Samples positive for both T. vivax and T. congolense were re-screened with species specific 
primers in order to confirm the results however only 27 out of a total of 103 ITS T. vivax 
samples were confirmed with species specific primers and no T. congolense positive ITS 
samples were positive with any of the three species specific T. congolense primer sets. 
 
6.2.4. T. theileri 
The ITS PCR results revealed a high proportion of T. theileri infections in the cattle, out of 
2877 cattle screened 1,106 (38.4%) were positive. The numbers of T. theileri fluctuated but 
remained relatively stable and was significantly different (P<0.05) between areas with and 
without Tiny Targets.  T. theileri is not transmitted by tsetse and so the difference was 
unexpected and unexplained. 
6.2.5 Chapter 6: Looking for T. b. gambiense in Glossina and domestic animals  
The purpose of this chapter was to try and identify the presence of T. b. gambiense from the 
vector population as well as local domestic animals sampled from HAT foci in NW Uganda. 
The T. brucei s.l. positive tsetse samples from chapter 3 and cattle samples from chapter 5 
were included. Pigs were chosen as a secondary domestic animal to screen for T. b. 
gambiense as they had been recorded with a high incidence of T. brucei s.l. from a previous 
study (393). To this end 766 pigs were sampled across two HAT foci from Arua and Moyo 
districts from areas that had previously reported sleeping sickness cases. These pig samples 
were processed in a similar manner to the cattle samples but were screened only using the 
T. brucei s.l. specific Tbr-FIND primers. 
 
6.2.6 prevalence of T. b. gambiense and the role of animal reservoirs 
The role of domestic animal reservoirs in the transmission of T. b. gambiense has not been 
definitively answered. To further investigate this question the Tbr-FIND positive cattle and 
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pigs were re-screened using primers specific for both T. b. gambiense and T. b. rhodesiense 
as well as a universal single copy Trypanozoon target. To collect the pig samples the sleeping 
sickness foci of Arua and Moyo were targeted for blood samples taken from ear vein-
punctures. A total of 766 pigs were sampled from both sites, 400 from Arua and 366 from 
Moyo, The T. brucei s.l. positive tsetse samples were also screened for T. b. gambisense. 
 
6.2.6.1 T. brucei s.l. positives in tsetse, cattle and pigs 
Within the NW sleeping sickness foci of Arua and Koboko, 1.8% of tsetse tested were 
positive for T. brucei s.l. using the multiplex ITS primers and of the cattle samples screened 
with PCR 5% were positive for T. brucei s.l. by ITS and 1.5% by Tbr-FIND PCR. The results 
from the Tbr-FIND assays were considered to be more reliable than those from the generic 
ITS PCR and only these were screened with the HAT specific primers. The pig survey resulted 
in 3% positive rate in pigs for T. brucei s.l., all 25 positive pigs came from Arua whereas no 
pigs from Moyo were found to be infected. 
 
6.2.6.2 T. brucei multiplex and sub-species specific PCR 
Following on from the Trypanozoon multiplex PCR 24 (63%) of cattle, 15 (60%) of pigs and 
25 (56%) of tsetse samples had enough genetic material for the species specific primers. 
These samples were then re-screened with the T. b. gambiense specific TgsGP primers and 
T. b. rhodesiense SRA primers. Both the cattle and pig samples were negative for both the 
Gambiense and Rhodesiense sub-species of T. brucei. The tsetse samples were negative for 
T. b. rhodesiense but 16 samples produced a faint product which appeared to be close to the 
308bp size expected of the TgsGP primers. Three of these samples were sent for sequencing 
alongside the positive control. The results from the positive control resulted in a 100% query 
cover and identity match with T. b. gambiense however the three samples returned a 
different sequence. The sequence returned from all three samples was the same and failed 
to match any on the NCBI database.  
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6.3 Research questions revisited 
This thesis has examined four research questions that relate to the transmission and control 
of T. brucei s.l. in the historical HAT foci of the West Nile region of Uganda within the 
context of the elimination goals of the London declaration. 
 
6.3.1 What is the prevalence of T. brucei gambiense in the tsetse population? 
The NW of Uganda is known to be a historic focus of gHAT (56), however the factors that 
contribute towards maintaining these foci are not well understood (431). Despite being 
understood as the sole vector of T. b. gambiense, the pathogen causing gHAT (161), the 
prevalence of the disease amongst wild tsetse population is often extremely low (391, 432, 
433) and attempts to infect tsetse with T. b. gambiense under laboratory conditions have 
often proven unsuccessful (434). Modelling studies have suggested the prevalence of T. b. 
gambiense in the wild may be as low as 1/4000 flies (435) and in light of this evidence the 
role of tsetse in gHAT has recently been called into question (436). The need to establish the 
prevalence of T. b. gambiense is therefore critical in understanding the role of the vector in 
the gHAT foci of NW Uganda and what interventions are required in order to achieve 
elimination by 2020. 
 
The prevalence of T. brucei s.l. in the tsetse population of NW Uganda was investigated in 
Chapter 3 and differed between the microscopy and PCR results. Microscopy results could 
only identify a mature T, brucei s.l. positive whereas the mITS PCR assay was able to identify 
both immature and mature T. brucei s.l. infections. Using microscopy 0.11% of the tsetse 
were identified as having a mature infections by observing trypanosomes in the salivary 
glands (135). This low prevalence is consistent with previous studies (135, 203). The mITS 
PCR reactions identified T. brucei s.l. DNA in 2% of the tsetse screened, of which 0.6% were 
salivary glands, indicating a mature infection. In order to answer the question of T. b. 
gambiense prevalence in the tsetse population of the historic gHAT foci of NW Uganda, the 
samples identified as T. brucei s.l. positive by mITS were then re-screened in Chapter 6 with 
sub-species specific primers. None of the samples tested positive for either of the 
trypanosomes responsible for HAT. A product was produced by the TgsGP primers but this 
was smaller than the expected T. b. gambiense product and when its sequence was 
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analysed it did not match with that of anything recorded on the NCBI online database. The 
lack of any tsetse infected with T. b. gambiense out of a total of 2, 184 tsetse is in keeping 
with previous results from wild tsetse surveys. This apparent lack of T. b. gambiense in NW 
Uganda could well be down to the number of tsetse screened, as the number was <4,000 
calculated by the model and the incidence of disease is decreasing in the area with only four 
cases reported in 2015 (418). The low sensitivity of the methods used greatly reduce the 
chance of identifying the few tsetse positive for T. b. gambiense. 
 
The alternative explanation for the lack of T. b. gambiense positive tsetse samples is that, in 
the areas sampled, there is currently no active transmission of the disease. Due to the 
chronic nature of the disease the four individuals positive in 2015 for gHAT could well have 
been infected years before the tsetse sampling conducted in this study. 
There are only two possible explanations for the non-target product amplified by the  
TgsGP primers. Either it is a true result and an unknown strain or sub-species of 
trypanosome was identified as a member of the Trypanozoon sub-species group by the mITS 
primers and shared enough similarities with T. b. gambiense to produce a PCR product when  
screened with the gHAT specific primers, or it is a false result due to non-specific binding  
to DNA resulting in the amplification of a random product. Attempts to sequence the  
sample were hampered by the presence of B. saltans present in the sample. Due to time  
constraints it was not possible to investigate the non-target product further. 
 
6.3.1.1 Constraints of the study 
The number of tsetse screened with the mITS primers may not have been large enough as 
the modelling studies suggest the prevalence of T. b. gambiense in tsetse could be 1 in 4,000 
(435). There is also the issue of sensitivity with the sub-species specific primers being unable 
to identify low prevalences of target species. An option of increasing the yield of 
trypanosome DNA would be to have cultured any microscopy positive tsetse to increase the 
final DNA yield collected from the sample (437). The ability to sequence the samples was 
compromised due to the contamination of samples by Neobodo designis which was 
introduced when contaminated water was used in the preparation of PBS for dissection. The 
generic nature of the 18S sequencing primers would often result in the amplification of N. 
designis over any salivarian trypanosome present DNA. The ITS multiplex primers were 
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designed to help focus the study to the most common species of salivarian trypanosomes 
that were likely to be found and reduce the confusion that the generic ITS primers caused, 
however due to this increased specificity other salivarian species of trypanosome such as T. 
simiae and T. grayi would not be observed. The inclusion of more trypanosome species 
could help uncover co-infection patterns which could be used to further understand the 
transmission of the disease. Issues of comparative sensitivity between the two tests were 
alleviated with the use of the same outer primer in both nests thereby requiring the inner 
primers be designed from the same internal sequences which will have comparative copy 
numbers across both primer sets for each species. 
Despite the improved specificity of the multiplex ITS reaction both PCR methods still rely on 
the use of gel imaging to process the results. Gel imaging itself can present problems from 
warped gel combs, uneven gel runs, sub-optimal UV light boxes and issues with determining 
accurate band sizes. A nested PCR reaction improves the sensitivity of the assay but also 
increases the risk of contamination as the reaction tubes from the outer nest are opened 
post amplification of DNA in order to seed the inner nest. 
 
6.3.1.2 Future Research 
What is the identity of the DNA that resulted in the non-target TgsGP ?  
An unknown DNA template has successfully cross-reacted with a highly specific primer set 
designed to identify T. b. gambiense the parasite responsible for gHAT. Identifying the 
source of the DNA template would determine if the results observed are true results, in 
which case an unknown trypanosome cross-reacted with the TgsGP primers, or false results. 
 
By further analysing the human blood meal samples is there a difference between the sexes 
with regard to feeding frequency? 
The roles of men and women typically differ in the rural communities of NW Uganda. These 
differences in behaviour may result in different exposure risks to tsetse bites and 
subsequently gHAT. Using sex-specific primers (438, 439) it would be possible to identify 
what proportion of the human blood meals identified in Chapter 3 are male or female and 
whether or not there is a risk factor associated with gender. 
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6.3.2 Can commercial LAMP kits be used for xenomonitoring? 
One of the study limitations conducted in Chapter 3 is that the number of tsetse screened 
for T. b. gambiense may be too small. If a larger number of tsetse need to be sampled then a 
different approach to sampling may need to be employed. Microscopy is more pragmatic for 
use in the field however lack sensitivity, LAMP provides an alternative to either microscopy 
or PCR. Such an approach may also be more suited to the detection of gHAT transmission 
sites where control measures have successfully driven down the prevalence of disease (53). 
 
The assessment of the LAMP kits showed that they would work on DNA samples that had 
undergone a simplified extraction process and that the LAMP tests were extremely 
sensitive, being able to detect the equivalent of 0.1 trypanosome per mL. The ability of the 
LAMP kits to detect Trypanozoon DNA in the midgut of the tsetse showed that after 48hrs 
the trypanosome DNA was still detectable in 100% of the samples and even after six days it 
was still possible to detect the Trypanozoon DNA in 1/9 samples. 
Whereas the microscopy is limited to only being able to detect identify T. brucei s.l. if there 
is a mature salivary gland present molecular methods are capable of detecting DNA, even 
from transient infections. Therefore, xenomonitoring of tsetse using LAMP is not going to 
just identify those tsetse with an active mature infection, but rather any tsetse that has 
detectable DNA from either a bloodmeal or transient infection. This will, in theory, increase 
the chances of detecting T. b. gambiense DNA in the tsetse population. 
The LAMP kits have also been shown to work well with pooling samples together. In the 
current study the maximum number of samples pooled was 20. If the model data is correct, 
and ignoring the fact that xenomonitoring does not need to identify an active infection, the 
likelihood of detecting a T. b. gambiense positive tsetse is 1/4000 (435). By pooling the 
samples in groups of 20 this would reduce the number of reaction down to 200. It may be 
possible to reduce this down further as this study did not identify the limits of pooling tsetse 
samples. As the prevalence of gHAT continues to decrease the surveying approach currently 
employed will no longer be suitable as the number of cases will be so low no sampling of the 
human population will have enough statistical power to inform the decision making process 
(53). The application of xenomonitoring may provide a valid alternative in checking areas for 
the presence of gHAT towards the late stages of the elimination campaign. 
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6.3.2.1 Constraints of study 
Although proven to work under laboratory conditions this work has yet to be carried out in 
the field. There is also the disadvantage that the LAMP kits are only able to identify 
Trypanozoon positive tsetse and a further sub-species specific test would need to be run to 
confirm the presence of T. b. gambiense. Currently the only assay capable of doing this 
relies on the single copy TgsGP primer. Therefore, the limitations for detecting other T. b. 
gambiense positives still apply. There is also the issue of assessing the limits of pooling 
samples, currently the largest pool used is 20 however it may be possible to use larger 
pools, so as to reduce the number of test required to identify any positive T. b. gambiense 
tsetse. 
 
6.3.2.2 Future research questions 
What are the pooling limits of the LAMP kits? 
With the potential prevalence of T. b. gambiense in the tsetse population potentially being 
as low as 1 in 4,000 a larger pool of samples would help in screening a large enough sample 
size faster and with fewer resources. It would therefore be advantageous to identify what is 
the maximum pooling size to use with the LAMP assay. 
 
How practical are the methods developed in Chapter 4 for use in the field?  
Chapter 4 has shown that the LAMP assay works well in detecting T. brucei s.l. infected 
tsetse, however this was conducted in a well-equipped laboratory using colony reared 
tsetse. In order to properly assess the suitability of this method it would need to be 
conducted in the field. 
 
What are the health economics of xenomonitoring gHAT foci with LAMP kits compared to 
standard screening campaigns of the human population? 
The currently there is no analysis of the cost benefit of using the LAMP xenomonitoring 
strategy studied in Chapter 4. In order for this method to be a viable alternative to screening 
the human population it would need to be able to identify T. b. gambiense in the 
environment at a lower cost than the current methods used.  
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6.3.3 Do ‘Tiny Targets’ affect the prevalence trypanosomes in the local cattle? 
The deployment of Tiny Targets in NW Uganda has been shown to reduce the tsetse 
population by >90% and it has been calculated that a drop of 72% in the tsetse population is 
sufficient to break transmission (236). Therefore, based on the drop in tsetse catch numbers 
from the NW Uganda following the tiny target intervention one would expect to see a 
decrease in the prevalence of cattle infected with salivarian trypanosomes. However, this 
expected drop in infected cattle from the intervention site of Arua was not observed in 
either the microscopy results or in the PCR results, with the exception of cases for T. vivax. 
The design of the study required the intervention and non-intervention sites to be revisited 
across the study period (August 2011-December 2013) and for the cattle sampled and 
treated in the previous round to be re-sampled and treated. This ensures that at each 
sampling round animals are cleared of infection allowing for reinfection rates to be 
observed. The number of cattle lost between rounds was ~30% with both sites losing similar 
numbers of cattle. Therefore, the most accurate results for reinfection rates are from the 
animals present in two consecutive sampling rounds rather than comparisons between all 
animals in each sampling round.  The analysis of microscopy results from animals present in 
consecutive rounds did not show a significant difference, between the intervention and 
non-intervention sites.  Morever, analyses based on the generic ITS PCR results found no 
significant difference in the total salivarian prevalence between the two sites during the 
sampling period. The samples were also processed with the highly sensitive and specific Tbr-
FIND primers to identify the prevalence of T. brucei s.l. as an alternative to the generic ITS 
primers. These results showed a significant difference between the two study sites with the 
majority of the T. brucei s.l. positives coming from the intervention site and only appearing 
in the non-intervention site in round four. Despite having a lower limit of detection the Tbr-
FIND primers detected more than three times fewer T. brucei s.l. positives. The reason for 
this is discussed more extensively in Chapter 5 but essential it is most likely due to mis-
identification due to similar sized T. theileri PCR products. 
 
T. theileri, as identified by the generic ITS primers and the 18S sequencing primers, was 
present in 41% of the 2,877 cattle screened with PCR and most likely contributed towards 
the majority of the microscopy positives as the parasite is very large and is easier to see 
than the much smaller salivarian species. The analysis of the ITS PCR results showed a 
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significant difference in the number of T. theileri cases between the intervention and non-
intervention sites with the latter having a higher incidence of positives. T. theileri parasites 
were also present as a co-infection in 60% of the salivarian positive cattle.  
 
6.3.3.1 Constraints of study 
The Tiny Targets have been proven to drastically reduce the number of tsetse and maintain 
this reduction so long as the targets are regularly maintained. Barring the results for T. vivax 
there was no significant difference between the two study sites with regards to re-infection 
numbers. This is likely to be caused by the cattle leaving the protection of the intervention 
sites as they are taken out to graze and water. We had no methodology setup whereby we 
could track the movements of the cattle and either prove or disprove this theory by showing 
them leaving the protection of the intervention sites.  
 
The alternative would be to have a cohort of animals that belonged to the study and were 
under its control in order to ensure the animals never left the intervention sites. The cost of 
cattle and their general need to graze results in these animals being ill suited for such a role. 
Pigs would be a better candidate for a more stationary cohort of animals as they are 
cheaper than cattle and they possessed a higher T. brucei s.l. positive infection rate 
compared to cattle. The major disadvantage of using pigs is that they are not found in the 
control site in large enough numbers due to the majority of people in Koboko being Muslim. 
Another potential downside to using pigs could be their relatively high turn-over rate 
compared to cattle. 
 
 A second limitation relates to the approaches used to identify the trypanosome species in 
the cattle. With regards to the microscopy screening no steps were taken to measure the 
size of the trypanosome which would have allowed for the distinction between T. theileri 
and salivarian infections in cattle as the average size of T. theileri is 47.2µ (133) whereas the 
salivarian species range in size from 9-33µ (440). The generic ITS primers were also not well 
suited for the purpose of screening the cattle as they amplified the T. theileri parasites 
resulting in confusion of species identification based on PCR product size.  
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A better solution would have been to design and screen the samples using qPCR ideally 
TaqMan as it would have been possible to design generic primers but use a multiplex of 
different probes to be able to detect multiple, sequence specific, targets. The number of 
probes would be limited by the number of light channels available in the machine. Currently 
at LSTM there are machines available with five light channels, this would be sufficient to 
target T. brucei s.l., T. congolense, T. vivax and two extra, potentially T. simiae and T. grayi. 
Or alternatively one of the extra light channels could be used as an internal positive control 
to ensure there are no inhibitors in the reaction, a suitable candidate for this would be the 
seal herpesvirus (441, 442). The use of TaqMan would also allow for the quantitation of 
parasite DNA loads which would be an additional element of enquiry, naturally it may be 
hard to make a direct correlation between interventions and Ct values due to the fluctuating 
parasitaemia. 
The method of sample collection could also have been a limiting factor as venous blood was 
collected from the ear in order to screen for trypanosome infection but very recent studies 
have shown that the skin may be an important anatomical reservoir for salivarian 
trypanosomes (413).  
 
6.3.3.2 Future research question 
How suitable are different sampling methods in detecting the prevalence of salivarian 
trypanosome infections? 
Current sampling methods for diagnosing the hemolymphatic stage of trypanosome 
infections rely blood from either a pin-prick or veinous extraction. These can then be 
screened in a number of ways such as microscopy, PCR and serology, to try and identify the 
presence of trypanosomes. The confirmation that skin may be an important reservoir tissue 
for trypanosomes raises the question of how suitable are skin samples, such as skin-snips, in 
the screening of mammalian hosts for trypanosome infections. 
 
Could ticks be a suitable alternative to current blood sampling methods for the detection of 
Salivarian trypanosomes in animals? 
Ticks are common parasite on the cattle in Uganda and feed in a similar manner to tsetse 
flies, by pool feeding (443). This method of feeding involves the laceration of tissues around 
the bite wound including the capillaries in order to generate a pool of blood from which to 
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feed. This disruption of the skin followed by the introduction of anticoagulants and 
subsequent blood feeding may result in an increased chances of trypanosome uptake by a 
tick as compared to the use of a lancet and for pin-prick extraction of blood from the ears of 
cattle. This is a similar concept to the use of tsetse in xenomonitoring, in that the tick does 
not need to go on to develop a mature infection rather the presence of a trypanosome 
within the digestive tract would be sufficient to allow detection with a molecular assay such 
as PCR. 
 
What are the normal movements of cattle, where do they graze and water?  
A key piece of information missing from the study described in Chapter 5 is the movements 
of the cattle in the tsetse infested areas. Knowing the movements of cattle would help 
better understand the results generated in the Chapter. 
 
Based on the blood meal results from Chapter 3, cattle are the primary hosts in the area, 
could they be used as a tsetse control by being treated with insecticide? 
The tsetse blood meal results from Chapter 3 showed that the majority of blood meals 
originated from cattle. This implies a high interaction between the tsetse and local cattle 
populations raising the possibility that insecticide treated cattle could be used as a 
complementary vector control alongside the Tiny Targets. 
 
6.3.4 Is T. b. gambiense present in the cattle and pigs from the gHAT foci in NW Uganda? 
Modelling studies show that the success or failure of meeting the sleeping sickness 
elimination goal of 2020 will depend on a number of parameters. An animal reservoir host 
has been shown to delay and even prevent the elimination of gHAT using the current 
strategies (61, 394, 435). The presence of an animal reservoir also changes the importance 
of the other parameters. Without an animal reservoir the most important factor in 
transmission of the disease is the number of people commuting to an area with a high 
tsetse biting rate, however with an animal reservoir the importance of this changes and the 
ratio of tsetse to humans becomes the most important parameter (435). Therefore, to be 
able to identify an animal reservoir would be important in informing and developing future 
control strategies. The identification of T. b. gambiense in wild and domestic animals (63, 
64, 391) supports the theory of a potential reservoir host as does the presence of the 
158 
 
parasite in the vector population in an area with no human cases (60). This chapter aims to 
try and answer this question for the foci in NW Uganda. A previous study had been 
conducted in this area (393) however it is not clear where the sampling took place and as 
the disease distribution is highly focal it is not clear if the sampling had occurred in the 
correct place. Our study aimed to sample animals from areas that had recently reported 
gHAT cases (406). Based on the results of the blood meal analysis from Chapter 3 in which 
cattle featured as the most common host the Tbr-FIND positive cattle from Chapter 5 were 
screened for T. b. gambiense. Alongside the cattle, pigs were also chosen as a potential 
reservoir host based on evidence in the literature of high T. b. gambiense infection rates (64, 
65, 395) and also on the blood meal analysis from Chapter 3, as pigs were the third most 
common mammalian host despite comprising only ~0.1% of domestic animals in the area. 
 
A total of 766 pigs were sampled for this study from two districts with a high incidence of 
gHAT, Arua and Moyo. The samples were processed in the same manner as the cattle 
samples resulting in 3% of the pigs identified as T. brucei s.l. positive using the Tbr-FIND 
primers. The cattle and pig T. brucei s.l. positives were then screened with the T. brucei-
multiplex primers (271) to determine if there was sufficient Trypanozoon DNA present for 
single copy gene detection and to rule out the presence of T. b. rhodesiense. Following this 
assay the samples were processed using the T. b. gambiense sub-specific primers (272). This 
final assay found no T. b. gambiense positives in either the pig or cattle samples. This 
corresponds with the finds of the previous study and supports the notion that in the HAT 
foci of NW Uganda neither cattle nor pigs are acting as a reservoir host for gHAT. The 
implications for this finding are that the current control methods, case-detection and 
treatment of the human population combined with the new Tiny Target vector control 
technology are sufficient to eliminate gHAT from this foci. 
 
6.3.4.1 Constraints of study 
This study suffers from similar limitations to those mentioned in the first question regarding 
the sensitivity of the TgsGP primers. Of all the T. brucei s.l. positives in both cattle and pigs 
~40% lacked enough DNA material for the detection of single copy genes. Therefore, for 
these samples it is not possible to determine which species of T. brucei s.l. is present.  
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Another weakness of the study is that the numbers used for both pigs and cattle may not 
have been large enough for the purpose of the study resulting in it being underpowered. 
 
6.3.4.2 Future research question 
Could a combination of CATT and KIVI identify reservoir hosts?  
A recent study has used the CATT to screen cattle and pigs (444) for the presence of T. 
brucei s.l. in the field prior to the collection of the samples. Using this method, animals with 
possible active infections of T. brucei gambiense can be identified and a blood sample taken 
for culturing using kits for in vitro isolation of trypanosomes (KIVI). Culturing the parasites  
would amplify their number and increase the DNA yield to allow for easier detection of 
single copy genes. Such an approach should overcome the shortfalls of the previous study 
and so provide a more reliable result. Ideally such a study design would be better trialled in 
an area where previous studies have found animal reservoirs of T. b. gambiense. 
 
6.3.5 Final Conclusion 
The results of the study show that although the detection of T. brucei s.l. in both the vector 
and local animal populations is relatively straightforward the ability to detect down to the 
sub-species level and identify T. b. gambiense is limited by the lack of highly sensitive 
diagnostic assays. This is demonstrated in the ~40% of T. brucei s.l. positive samples that 
lacked enough genetic material for single copy gene detection and in the inability to identify 
any T. b. gambiense. Therefore, there is a need to develop a highly sensitive assay that can 
detect T. b. gambiense from multiple sources including the vector and non-human 
vertebrate host animals. 
 
 The results of the LAMP assay are promising and have the potential of screening large 
numbers of tsetse for the presence of T. brucei s.l. however once more the assay required to 
identify down to the sub-species level lacks sufficient sensitivity. A sub-species specific test 
with an increased sensitivity would greatly benefit the current elimination goals. 
Finally, the assessment of the impact of Tiny Targets on the transmission of salivarian 
trypanosomes was inconclusive due to confounding factors of sub-optimal numbers of 
cattle sampled and the inability to monitor where the cattle moved to in the intervening 
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period between rounds. However, based on the effects on tsetse catch numbers and the 
modelling data the Tiny Targets are a cost effective method of vector control that can 
complement the screening and treatment of the human population in endemic foci. 
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Abstract 
Background 
As the reality of eliminating human African trypanosomiasis (HAT) by 2020 draws closer, the need to 
detect and identify the remaining areas of transmission increases. Here, we have explored the 
feasibility of using commercially available LAMP kits, designed to detect the Trypanozoon group of 
trypanosomes, as a xenomonitoring tool to screen tsetse flies for trypanosomes to be used in future 
epidemiological surveys. 
 
Methods and Findings 
The DNA extraction method was simplified and worked with the LAMP kits to detect a single positive 
fly when pooled with 19 negative flies and the absolute lowest limit of detection that the kits were 
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able to work at was the equivalent of 0.1 trypanosome per ml. The DNA from Trypanosoma brucei 
brucei could be detected six days after the fly had taken a blood meal containing dead trypanosomes 
and when confronted with a range of non-target species, from both laboratory-reared flies and wild-
caught flies, the kits showed no evidence of cross-reacting. 
 
 
Conclusion 
We have shown that it is possible to use a simplified DNA extraction method in conjunction with the 
pooling of tsetse flies to decrease the time it would take to screen large numbers of flies for the 
presence of Trypanozoon trypanosomes. The use of commercially-available LAMP kits provides a 
reliable and highly sensitive tool for xenomonitoring and identifying potential sleeping sickness 
transmission sites. 
 
 
 
Author summary 
Recent control efforts have reduced the global incidence of Gambiense human African 
trypanosomiasis (HAT) to <5,000 cases per year, strengthening the prospect of eliminating the 
disease as a public health problem by 2020. To meet this goal, new methods for identifying 
transmission must be explored to provide a cost-effective way of identifying hotspots and areas of 
re-emergence; commercial loop-mediated isothermal amplification (LAMP) kits that detect the 
trypanosome subgenus, responsible for the two forms of sleeping sickness, have been developed. 
The LAMP kits were tested to assess their sensitivity, specificity and suitability as a method of 
screening the vector of the disease, Glossina, for Trypanozoon infection, in xenomonitoring 
campaigns. A simplified DNA extraction process that worked in conjunction with the LAMP kits on 
pooled samples demonstrated a faster method of processing large numbers of flies compared to 
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other molecular tools. The kits performed well in our experiments and demonstrated the ability of 
detecting low levels of target DNA, equivalent to 0.1 trypanosome per ml. The lack of cross reaction 
with non-target species of trypanosomes makes the kits reliable in so far as they will only react with 
the Trypanozoon group of parasites of which the two human forms of the disease belong, however, 
further species-specific tests would need to be undertaken to identify HAT areas on selected 
samples. 
 
 
Introduction 
Human African trypanosomiasis (HAT), commonly known as sleeping sickness, is a parasitic disease 
caused by two sub-species of trypanosome, Trypanosoma brucei gambiense in West and Central 
Africa, which causes a chronic disease and T.b. rhodesiense in East and southern Africa which causes 
an acute disease. These pathogens are transmitted by several species of tsetse flies (Glossina sp.).  
Through active case detection and treatment, cases of Gambiense sleeping sickness are estimated to 
be ≤5000 as of 2014 (445). The greatest contribution to overall HAT burden is the west African 
(Gambiense) form of the disease  as this accounts for 98% of all sleeping sickness cases in most 
recent estimates(56). This is reflected by the number of people at risk of the disease, with 57 million 
people at risk of Gambiense sleeping sickness compared to 12.3 million at risk of the Rhodesiense 
form (360). The methods of controlling HAT differ according to the underlying nature of the two 
forms, with more emphasis being placed on vector control in the case of Rhodesiense HAT. 
Gambiense HAT is generally considered to be anthroponotic and control is achieved mainly by 
screening and treating human cases; vector control has not played an important role. However with 
the development of more cost-effective methods (234) it seems likely that tsetse control will play an 
important role in efforts against Gambiense HAT.  (446).  
Detection of Gambiense HAT relies largely on active or passive screening of the population at risk. 
Active screening is difficult; screening >70% of a target population is seldom achieved  (353) and 
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there are sensitivity issues as the card agglutination test (CATT) is not 100% accurate and is often 
one of a series of tests including lymph node puncture, fresh blood and thick blood film examination 
(355-357) .  Moreover, as the prevalence of HAT decreases, the cost of detecting each case 
increases, leading to active screening programmes being scaled down or abandoned as other health 
priorities take precedent (361, 447). 
An alternative to screening people is to screen vectors for the presence of the pathogen.  This 
approach, termed xenomonitoring,  has proven useful in the control of other vector transmitted 
diseases such as lymphatic filariasis (362).  Rather than screening people, tsetse flies might be caught 
using simple traps and subsequently analysed for presence of T. brucei s.l.. By monitoring 
trypanosomes in tsetse, xenomonitoring would measure current rates of transmission in a defined 
area.  By contrast, the chronic nature of Gambiense HAT and the mobility of humans mean that 
cases are detected months, if not years, after infection, and in places far removed from sites of 
transmission.   
Hitherto, detection of pathogenic trypanosomes in individual tsetse flies relied largely on dissection 
and microscopic evaluation of individual flies which is technically demanding and time consuming 
(349).  Molecular techniques are more sensitive than classical dissection, but they are also laborious, 
requiring skilled workers and well-equipped laboratories (364).  Xenomonitoring for HAT requires 
novel methods that are easy, rapid, cheap, specific and sensitive.   A method that offers the prospect 
of being fit for this purpose is coupling a rapid and robust method of extracting trypanosome DNA 
from a fly with a simplified molecular test such as loop-mediated isothermal amplification (LAMP).  
The LAMP test for HAT amplifies the repetitive insertion mobile element (RIME) of the Trypanozoon 
group (152) . LAMP is carried out at a constant temperature, thereby removing the need for 
thermocyclers, and results are read visually (150).  
Studies of trypanosome infection in tsetse flies are generally concerned with quantifying the 
prevalence of pathogens in the vector population.  For this purpose, the status of infection in 
individual flies must be quantified; only tsetse with a mature infection where T. brucei s.l. are 
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observed in the salivary glands are infectious.  For xenomonitioring however, the aim is to detect the 
presence or absence of pathogens in a vector population.  This specific aim offers two opportunities 
to improve the cost-effectiveness of screening.  First, pooled groups rather than single individuals 
might be screened for the presence of pathogens. Second, a molecular method may be able to 
detect trypanosomes that have been recently ingested but which will not lead to a mature infection.  
Older tsetse flies are much less susceptible to infection with T. brucei (368). However, flies that are 
refractory to infection will nonetheless ingest trypanosomes from infected hosts and a sensitive 
method may be able to detect these transient trypanosomes in recently-fed flies.  
Previous work has demonstrated the ability of an in-house LAMP assay to detect T. brucei in 
laboratory-infected tsetse and in pooled groups of tsetse (154).  Here, we assessed various simple 
methods for (i) extracting trypanosome DNA from tsetse, and (ii) the potential of using a 
commercially-available LoopampTM Trypanosoma brucei detection kit developed by Eiken Chemical 
Co (Japan). Performance of LAMP was assessed with laboratory flies experimentally infected with 
trypanosomes and wild-caught tsetse flies from an area of northern Uganda where T. brucei s.l. is 
present.  
 
Methods 
Tsetse fly samples were tested using the LoopampTM kit to determine the presence of trypanosome 
DNA, and the limit of detection of LAMP. DNA extraction methods were optimised for field settings 
and tested with the LAMP kits in pooled fly assays. The specificity of the kit was tested against flies 
infected with non-target species of trypanosomes, most likely Trypanosoma congolense sl. and 
Trypanosoma vivax  in both laboratory-infected (Glossina morsitans morsitans) and wild flies 
(Glossina fuscipes fuscipes).  
 
DNA Extraction 
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Tsetse flies were dissected and their midguts stored in 60µl of 100% ethanol (EtOH). At the Liverpool 
School of Tropical Medicine (LSTM) a standard DNA extraction procedure, hereafter referred to as 
the Chelex method, was followed: 70ul of distilled water was added to the midgut sample followed 
by centrifugation at 13,000rpm (15sec) and removal of 100µl of supernatant. Tissue samples were 
washed three times by adding and removing 100µl of distilled water. To the washed tissue a 100µl 
suspension of Chelex and Proteinase K (20mg/ml) was added to give a final concentration of 1% 
Chelex, and incubated at 56˚C for 1 h. The sample was then incubated for 30 minutes at 93˚C, 
centrifuged at 13,000rpm (15sec), the supernatant removed, and stored at -20C. 
 
Simplification of DNA extraction 
The current Chelex DNA extraction method, although robust, is not field-friendly and takes ~2 h to 
complete with a number of steps and components, some of which require a cold chain. To use this 
kit in the field, the current method needs to be optimised to ensure it is rapid, robust and simple. 
Five alternative DNA extraction methods aimed at reducing the time and complexity of the current 
Chelex extraction method for use in field studies were designed (Table 1). 
Table 1. Details of five alternative field-friendly DNA extraction methods. 
Method Spin 
13,000 
rpm 
Wash x3 Spin 
13,000 
rpm 
5 % Chelex 
or 1% TE 
Proteinase 
K 
 
Incubation Total 
Time 
(Min) 
56˚C 93˚C 
Chelex Y Y Y Chelex Y 60 m 30 m  120 
1/2 time chelex Y Y Y Chelex Y 30 m  15 m  50 
1/4 time chelex Y Y Y Chelex Y 15 m  7.5 m  30 
TE wash off alcohol Y Y Y TE 
  
15 m  45 
TE with chelex Y * 
 
Chelex 
  
15 m  15 
TE leave in alcohol Y 
  
TE 
  
15 m  22 
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*The alcohol was not washed off, instead the samples were transferred out of the EtOH and into a 
clean empty tube 
These different DNA extraction methods were tested against two sets of trypanosome 
concentrations at 102 and 104 trypanosomes per ml, with each of these concentrations being tested 
in eight replicates with a combined total of 16 replicates across the two concentrations. 
 
Amplification tests 
LAMP 
The RIME LAMP test was performed using the LoopampTM Trypanosoma brucei Detection Kits 
manufactured by Eiken Chemical Co.,Ltd, Japan, according to the manufacturer’s specifications.  
Briefly, 2.5µl of template DNA was added to 22.5 µl of nuclease-free water. LAMP reagents were 
reconstituted in the lids of the tubes, and after two minutes incubation, the tubes were inverted five 
times. A thermocycler was used to heat the samples for forty minutes at 65˚C and then at 85˚C for 
five minutes to stop the reaction. Results were determined by visualising presence or absence of 
fluorescence in the reaction tubes on a UV gel imager, and each sample was classed as positive or 
negative based on two separate blind screenings by two of the co-authors (LJC, JKL). 
 
PCR 
Alongside the RIME LAMP assays, samples were also amplified using the TBR Trypanozoon primers 
and a nested universal trypanosome ITS primer set(147) (Table 2). 
Table 2. Primers used in this study. 
Primer name Target species Primer sequence 5’-3’ Published/designed by 
TBR Forward T. brucei s.l. TGCGCAGTTAACGCTATTATACA Matovu 
TBR Reverse T. brucei s.l. AAAGAACAGCGTTGCAAACTT Matovu 
Tryp 1 Trypanosomatidae AAGCCAAGTCATCCATCG Adams et al. 2006 
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Tryp 2 Trypanosomatidae TAGAGGAAGCAAAAG Adams et al. 2006 
Tryp 3 Trypanosomatidae TGCAATTATTGGTCGCGC Adams et al. 2006 
Tryp 4 Trypanosomatidae CTTTGCTGCGTTCTT Adams et al. 2006 
 
The PCR reactions consisted of 12.5 µl MyTaq Red Mix (Bioline), 1 µl of forward and reverse primer 
(25mmol), 8.5 µl of nuclease free water and 2 µl of DNA template. For the TBR primers the PCR 
cycles were: an initial denaturation step at 93˚C for 2 mins, followed by 35 cycles at 94˚C for 10 s, 
55˚C for 10 s and 72˚C for 10 s with a final extension step of 30 s at 72˚C, for the nested PCR 1 µl of 
PCR product from the first nest was added to the second to act as the template. 
For both nests of the ITS primers the PCR cycle had an initial denaturation at 95˚C for 5 mins 
followed by 35 cycles of 94˚C for 15 s, 54˚C for 15 s and 72˚C for 10 s with a final extension step at 
72˚C for 5 mins. 
 
Limit of Detection 
Colony-reared G. m. morsitans were dissected three days after their first blood meal, the midguts 
were collected into individual tubes and preserved in 100% EtOH.  A trypanosome dilution series was 
created by first making a stock concentration of 2x105 trypanosomes per ml using a 
haemocytometer (20).  The trypanosomes were then heated at 93˚C for 30 mins to lyse the parasites 
and extract the DNA. Using the eluted DNA, a tenfold dilution series was then created with the 
equivalent number of parasites for each gradient step as follows: 
 2x105/ml (stock), 2x104/ml, 2x103/ml, 2x102/ml, 2x101/ml, 2/ml, 0.2/ml and 0.02/ml. 
To prepare the samples for analysis a modified version of the Chelex method was used. To remove 
residual EtOH from the preserved tsetse tissue, midguts were washed three times as previously 
described.  To each washed midgut, 50µl of a trypanosome DNA concentration was added. Following 
the addition of trypanosome DNA, 50µl of a Chelex suspension (10% Chelex with a 2% proteinase K 
concentration) was added to the midgut tissue for a final volume of 100µl.  The DNA concentration 
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series represents 1x105/ml, 1x104/ml, 1x103/ml, 1x102/ml, 1x101/ml, 1/ml, 0.1/ml, 0.01/ml 
trypanosomes suspended in 5% Chelex suspension/1% proteinase K.  Each DNA dilution was 
processed according to the standard Chelex extraction method. Table 3 summarises the number of 
trypanosomes in the DNA dilution series per ml, per 100µl, and per reaction for both the LAMP 
(2.5µl of template) and PCR (2µl of template) assays. 
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Pooling 
Infected G.m. morsitans flies were generated by adding 200µl of thawed T.b. brucei GFP J10 blood 
stabilates to five ml of defibrinated horse blood (TCS Biosciences Ltd). Teneral flies were fed through 
a silicon membrane placed over the blood which was heated to 37˚C. After seven days the flies were 
dissected and their midguts visually screened for infection using a compound microscope. Positive 
midguts were then stored individually in 100% EtOH and later they were processed using the chosen 
simplified DNA extraction method. Parallel to the infected flies a group of uninfected flies were also 
generated apart from the omission of the 200µl of T. b. brucei blood stabilate to the five ml of horse 
blood. The midguts of negative flies were screened prior to being stored in the EtOH with 
microscopy and also later, after DNA extraction using the Chelex method, with TBR PCR to ensure 
they were truly uninfected. 
Pools of tsetse flies were generated by adding 3µl of DNA template from a single positive fly sample 
to pools of four, nine and nineteen uninfected fly samples, in which each fly contributed 3µl of DNA 
extract to the pool. A total of 9 replicates were performed per pool and each pool was tested with 
LAMP.  
 
Persistence of DNA in tsetse material  
To assess the ability of the LoopampTM kit to detect trypanosomes from a previous blood meal 200µl 
of a 106/ml T. b. brucei blood stabilate was incubated for 15 minutes at 54˚C to kill the trypanosomes 
and hence prevent establishment of an infection in the tsetse. The heat-killed trypanosomes were 
added to 5ml of defibrinated horse blood. The viability of the parasites was determined through 
microscopy and the use of the stain Trypan blue(372). If no living trypanosomes were observed the 
blood was then fed to teneral flies. A similar volume of uninfected blood was heated and fed to a 
control group of flies. Every 24 hours after the initial blood meal, three experimental flies and one 
control fly were dissected and the midgut removed and stored in 95% EtOH. During each dissection 
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the midgut samples were screened visually for living trypanosomes using a compound microscope as 
a secondary measure to ensure no trypanosomes had survived and had started to infect the flies. 
The midgut samples were processed using the Chelex method followed by LAMP and PCR assays as 
described. The experiments were repeated until the LAMP and PCR tests showed two consecutive 
days of negative results in all experimental fly samples. 
 
Mixed infections 
LAMP kits were tested for cross reactivity with single and mixed species infections of both T. 
congolense (1/148) and T.b. brucei (GFP J10). Flies were infected by artificial membrane 
feeding (373). Partially fed flies were removed. On the seventh day post-infection all flies were 
dissected and their midguts screened for trypanosomes by microscopy (448).  
The four groups were processed using the Chelex method and analysed using the Trypanozoon 
specific TBR primers and the universal ITS primers alongside the RIME LAMP kits.  
 
Wild-caught tsetse flies 
From NW Uganda, 449 G.f. fuscipes were caught and screened by microscopy, universal ITS primers 
and the LAMP kits. The flies were caught from April to June 2013 from eight trap sites (Northings 
381161-383674, Eastings 276506-287545) in the district of Koboko.  The flies were dissected in the 
field and their mouthparts, salivary glands and midguts were separately screened for trypanosomes 
by microscopy. All samples were then stored individually in 100% EtOH and shipped at room 
temperature to LSTM where they underwent the Chelex extraction prior to PCR and LAMP analysis. 
 
Results 
Simplification of DNA extraction 
The results for the six different DNA extraction methods, tested with the LAMP kits, are shown in 
Table 4.  The method that produced the highest number of positive results was ‘½ time Chelex 
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‘followed by ‘TE with Chelex’ detecting 13 and 12 positive samples respectively out of a total of 16 
positives. The lowest scoring methods were ‘TE Leave in alcohol’ and ‘TE wash off alcohol’. Taking 
into account the number of steps involved for each method and the total time it takes ‘TE with 
Chelex’ was deemed the most efficient as it took half the time of ‘½ Chelex’ but only identified one 
less positive sample (Table 4). 
 
Table 4. Overview of the results for the different DNA extraction methods. 
DNA Extraction methods 
Positive results 
(trypanosome/ml) Total number 
of positives 
% of positive 
samples identified 10^2 10^4 
Chelex 4 7 11 69 
½ time Chelex 6 7 13 81 
¼ time Chelex 5 6 11 69 
TE Leave in alcohol 2 5 7 44 
TE wash off alcohol 1 8 9 56 
TE with Chelex 8 4 12 75 
 
 
Limit of Detection 
The results (Figure 1) shows that the LAMP kit was able to detect 100% of the spiked samples up 
until 104 trypanosomes per ml, after which there was a decline in the ability to detect the 
trypanosome DNA until 10-1  trypanosomes per ml. The sensitivity of the LAMP kit when compared 
with the TBR PCR was better by a factor of two, as the TBR PCR had a limit of detection of 101 
trypanosomes/ml. Although the template volumes for the LAMP and TBR assays varied slightly by 
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0.5 µl (or 25%) this variation is too small to explain the two fold, (or 100 x) greater difference in the 
sensitivity of the two assays. 
Fig 1. Limit of detection results for LAMP and TBR primers, a total of six flies were used for each 
dilution gradient for both assays. 
Pooling 
Pooling experiments show that LAMP was able to amplify one positive midgut in pools of four, nine 
and 19 uninfected midguts - this was repeated in nine independent tests. There were two kit 
failures, one in ratio 1:5 and the other in 1:20. The failure was caused by the dried reagents failing to 
properly dissolve and integrate into the reaction. 
DNA Persistence 
The number of tsetse that were able to give a positive LAMP results declined from 100% after 48 
hours to just 11% by day 6 (Fig 2). 
Fig 2. Persistence of T. b. brucei DNA in G. m. morsitans 
Mixed infections 
Thirteen out of sixteen surviving flies from a mono T.b. brucei infection were identified as positive by 
both microscopy and TBR PCR (Table 5). When the same samples were tested with LAMP, all 16 flies 
tested positive. Of the 17 surviving flies from the T. congolense single infection, 14 were positive by 
microscopy, 13 tested positive with the ITS primers (which amplifies and differentiates both T. brucei 
and T. congolense) and none were detected by LAMP, which is specific for T. brucei s.l.. Of the mixed 
infection group, 15 flies were positive by microscopy, 18 tested positive using the generic ITS 
primers, 17 tested positive with the brucei-specific TBR primers and 20 tested positive with the 
LAMP kits. Of the 18 flies identified as positive with the ITS PCR, one had a single T. congolense 
infection, 3 had single T. b. brucei infections and 14 had mixed infections. Both the TBR PCR and 
LAMP did not cross-react with the single T. congolense infection (Table 5). The negative control 
group tested negative with microscopy, PCR and LAMP assays. LAMP is shown to be more sensitive 
than either the ITS or TBR primer sets.  
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Table 5. The results of testing cross reactivity with flies containing single and mixed infections of 
T.b. brucei and T. congolense. 
Infection Assay Positive Negative Lost Flies Total 
Single T. brucei infection 
LAMP 16 0 9 25 
TBR 13 3 9 25 
Microscopy 13 3 9 25 
Single T. congolense 
infection 
LAMP 0 17 8 25 
ITS 13 4 8 25 
Microscopy 14 3 8 25 
Mixed infection T. b. brucei 
and T. congolense 
LAMP 20 3 2 25 
TBR 17 6 2 25 
ITS 18 5 2 25 
Microscopy 15 8 2 25 
Negative control 
LAMP 0 16 9 25 
TBR 0 16 9 25 
ITS 0 16 9 25 
Microscopy 0 16 9 25 
 
Wild flies 
Of the 449 wild-caught tsetse, microscopy identified one salivary gland positive T. brucei s.l. sample, 
the universal ITS primers identified two T. brucei sl. samples while LAMP identified six. The ITS assay 
identified 40 flies positive for non-Trypanozoon trypanosomes (T. vivax n:11, T. congolense s.l. n:5, T. 
grayi n: 22, T. simiae n:2) which the LAMP kits did not cross-react with.  
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Discussion 
This study has demonstrated the potential of the Loopamp™ Trypanosoma brucei detection kit as a 
tool for identifying Trypanozoon DNA in tsetse. The LAMP kits showed a high degree of specificity, 
with no cross-reaction when challenged with non-target species of trypanosomes. LAMP was more 
sensitive than standard PCR in both laboratory-infected and wild-caught tsetse flies. Further we 
show that a single trypanosome-infected tsetse could be detected in a pool of 20 flies. Simplified 
DNA extractions were developed and the results show the ability to reduce the time of DNA 
extraction, although moderate equipment and skill is still required. The results suggest that LAMP 
may be a useful tool for epidemiological surveillance of T. brucei s.l. in HAT endemic regions to 
estimate the burden of the disease (in combination with species-specific PCR). This may be more 
cost-effective than active detection of human cases, and would allow control programmes to 
prioritise areas for HAT control. 
The field extraction methods tested here have been assessed by balancing the length of the process, 
reliability at detecting positive samples and the number of steps involved in the method, which is a 
proxy for its complexity. The most successful method at identifying spiked samples was the ‘½ time 
Chelex method’ but once the complexity and time was taken into account ‘TE with Chelex’ was 
decided as the most efficient DNA extraction method. However, all of these extractions still require 
access to centrifuges, multiple reagents and handling steps and must be improved before 
implementation.   
In previous studies, LAMP assays on pooled samples showed a decline in sensitivity by 60% with a 
ratio of 1:15 (154). In the present study, the LAMP kit was capable of detecting one infected tsetse 
amongst 19 uninfected flies 100% of the time when coupled with the TE Chelex extraction method. 
This demonstrates that both the kit and the TE Chelex extraction have good potential for use as tools 
in the xenomonitoring of tsetse. 
The serial dilution experiment confirms that the LAMP kits have an extremely high sensitivity in 
detecting trypanosomes. Previous studies have reported limits of detection ranging from the 
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equivalent of 100 to 0.001 trypanosomes per ml (152, 154, 364) using in-house LAMP assays in 
accordance with results shown here. The advantage of using a commercially available, standardised 
LAMP kit would allow researchers to compare different settings with each other without differences 
in method confounding the results. The ability of the LAMP kits to detect such a low number of 
trypanosomes per ml is advantageous for its use in xenomonitoring as flies actively transmitting the 
disease can have infections ranging from <1 x 101 to 1 x 104 depending on the stage of 
infection(374).  
Another, less obvious, advantage with xenomonitoring is that the tsetse flies are continuously 
feeding on a wide range of local vertebrates(290) and could, in effect, act as an efficient source of 
blood for screening in order to detect Trypanozoon species in the environment. If tsetse are able to 
pick up T. brucei s.l. trypanosomes in blood meals and trypanosome DNA can be amplified, it would 
be possible to detect if HAT is present in a region. The results for T. b. brucei DNA persistence are 
highly encouraging as they demonstrate that it is possible to detect DNA from a blood meal 100% of 
the time after 48 hours post-feeding and in the extreme we have shown it is possible for the DNA to 
remain in a detectable state for up to six days in our colony flies. This is despite the fact that the 
tsetse flies in our experiment were not only digesting the initial infected blood meal, but they 
subsequently took on fresh blood, at later feeds, which helped flush their digestive system of 
previous meals. 
The situation in the field may also be complicated by the presence of other trypanosome co-
infections in the tsetse flies (254). The results from the co-infection experiments demonstrate that 
even with co-infected flies it was still possible to identify those that had a T.b. brucei infection and in 
the one case where the fly cleared the T.b. brucei infection but maintained a T. congolense infection, 
the LAMP kit recorded this as a T.b. brucei negative fly. 
The specificity of the LAMP kits was good when tested against single infections of T. congolense and 
T.b. brucei, with no cross-reaction with the flies infected with T. congolense. 
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In wild-caught flies, the LAMP test was more sensitive than the PCR based method, and was able to 
identify more T. brucei s.l. infections in the 449 flies caught from Uganda.  
The LAMP kit used in the present study is only able to identify the Trypanozoon group, meaning that 
a species-specific PCR would still be necessary to differentiate human infective forms from the other 
trypanosomes in order to guide HAT control programmes effectively. Unfortunately the species-
specific PCRs used to differentiate the Trypanozoon group use single-copy gene targets, making 
them significantly less sensitive than LAMP and other PCRs (e.g., TBR, ITS). In addition, it is currently 
not possible to conduct LAMP in a high-throughput manner, and the cost of kits is still significant, at 
$2.60 per test. A larger study involving cost analysis of PCR vs LAMP should be conducted to verify 
that molecular xenomonitoring is a suitable tool for studying the epidemiology of HAT and is able to 
highlight hotspot areas of transmission.  
 
Conclusion 
This study has demonstrated a robust detection limit of the Loopamp™ Trypanozoon detection kit of 
0.1 trypanosome per ml in dissected tsetse midguts. We demonstrated that the kit has high 
specificity, with no cross-reactivity in flies with multiple infections, including wild caught flies that 
had a greater variation of non-target species and provided a more realistic challenge. The kits could 
also detect T.b. brucei DNA 6 days after consumption of a contaminated blood meal, despite having 
fresh feeds every 48 hrs, which would be flushing their digestive system with clean blood. The 
sensitivity of the kits was high enough to allow for the detection of a single infected fly in a pool of 
20 flies. The next step would be to test the DNA extraction and pooling methods in the field 
alongside a wider cost and feasibility evaluation of LAMP vs PCR and the ability to use 
xenomonitoring of HAT over time in the elimination campaign. 
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